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ABSTRACT 
 
 
 
Genetic Analyses of Bovine CARD15, a Putative Disease 
Resistance Gene.  (May 2004) 
Kristen Hawkins Taylor, B.S., Lamar University 
Chair of Advisory Committee:  Dr. James E. Womack 
 
 
 
Through a binding partner the CARD15 gene activates NF-kB, a molecule with a 
role in the initiation of the inflammatory immune response.  The gene is highly 
conserved in both structure and function in human and mouse and has recently been 
implicated as a disease resistance gene in Crohn’s disease and Blau Syndrome in human.  
The gene’s relationship to disease and its conservation between species suggests that it 
may also have a conserved role in bovine disease resistance.  To elucidate the potential 
role of bovine CARD15 in disease resistance, the gene was characterized in cattle.  
Bovine CARD15 is located 4.2 cR5000 telomeric to ADCY7 on chromosome 18.  It spans 
~30 kb and is comprised of 12 exons, 11 of which are coding.  Bovine CARD15 is 
expressed in many tissues, but is most abundant in peripheral blood leukocytes.  An 
extensive comparative analysis between the bovine, mouse and human CARD15 genes 
revealed high levels of inter-species conservation in sequence, genomic structure and 
protein domains.  Conserved putative regulatory motifs were identified in the three 
species comparison of the 5’UTR, 3’UTR and the intronic sequences flanking exons.  
Additionally, diverse regulatory motifs were identified in each of the species indicating 
an evolutionary divergence in the mechanisms of regulation of gene expression.  To 
assess the extent of genetic diversity within bovine CARD15, 41 individuals from nine 
breeds representing two subspecies were sequenced and screened for polymorphisms.  
Thirty-six single nucleotide polymorphisms (SNPs) were identified including 26 within 
the gene transcript.  Haplotypes were estimated for each individual and parsimonious 
SNP sets were identified with which the multi-locus Bos taurus and Bos indicus 
iv 
haplotypes may be reconstructed.  There was a significantly higher rate of substitutions 
within Bos indicus than in Bos taurus.  A significantly higher rate of nonsynonymous to 
synonymous substitutions was found in Bos taurus indicating that positive Darwinian 
selection is acting on the gene within this subspecies.  Association analyses were 
performed between these SNP loci and haplotypes with Johne’s disease.  No 
overwhelming evidence for a simple causal relationship was detected.  Assays are 
provided to screen populations of cattle for variation in the CARD15 gene. 
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INTRODUCTION 
Infectious diseases can have devastating effects on the livestock sector in terms 
of production and economic loss.  The cost of treatment and veterinary care of infected 
animals can be an onerous financial burden.  There is considerable evidence that 
resistance to infectious disease in animals has a genetic basis and that additive genetic 
variation exists among animals in their response to various infectious challenges (Bishop 
and MacKenzie 2003).  Therefore, breeding for enhanced disease resistance appears to 
be an alternative to the exorbitant cost of treatment and veterinary care and has the 
desirable consequence of enhancing animal welfare and well-being while simultaneously 
enhancing productivity and enterprise profitability.  Natural selection may not have a 
dramatic impact on increasing the resistance of animals to diseases such as “shipping 
fever” or Johne’s disease since the relative fitness of susceptible and resistant animals 
may be similar.  Shipping fever is a transient infection and Johne’s disease may not be 
expressed until late in an animal’s life allowing similar reproductive rates and progeny 
survival among susceptible and resistant animals. 
The efficiency of breeding animals possessing innate disease resistance might be 
greatly enhanced if the genes and mutations responsible for variation in disease 
resistance could be identified.  The identification of these genes and mutations 
underlying resistance and susceptibility will also provide new tools to facilitate research 
into the mechanisms of infection possibly leading to additional pharmacological and 
management approaches for the control of disease transmission.  Once the causal 
mutations have been identified, simple and relatively inexpensive DNA tests can be 
developed to screen populations of animals for presence of the desirable alleles.  
Consequently, considerable research effort has been directed towards identifying disease 
resistance genes in livestock.  Genes that have previously been identified in human and 
mouse to be associated with disease resistance phenotypes and that possess conserved 
sequence homology and conserved function in both species are excellent candidates for 
____________ 
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investigation in cattle. 
Toll-like receptors (TLRs) are a relatively new family of proteins identified in 
mammals that have unequivocally been shown to participate in the recognition of 
microbial components and the activation of innate immunity, leading to the development 
of antigen-specific immune responses (Aderem and Ulevitch 2000, Zhang and Ghosh 
2001).  Members of this family are composed of three domains: a cytoplasmic signal 
transduction toll/interleukin-1 receptor domain (TIR), a short transmembrane sequence 
and extracellular leucine rich repeats (LRR) (Rock et al. 1998).  They recognize, via 
their extracellular LRR, pathogen associated molecular patterns and initiate immune 
responses via their cytoplasmic domain (Janeway 1989).  Each of these membrane-
associated TLRs appears to recognize a specific fraction of microbial components (Akira 
et al. 2001).  Two TLRs, TLR2 and TLR4, have been extensively studied in human and 
mouse and have been shown to play a role in resistance to certain pathogens (O’Brien et 
al. 1980; Takeuchi et al. 1999).  Since these genes are conserved in both structure and 
function between human and mouse, they were recently examined as candidate disease 
resistance genes in cattle (White et al. 2003). 
A second family of proteins that have been implicated in the recognition of 
pathogen components share a nucleotide oligomerization domain and have thus been 
termed the “Nods.”  Unlike the TLRs, these proteins appear to function within the cell 
(Inohara et al. 2001).  Furthermore, these proteins display a striking similarity to a class 
of disease resistance (R) gene protein products found in plants which are known to aid in 
the plant’s defense against multiple pathogens (Dixon et al. 2000).  In particular, the 
product of the caspase recruitment domain 15 gene (CARD15), like the plant R gene 
products, contains an amino-terminal effector domain.  In the case of CARD15, this 
domain is comprised of two caspase recruitment domains (CARDs) and it is the only 
gene identified to date to possess two such domains (Ogura et al. 2001b).  CARD15 and 
the plant R proteins also have centrally located nucleotide binding/oligomerization 
domains (NODs) which mediate both nucleotide binding and oligomerization (Hu et al. 
1998; Yang et al. 1998).  In the case of CARD15, the NOD is believed to comprise a 
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''self-oligomerization'' motif that promotes activation of effector molecules through self-
association and the induced proximity of binding partners (Inohara and Nunez 2001).  
Finally, both CARD15 and plant R proteins have C-terminal domains containing leucine 
rich repeats (Bertin et al. 1999; Inohara et al. 1999; Ogura et al. 2001b).  In plants, 
genetic variation in the LRR determines pathogen specificity (Parniske et al. 1997), 
while variation in the LRR can result in unresponsiveness to particular pathogens 
(Parniske et al. 1997; Ellis et al. 1999; Dixon et al. 2000).  Likewise, the LRR of 
CARD15 are believed to serve as a sensor for intracellular ligands (Ogura et al. 2001a) 
such as pathogenic bacteria. 
The human CARD15 mRNA has two in-frame translation initiation sites 
separated by 81 nucleotides resulting in the encoding of proteins of 1040 and 1013 
amino acids (Ogura et al. 2001b), although the 1013 amino acid protein seems dominant 
(Lesage et al. 2002).  The full-length mouse CARD15 transcript also contains 2 potential 
translation initiation sites and encodes proteins of 1020 and 1013 amino acids (Iwanaga 
et al. 2003).  In both species, CARD15 comprises 12 coding exons and domain analyses 
have revealed that human and mouse CARD15 both contain 2 N-terminal CARD 
domains, one centrally located nucleotide binding domain and 10 tandem LRR in the C-
terminus (Ogura et al. 2001b; Iwanaga et al. 2003; Ogura et al. 2003).  Alignment of 
human and mouse CARD15 reveals that 78% of the amino acids are identical (Iwanaga 
et al. 2003). 
Over-expression of both human and mouse CARD15 in HEK293T cells induces 
NF-kB activation (Ogura et al. 2001b; Iwanaga et al. 2003; Ogura et al. 2003) and the 
CARD15 gene has been shown to confer responsiveness to lipopolysaccharide (LPS) 
and peptidoglycan (PGN) in both human and mouse (Ogura et al. 2001b ; Ogura et al. 
2003).  More specifically, it has recently been demonstrated that the muramyl dipeptide 
moieties from PGN are the key components selected by the LRR of the CARD15 gene 
(Girardin et al. 2003; Inohara et al. 2003).  CARD15 functions through the CARD-
containing serine/threonine kinase Rip2 (also known as RICK, CARDIAK, CCK and 
Ripk2) via a homophilic CARD-CARD interaction to activate a NF-kB signaling 
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pathway (Ogura et al. 2001b).  Thus, not only is the CARD15 gene product highly 
conserved between human and mouse, it also has similar activity in activating NF-kB 
which is known to be involved in the triggering of cytokines, enzymes and adhesion 
molecules in response to chronic inflammatory diseases. 
In human, CARD15 has been mapped to chromosome 16q12 which harbors the 
IBD1 locus associated with susceptibility to Crohn’s disease (CD), a chronic 
inflammatory disorder of the gastrointestinal tract in human (Cavanaugh et al. 1998).  
The disease is characterized by granulomas, most frequently involves the ileum and 
results in malnutrition and wasting (Crohn et al. 1932).  Onset is most common between 
the ages of 15 and 24, although cases have been reported in every age group.  The 
prevalence of CD has been estimated to be about 1 per 1000 in the western world (Hugot 
et al. 1996).  Recently a frameshift and two single nucleotide polymorphisms in the 
CARD15 gene have been found to be associated with susceptibility to CD (Hugot et al. 
2001; Ogura et al. 2001a).  These mutations have been tested in several independent 
populations and the association between the mutations and CD has been validated by 
several groups (Hampe et al. 2001; Lesage et al. 2002, Murillo et al. 2002, Vermeire et 
al. 2002, Croucher et al. 2003).  The frameshift mutation results in a truncated CARD15 
protein which is deficient in inducing LPS-mediated NF-kB activation (Ogura et al. 
2001b).  Mouse CARD15 mutants corresponding to the frameshift mutation and the 
G908R point mutation in human were also deficient in responding to LPS and PGN 
(Ogura et al. 2003) suggesting that the mutations associated with Crohn’s disease share a 
signaling defect in response to bacterial components.  Additional single nucleotide 
polymorphisms located in the NOD of the CARD15 gene have been shown to be 
associated with Blau Syndrome (Miceli-Richard et al. 2001).  Blau syndrome is an 
autosomal dominant disorder which results in arthritis, uveitis and skin rash.  Both 
disorders are characterized by granulomatous inflammation but have no further 
similarity. 
The CARD15 gene appears to be an excellent candidate for disease resistance in 
cattle.  The seminal work performed in human and mouse provides insight to the 
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function of the gene and its possible role in immune response to pathogens.  More 
specifically, the bovine CARD15 gene could play an important role in protection against 
granulomatous disorders.  One such disorder, Johne’s disease, is believed by some to be 
related to Crohn’s disease.  Although there is no conclusive evidence that Crohn’s and 
Johne’s diseases are related, the parallels between the diseases are striking.  For 
example, both diseases have similar clinical manifestations including chronic diarrhea 
and weight loss, both species respond to the disease by developing granulomas in the 
ileum and both species suffer periods of remission and relapse. 
Like Crohn’s disease, Johne’s disease (JD) is a chronic digestive disorder.  
Although the etiology of CD is unknown, JD is caused by the intracellular bacterium, 
Mycobacterium avium subspecies paratuberculosis (M. ptb.) (Chiodini et al. 1984a).  
The disease is characterized by a granulomatous enteritis and clinical indications usually 
include progressive weight loss, persistent diarrhea and eventual death.  The infection 
can be transmitted by either direct or indirect contact between infected and susceptible 
animals and most often occurs via the fecal-oral route (Sweeney 1996).  Resistance to 
the development of a paratuberculosis infection appears to be age related, since 
susceptibility to infection appears to be much greater during an animal’s first few 
months of life than in adults, who are quite resistant (Sweeney 1996). Although the 
initial infection frequently occurs during calfhood, the manifestation of clinical disease 
does not occur until adulthood.  Animals infected with M. ptb. may become clinically 
diseased, subclinically infected, or may be asymptomatic carriers of infection.  Both 
diseased and clinically normal animals may shed bacilli in feces, and carrier animals 
readily spread infection in the herd.  The degree of fecal shedding of bacilli tends to 
increase as the disease progresses and whenever animals are subjected to stress, such as 
during calving or transport. 
Johne’s disease is considered, by some, to be one of the most serious diseases 
that affects cattle, costing the U.S. industry as much as $1.5 billion annually as a result 
of reduced productivity and premature culling (Stabel 1998).  Some breeds of cattle, 
including Jersey (Jakobsen et al. 2000) and Brahman (Roussel, unpublished data) 
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possess an increased risk of being seropositive against paratuberculosis.  The heritability 
of susceptibility to M. ptb. in cattle has been estimated to be 0.09 (Koets et al. 2000), 
which is consistent with estimates of heritability of susceptibility to other disease traits 
(Philipsson et al. 1980; Simianer et al. 1991).  The disease is widespread, affecting 
approximately 22% of dairy herds and 8% of beef cattle herds in the U.S. (United States 
Department of Agriculture 1997).  There is no cure for the disease and no effective 
treatment for the elimination or reduction of bacteria in feces, however, there currently 
are available treatments to improve the condition and well-being of infected animals. 
M. ptb. is an obligate pathogen and though it is unable to multiply outside the 
bodies of host animals (Chiodini et al. 1984a; McClure et al. 1987; Chiodini 1989) it can 
survive for many years in water or soil (Chiodini et al. 1984a).  Signs observed in 
infected animals are caused by the animal’s immune system mounting an attack on its 
own tissues.  This phenomenon is common in mycobacterial infections.  The bacterium 
can be transmitted across the uterine and placental barriers before birth as well as 
through the ingestion of colostrum, milk or feces from an infected individual (Sweeney 
1996).  The disease may be rapidly propagated through contact in young calves; 
whereas, animals exposed after weaning are much less likely to develop the disease 
(Whitlock and Buergelt 1996).  Infected animals can harbor the bacterium without 
showing signs of disease or reacting to serological tests, which makes diagnosis and 
detection of the disease particularly difficult.  The organism can be found in large 
quantities in the intestine of the diseased animal and to a lesser extent in lymph nodes, 
liver and spleen. Animals with clinical or subclinical disease shed the bacteria in feces 
and to a lesser extent in their milk, making the disease difficult to manage and control. 
Previous research suggests that CD may be caused by infection with M. ptb. and 
that the autoimmune symptoms which characterize the disease are caused by the body 
mounting an immune response against M. ptb. infection as occurs with JD (Cuvelier et 
al. 1994; Dell’Isola et al. 1994).  There is considerable evidence to support an 
association between M. ptb. infection and CD.  Several researchers have found 
associations based on microbiological data, multiple host studies, genetic probe data and 
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antimicrobial drug studies.  However, there are also researchers who do not 
acknowledge the relationship.  Their disbelief is based on the lack of a pathologic 
hallmark, low cultivation success, and variability in the PCR data.  Each of these 
concerns, however, can be explained.  For instance, the lack of a pathogenic hallmark 
can be explained by the fact that the bacterium thought to be responsible for CD was 
found in spheroplast form (which does not have a cell wall) and therefore does not stain 
using the acid fast staining technique used for the identification of the presence of the 
bacterium.  Low cultivation success is most likely due to the fact that the bacterium is 
extremely slow growing and therefore is difficult to grow in culture, as well as to the fact 
that it is easy to kill the spheroplast form of the bacterium with normal purification 
techniques.  The presence of conflicting PCR data (i.e., some studies show the presence 
of the mycobacterium in controls) can be explained if the bacteria are present in low 
amounts in the gut, but require susceptible individuals to contract the disease and 
develop symptoms. 
There is considerable evidence supporting an association between M. ptb. and 
CD.  Many groups have been successful in isolating M. ptb. from patients with CD 
(Chiodini et al. 1984b; Chiodini 1989; Cocito et al. 1994; Thompson 1994) suggesting a 
significant association between infection with the bacteria and expression of the disease. 
Furthermore, M. ptb. strains isolated from humans have produced intestinal disease in 
other hosts such as goats and chickens (Van Kruiningen et al. 1986; Van Kruiningen et 
al. 1991) which indicates that the bacterium is capable of causing similar signs of disease 
in several species.  Additional evidence has been provided from the spontaneous 
infection of non-human primates with M. ptb.  One such case involves a colony of 38 
stump-tail macaques, of which, 29 had paratuberculosis (McClure et al. 1987). A second 
example is the isolation of M. ptb. from cotton-top tamarins, which are now considered 
to be one of the best animal models for Inflammatory Bowel disease (Warren and 
Watkins 1994).  A third case involves a Mandrill baboon in a midwestern zoo (Zwick et 
al. 2002).  The cases described here indicate that M. ptb. is versatile and is undeniably 
linked to intestinal disease in a variety of species.  Evidence is further provided in 
8 
several studies that have used genetic probes and shown the presence of M. ptb. in a 
significantly higher percentage of CD patients than among people without the disease 
(Moss et al. 1992; McFadden et al. 1992; Sanderson et al. 1992; Wal et al. 1993; 
Dell’Isola et al. 1994; Fidler et al. 1994; Lisby et al. 1994; Yokoyama et al. 1994).  One 
study detected M. ptb. RNA in 100% of Crohn’s patients and in none of the controls 
(Mishina et al. 1996).  Finally, support for the connection between M. ptb. and CD has 
been generated through the use of antimicrobial drugs.  For example, Gui et al. (1997) 
found that more than 90% of the Crohn’s patients treated with antimicrobial drugs active 
against M. ptb. experienced clinical remission. 
Due to the conservation of sequence and function between species and the 
detected association with CD, CARD15 is strongly suggested as a candidate for disease 
resistance in cattle.  CARD15 activates NF-kB in response to LPS which is found in 
gram negative bacteria and also to PGN which is found in gram negative bacteria, gram 
positive bacteria and mycobacteria.  For these reasons, a series of analyses of bovine 
CARD15 was performed in order to provide the fundamental tools that will be required 
for future studies involving CARD15 as a candidate gene for disease resistance in cattle. 
The first study reports the sequence, genomic structure and tissue expression 
profiles for the bovine CARD15 gene.  In this study, a somatic cell hybrid panel and a 
radiation hybrid panel (Womack and Moll 1986; Womack et al. 1997) were utilized to 
unequivocally determine the map location of bovine CARD15 and to confirm homology 
to human CARD15 based on chromosomal location.  This information will prove useful 
in comparative studies of the gene involving other species, or in QTL or candidate gene 
studies aimed at identifying regions of the bovine genome harboring genes implicated in 
disease resistance. 
The second study provides a sequence comparison of the CARD15 gene in 
human, mouse and bovine.  These data provide information concerning the homology of 
the CARD15 gene among species and reveal putative regulatory regions included in the 
3’UTR, 5’UTR and the introns.  Finally, in this study consensus sequences for the 
CARD15 gene in Bos indicus and Bison bison are reported. 
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The third study provides a survey of single nucleotide polymorphisms and the 
haplotypes found in the CARD15 gene among selected cattle breeds.  This study 
identifies variant forms of the CARD15 gene which may be used in future studies to 
identify mutations associated with a particular disease.  This study also includes tests of 
association between the identified polymorphisms or haplotypes and Johne’s disease. 
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SEQUENCE, GENOMIC STRUCTURE, CHARACTERIZATION AND 
EXPRESSION OF BOVINE CARD15 
 
Introduction 
 
CARD15 is a gene that has been identified in human with structural homology to 
plant disease resistance genes (R).  In plants, these R genes are known to aid in the 
recognition and defense of various intracellular pathogens (Dixon et al. 2000).  In 
human, CARD15 expression has been shown to be enhanced by proinflammatory 
cytokines and bacterial components including lipopolysaccharide (LPS) and 
peptidoglycan (PGN) via NF-kB (Gutierrez et al. 2002).  NF-kB is a molecule that plays 
a role in almost every aspect of cell regulation: immune cell activation, proliferation, 
apoptosis, stress responses, differentiation and oncogenic transformation. NF-kB can be 
activated by a variety of pathogenic stimuli, including bacterial products.  Activation 
occurs within minutes of stimulation and mediates the expression of a diverse set of 
inflammatory and immune response mediators.  It is considered to be a central regulator 
of cellular responses and plays a pivotal role both at the stage of initiation and 
perpetuation of chronic inflammation.  The behavior of CARD15 when stimulated with 
bacterial components and its association with the NF-kB pathway, suggests that 
CARD15 may function as an intracellular regulator of pathogens in mammals. 
Human CARD15 consists of two N-terminal caspase recruitment domains 
(CARD), a centrally located nucleotide binding oligomerization domain (NOD) and 10 
leucine rich repeat domains (LRR) at the C-terminus (Ogura et al. 2001a).  Associations 
between mutations in CARD15 and two granulomatous disorders, Crohn’s disease 
(Hugot et al. 2001; Ogura et al. 2001a) and Blau syndrome (Miceli-Richard et al. 2001), 
have recently been reported.  Little is known about the mechanism(s) by which these 
mutations confer susceptibility to disease.  However, initial experiments in human have 
shown that the 3020insC mutation associated with susceptibility to Crohn’s disease 
decreases the responsiveness of CARD15 to LPS and to muramyl dipeptide (MDP) 
derived from PGN (Ogura et al. 2001b; Gutierrez et al. 2002; Inohara and Nunez 2003; 
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Girardin et al. 2003).  Additional experiments involving mouse Card15 have shown that 
mutations equivalent to the human G908R and 3020insC mutations associated with 
susceptibility to Crohn’s disease result in a loss of NF-kB activation in response to LPS 
and PGN (Ogura et al. 2003).  These experiments suggest that mutations in the LRR of 
CARD15 inhibit recognition or binding ability to bacterial components resulting in a 
perturbation of NF-kB activation which is coupled with the formation of granulomas.  
While the exact mechanism(s) by which the mutations contribute to the development of 
Crohn’s disease and Blau syndrome is unknown, it is clear that mutations in CARD15 
are associated with susceptibility to both diseases. 
Granulomatous disorders have detrimental consequences to animal health, which 
result in reduced longevity and productivity and cost the livestock industry millions of 
dollars each year.  Furthermore, these disorders are often highly contagious and can 
rapidly spread, devastating entire operations.  A far more significant consequence of 
these disorders is the contamination of food products for human consumption and 
ensuing zoonoses.  In particular, cattle are affected by granulomatous disorders such as 
Johne’s disease, brucellosis and tuberculosis; all of which are known, or are believed by 
some, to be zoonotic.  Of these, some researchers believe that Johne’s disease has a 
similar etiology to Crohn’s disease (Chiodini 1989; Cocito et al. 1994; Thompson 1994).  
Consequently, one might expect genes involved in susceptibility to Crohn’s disease to 
also be involved in susceptibility to Johne’s disease.  Consequently, characterization of 
the bovine CARD15 homolog should prove useful in downstream tests of association 
with granulomatous disorders in cattle such as Johne’s disease and this information may 
also have utility in other livestock species.  Here, the genomic location, sequence, 
structure and tissue-specific mRNA expression patterns for the bovine CARD15 gene 
are reported. 
 
Materials and Methods 
 
Probe development.  Nucleotide sequences with homology to human CARD15 
(GenBank accession AF178930) were identified in the GenBank non-human, non-
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mouse, expressed sequence tag database (EST_other).  One of these sequences, Bos 
taurus (GenBank accession BF605150), was used for primer design using Primer3 
available at http://www.broad.mit.edu/cgi-bin/primer/primer3_www.cgi.  The primer 
pair (5’-GCACAACCTCCAGATCACAG-3’, 5’-GACACCGCTGGACACAATC-3’) 
was optimized for annealing temperature and PCR was performed on a Perkin Elmer 
9700 thermocycler.  The PCR reactions were carried out in a 50 µl reaction volume: 15 
mM Tris, 50 mM KCl, 1.5 mM MgCl2, 200 µM of each dNTP (dATP, dCTP, dGTP and 
dTTP), 1 µM each primer, 50 ng DNA, 0.5 units of AmpliTaq Gold DNA Polymerase 
(Applied Biosystems, Foster City, Calif.). The general PCR reaction included an initial 
hot start of 10 min at 95°C followed by 35 cycles for 30 s at 94°C, 30 s at 58°C and 45 s 
at 72°C, followed by a final elongation step at 72°C for 7 min. The PCR products were 
analyzed by electrophoresis on 2% agarose gels in 1.0× TBE buffer (90 mM Tris/64.6 
mM boric acid/2.5 mM EDTA, pH 8.3) and stained with ethidium bromide. The PCR 
product was purified using QIAquick® (Qiagen, Valencia, Calif.) spin columns.  Five 
volumes of  Buffer PB (binding buffer) was added to each sample and was well mixed.  
The sample was then applied to a QIAquick spin column and centrifuged at maximum 
speed for 1 min.  The flow through was discarded and 750 µl of Buffer PE (wash buffer) 
was added.  The column was twice centrifuged at maximum speed for 1 min with the 
flow through being discarded after each spin.  The DNA was then eluted by adding 30 µl 
of Buffer EB to the center of the QIAquick membrane and incubated at room 
temperature for 1 min.  The assembly was centrifuged for 1 min at maximum speed to 
release the purified DNA.  Cycle sequence reactions were performed in a 10 µl reaction 
volume: 1 µl Big Dye v3.0 (Applied Biosystems), 10 ng amplified DNA, 0.5 µl of 5% 
dimethylsulfoxide (DMSO), 0.5 µl of 20 µM primer.  The general cycle sequence 
reaction included an initial denaturation step of 2 min at 96°C followed by 35 cycles for 
15 s at 96°C, 20 s at 50°C and 4 min at 60°C, followed by a final elongation step at 60°C 
for 15 min.  Unincorporated nucleotides and primers were removed from the reactions 
using a BioMax® Spin-50 mini-sephadex column (Millipore Corp., Bedford, Mass.).  
The columns were initially centrifuged at 1000 × g for 3 min to remove excess water, 10 
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µl of double distilled water was then added to each sequencing reaction and a total 
volume of 20 µl was added to each column.  The assembly was centrifuged a second 
time at 1000 × g for 3 min and the tube containing the sample was dried in a SpeedVac 
for 30 min.  All sequencing samples were stored at -20°C until ready for loading.  
Sequencing reactions were run on a 3100 DNA analyzer (Applied Biosystems).  The 
resulting sequence was analyzed by BLAST search and sequence alignment against the 
GenBank database to confirm homology to human CARD15. 
 
Genomic localization of bovine CARD15.  The appropriate annealing 
temperature for the confirmed primer pair was established to yield specific amplification 
of a bovine PCR product in a murine/hamster background.  The PCR products were 
analyzed by electrophoresis on a 2% agarose gel in 1.0× TBE buffer (90 mM Tris/64.6 
mM boric acid/2.5 mM EDTA, pH 8.3) and stained with ethidium bromide.  PCR was 
performed in 31 somatic and 90 selected radiation hybrid cell lines from a cattle-hamster 
somatic hybrid cell (SHC) panel and a 5000 rad whole-genome radiation hybrid 
(WGRH5000) panel, respectively (Womack and Moll 1986; Womack et al. 1997).  PCR 
products were scored as: ‘+’ for present, ‘–‘ for absent, or ‘?’ for ambiguous.  Syntenic 
assignment was made from correlations of marker retention (Chevalet and Corpet 1986).  
All WGRH5000 typing experiments were performed twice and were independently scored 
to increase the accuracy of the results.  Only data concordant in both experiments were 
used for RH mapping.  To assign bovine CARD15 to a chromosomal region, two-point 
linkage analysis was performed using the RHMAPPER software (Slonim et al. 1997). 
 
cDNA clone sequencing.  Three cDNA clones developed at the United States 
Department of Agriculture (USDA) Meat Animal Research Center (MARC), MARC 3 
BOV plate 54 row N column 10 (GenBank accession BF605150), MARC 2 BOV plate 
134 row A column 15 (GenBank accession BM032079) and MARC 3 BOV plate 41 row 
J column 13 (GenBank accession BF601658) previously identified as harboring ESTs 
with homology to human CARD15 were purchased from the Children’s Hospital 
Oakland Research Institute (CHORI) for complete sequence analysis.  The clones were 
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received as bacterial LB agar stab cultures.  On receipt, the cultures were streaked on LB 
agar plates containing 12.5 µg/ml chloramphenicol.  A single colony was inoculated in 3 
ml LB culture with 12.5 µg/ml chloramphenicol and incubated at 37°C for 16 hr with 
agitation at ~300 rpm.  The overnight culture was split and transferred into two 1.5 ml 
Eppendorf tubes and centrifuged for 3 min at 6500 rpm.  The supernatant was removed 
and the pellet was resuspended in 300 µl of Buffer P1.  To lyse the cells, 300 µl of 
Buffer P2 was added and incubated at room temperature for no more than 5 min.  To 
precipitate the DNA 300 µl of chilled Buffer P3 was added, mixed by inverting the tubes 
4-6 times and incubated on ice for 10 min.  The sample was centrifuged at maximum 
speed for 10 min and the cleared lysate removed for purification.  A QIAGEN-tip 20 
(Qiagen) was equilibrated by applying 1 ml Buffer QBT and allowing the column to 
empty by gravity flow.  The supernatant was then applied to the column and allowed to 
enter the resin by gravity flow.  The tip was then washed 4 times with 1 ml Buffer QC 
heated to 65°C and the DNA eluted with 800 µl Buffer QF.  The eluate was precipitated 
with 0.7 volumes of room temperature isopropanol and centrifuged at maximum speed 
for 30 min.  The supernatant was carefully removed with a pipette and the pellet was 
washed with 1 ml of 70% ethanol.  The sample was centrifuged at maximum speed for 
10 min and the ethanol completely removed.  The pellet was allowed to air dry for 15 
min before resuspending in TE buffer.  Approximately 300 ng of the purified plasmid 
DNA was used as a template in a 10 µl reaction volume: 2 µl Big Dye v3.0, 2 µl halfBD 
(Genetix USA Inc., Boston, Mass.), 0.5 µl MasterAmp, 0.5 µl of 20 µM primer 
(Universal M13 primers: 5’-TGTAAAACGACGGCCAGT-3’ or 5’-
CACACAGGAAACAGCTATGA-3’).  All sequencing reactions and subsequent clean-
ups were performed as previously described. 
 
BAC library screen.  The primer pair previously described was used to screen a 
bovine BAC library (Cai et al. 1995) for clones harboring the bovine CARD15 gene.  
The PCR systematic screening strategy of Green and Olson (1990) was used.  First, the 
DNA super pools which each consist of 480 BAC clones were screened.  The positive 
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pools identified in this screen point to a single 96-well microtiter plate.  By screening 8 
row and 12 column DNA pools prepared from this plate, positive clones were identified 
by locating the intersection of the positive row and column pools.  The PCR and 
visualization protocols were as previously described. 
 
BAC DNA extractions.  DNA from each BAC clone was prepared using a DNA 
midi-prep procedure from Qiagen.  A single colony from an LB/chloramphenicol agar 
plate streaked with BAC culture was inoculated into 100 ml 2× YT with 
chloramphenicol at a final concentration of 12.5 µg/ml into a 1 L flask.  The culture was 
incubated at 37°C for 20 hr with agitation at ~300 rpm.  The bacterial culture was split 
into two 50 ml conical Falcon tubes and centrifuged for 20 min at 4°C at 5,600 rpm in a 
Beckman centrifuge with a JA-12 rotor.  The supernatants were poured off and tubes 
were inverted for about 1 min to remove all traces of the supernatant without disturbing 
the pellet.  Each pellet was resuspended in 10 ml of P1 solution (Qiagen) with 10 µl of 
RnaseA (10 mg/ml).  Ten ml of P2 solution (Qiagen) was added, each tube was inverted 
four to six times, and the lysing reaction was allowed to continue for 5 min at room 
temperature or until the solution was clear.  Ten ml of solution P3 (Qiagen) was added to 
neutralize the reaction, tubes were inverted four to six times and incubated on ice for 10 
min, then centrifuged for 30 min at 4°C at 8000 rpm to separate the cell debris from the 
lysate.  The clear supernatants were transferred by pipette into a single clean 50 ml 
conical tube and again centrifuged at 8000 rpm for 10 min to ensure the removal of all 
cell debris that might interfere with column purification.  The supernatant was again 
transferred into a clean 50 ml tube.  A Qiagen column was placed in a 50 ml Falcon tube 
and 4 ml of Buffer QBT added as an equilibration wash.  The sample was added to the 
column and all flow through liquid was discarded.  Two volumes of 10 ml of Buffer QC 
were added to the column as a wash, and the BAC DNA was eluted using five 1 ml 
volumes of Buffer QF, preheated to 65°C.  DNA was precipitated by adding 3.5 ml of 
isopropyl alcohol and mixing.  After at least 5 min, samples were centrifuged at 8000 
rpm for 30 min at 4°C to precipitate the DNA and the supernatant was carefully poured 
off.  The pellets were resuspended in 1.5 ml of 70% ethanol, transferred to a 1.5 ml 
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Eppendorf tube and then centrifuged for 10 min at room temperature.  The ethanol was 
carefully removed using a 200 µl pipette and samples were inverted and allowed to dry 
for 20-30 min.  BAC DNA was dissolved in 40 µl of elution buffer (Buffer EB) and 
stored at room temperature overnight before use. 
 
BAC fingerprinting.  BACs harboring the bovine CARD15 gene were digested 
using BamHI and Sau3AI restriction enzymes.  Each reaction used 1 µg of DNA, 2.5 µl 
of appropriate buffer and 1 unit of enzyme in a 25 µl volume.  The digests were 
incubated at 37°C for 1 hr and heat inactivated at 65°C for 15 min.  Analysis was by 
electrophoresis on a 0.65% agarose gel in 1.0× filtered TBE buffer (90 mM Tris/64.6 
mM boric acid/2.5 mM EDTA, pH 8.3) and stained with ethidium bromide.  The 
fragments were size analyzed based on a HindIII digest of lambda DNA and a 1 kb DNA 
ladder. 
 
BAC sequencing.  Approximately 1 µg of DNA was used as a template in a 10 
µl reaction volume: 2 µl Big Dye v3.0, 2 µl halfBD (Genetix), .5 µl MasterAmp, .5 µl of 
20 µM primer.  All sequencing reactions were run under the following conditions: an 
initial denaturation step at 96°C for 2 min, 8 cycles of 96°C for 30 s followed by 58°C 
for 30 s with a 1 degree per cycle touchdown followed by 65°C for 4 min, 60 cycles of 
96°C for 30 s followed by 50°C for 25 s followed by 65°C for 4 min, and a final round 
of 96°C for 1 min followed by 50°C for 1 min followed by 65°C for15 min.  
Unincorporated nucleotides and primers were removed from the reactions using a 
BioMax Spin-50 mini-sephadex column (Millipore).  The columns were initially 
centrifuged at 1000 × g for 3 min to remove excess water, 15 µl of double distilled water 
was then added to each sequencing reaction and a total volume of 25 µl was added to 
each column.  The assembly was centrifuged a second time at 1000 × g for 3 min and the 
tube containing the sample was dried in a SpeedVac for 30 min.  All sequencing samples 
were stored at -20°C until ready for loading.  Sequencing reactions were run on a 3100 
DNA analyzer (Applied Biosystems).  This strategy was used with both gene specific 
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primers and primers with homology to BAC ends developed by Cai et al. (1995) and 
given the names LEIPCR and REPCR due to homology to the left end and the right end 
of the BAC respectively.  A description of primers used to derive sequence from BAC 
clones is presented in Table 1.  All resulting sequence was analyzed by BLAST search 
against the GenBank database for validation. 
 
RNA processing (Blood).  Whole blood was collected in heparin tubes, stored on 
ice and centrifuged at 2000 × g for 15 min at room temperature within 8 hr of collection.  
The plasma layer was removed using transfer pipettes and the white blood cell (WBC) 
layer was collected and combined with 1.2 ml of RNAlater (Ambion, Austin, Tex.).  The 
sample was mixed thoroughly by vortexing.  The WBC mixture was then centrifuged for 
1 min at maximum speed in a microcentrifuge.  The supernatant was completely 
removed by aspiration.  To lyse the cells and solubilize the pellet, 800 µl of lysis 
solution and 100 µl of sodium acetate solution were added and the tube was vortexed 
vigorously.  The RNA was then extracted by adding 500 µl of acid phenol chloroform, 
vortexing for 30 s and incubating at room temperature for 3 min.  To separate the 
aqueous and organic phases, the sample was centrifuged for 1 min at maximum speed.  
The aqueous phase was transferred to a new 2 ml tube and 600 µl of 100% ethanol was 
added.  The sample was mixed thoroughly and then applied 700 µl at a time to the 
cartridge assembly. With each addition of sample the cartridge was centrifuged briefly to 
pass the liquid through the filter and the flow through was discarded.  The sample was 
then washed by adding 700 µl of Wash Solution 1, centrifuging and discarding flow 
through.  An additional wash with Wash Solution 2/3 was repeated 2 times with a final 
centrifugation for 1 min to remove all residual fluid from the filter.  The RNA was eluted 
by applying 100 µl of Elution Solution preheated to 75°C.  The RNA was recovered by 
centrifugation for 30 s at maximum speed.  The eluted RNA was then treated with 
DNase I to remove contaminating genomic DNA. 
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Table 1.  Primers used to amplify regions of bovine CARD15 from BACs 
Primer Sequence 5’ to 3’ 
LEIPCRa CTAGAGTCGCCTGCAGG 
REPCRa GCGGATAACAATTTCACACAGG 
E2-5'.1b CAGAATACTCTCAAAGCCCTCCAG 
E2-3'.1b GACACCATCTGGAATAAGGGTACT 
E3con5'c TGTAGAAGGAAGGCAGCCAAT 
E3con3'c GGTTGGCTGCCTTTCTTCTAC 
E4 5'd CCATGGGTGGCTAAGGGTAG 
aBAC end-sequencing primers. 
bPrimers to amplify in the 5’ and 3’ directions from exon 2. 
cPrimers to amplify in the 5’ and 3’ directions from exon 3. 
dPrimers to amplify in the 5’ directions from exon 4. 
19 
RNA processing (Tissue).  Tissue was collected at slaughter from yearling 
Angus steers sourced from the Circle A Ranch, Iberia, Missouri.  Samples were obtained 
from: pancreas, liver, longissimus dorsi (ribeye) muscle, lower intestine, heart, lung, 
kidney, thyroid, spleen, hypothalamus, adrenal, anterior pituitary and bone marrow.  The 
tissue was dissected into approximately 500 mg pieces and placed immediately into 5 ml 
of RNAlater (Ambion) and stored on ice before finally being transferred to a -20°C 
freezer. 
RNA extractions were performed using TRIzol reagent.  The tissue samples were 
removed from RNAlater and approximately 100 mg of tissue was chopped into small 
pieces using a clean razor blade.  The tissues were then homogenized using a 
Dispergierstation T8.10 (IKA Works Inc., Wilmington, N. Carol.) in 1 ml of TRIzol 
reagent.  After homogenization, the samples were incubated at room temperature for at 
least 5 min to allow complete dissociation of nucleoprotein complexes.  In order to 
separate the phases, 0.2 mL of chloroform was added and each tube was shaken by hand 
for 15 s and then incubated at room temperature for 2 min.  The samples were 
centrifuged at 12,000 × g for 15 min and the aqueous phase was transferred to a clean 
tube.  To precipitate the RNA, 0.5 ml of isopropyl alcohol was added and incubated at 
room temperature for 10 min.  The tubes were then centrifuged at 12,000 × g for 10 min.  
The supernatant was removed by pouring and the pellet was washed in 1 ml of 75% 
ethanol.  The samples were mixed by vortexing and then centrifuged at 7500 × g for 5 
min.  The supernatant was removed by pouring and the pellet allowed to dry for 15 min.  
The pellet was then dissolved in 20 µl of DEPC treated water and incubated for 5 min at 
42°C.  RNA purity was determined from calculations of 260/280 ratios.  Integrity of the 
RNA was checked via gel electrophoresis. 
 
RT-PCR.  1 µg of total RNA was primed with random decamers using the 
SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen Life Technologies, 
Carlsbad, Calif. ).  RNA/primer mixtures were set up in 10 µl reaction volumes: 1 µg 
RNA, 1 µl of 10 mM dNTP mix, 1 µl of 20 µM gene specific primer.  The reaction was 
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incubated at 65°C for 5 min and then placed on ice for at least 1 min.  The RT reaction 
mixture was also set up in a 10 µl reaction volume: 2 µl 10× RT buffer, 4 µl of 25 mM 
MgCl2, 0.1 M DTT, 1 µl RNaseOUT.  To each RNA/primer mixture, 9 µl of RT reaction 
mix was added and incubated at 42°C for 2 min.  Each tube then received 50 units of 
SuperScript II RT and was incubated for an additional 50 min at 42°C.  The reactions 
were terminated at 70°C for 15 min and then chilled on ice.  RNase H (1 µl) was added 
to each tube and incubated for an additional 20 min at 37°C.  All RT products were 
tested for the presence of CARD15 and beta-actin transcripts before being used as a 
template in quantitative PCR. 
 
5’ and 3’ RACE.  Gene specific nested primers were designed for both the 5’ and 
3’ ends of bovine CARD15.  Using the FirstChoice RLM-RACE kit (Ambion), 10 µg of 
total RNA was treated with calf intestinal phosphatase to remove the 5’ phosphate from 
degraded mRNA, rRNA, tRNA and DNA and incubated at 37°C for 1 hr.  The reaction 
was terminated and a phenol:chloroform extraction performed.  The sample was then 
subjected to a Tobacco Acid Pyrophosphatase treatment to remove the cap structure 
from full-length mRNA leaving a 5’-monophosphate.  Next, a 45 base RNA adapter was 
ligated to the RNA population using T4 ligase.  Reverse transcription was then 
performed using random decamers supplied with the kit at 42°C for 1 hr. 
Nested PCR using outer gene specific primer and outer 5’RACE primer in a 50 
µl reaction volume: 1 µl RT product from the previous step, 5 µl 10× PCR buffer, 4 µl 
dNTP mix, 2 µl 10 µM gene specific outer primer, 2 µl 5’ RACE outer primer, 1.25 
units AmpliTaq Gold DNA Polymerase (Applied Biosystems).  The PCR reaction 
included an initial denaturation step of 10 min at 94°C followed by 35 cycles for 30 s at 
94°C, 30 s at 60°C, 30 s at 72°C with a final elongation of 7 min at 72°C.  The product 
from the 5’RACE outer PCR was used as a template for a second round of PCR using a 
nested gene specific primer and the inner 5’RACE primer supplied with the kit.  The 
same PCR conditions were used as for the outer RACE PCR.  The PCR products were 
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analyzed by electrophoresis on 2% agarose gels in 1.0× TBE buffer (90 mM Tris/64.6 
mM boric acid/2.5 mM EDTA, pH 8.3) and stained with ethidium bromide.  
The FirstChoice RLM-RACE kit (Ambion) was also used for 3’RACE.  Total 
RNA (1 µg) was used for reverse transcription in a 20 µl volume: 4 µl dNTP mix, 2 µl 
3’RACE adapter, 2 µl 10× RT buffer, 1 µl RNase Inhibitor, and 1 µl MMLV Reverse 
Transcriptase.  The reaction was incubated at 42°C for 1 hr.  The RT product was then 
used for an outer 3’RACE PCR reaction in a 50 µl volume: 1 µl RT reaction, 5 µl 10× 
PCR buffer, 4 µl dNTP mix, 2 µl 10 µM gene specific primer, 2 µl 3’RACE outer 
primer, 1.25 units AmpliTaq Gold DNA Polymerase (Applied Biosystems).  The PCR 
reaction included an initial denaturation step of 10 min at 94°C followed by 35 cycles for 
30 s at 94°C, 30 s at 60°C, 4 min at 72°C with a final elongation of 15 min at 72°C.  The 
product from the 3’RACE outer PCR was used as a template for a second round of PCR 
using a nested gene specific primer and the inner 3’RACE primer supplied with the kit.  
The same PCR conditions were used as described for the outer RACE PCR.  The PCR 
products were analyzed by electrophoresis on a 1% agarose gel in 1.0× TBE buffer (90 
mM Tris/64.6 mM boric acid/2.5 mM EDTA, pH 8.3) and stained with ethidium 
bromide. 
 
cDNA sequencing.  Total RNA was primed using a gene specific primer from 
the 3’ end of the bovine CARD15 gene (5’-CTAGGGAGCTGATGTGGTTGTTAG-3’) 
using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen) as 
previously described. 
Overlapping PCR primers were amplified in a 50 µl volume: 15 mM Tris, 50 
mM KCl, 1.5 mM MgCl2, 200 µM of each dNTP (dATP, dCTP, dGTP, and dTTP), 1 
µM each primer, 2 µl of template from the RT reaction, 0.75 units of AmpliTaq Gold 
DNA Polymerase (Applied Biosystems). The general PCR reaction included an initial 
hot start of 10 min at 95°C followed by 35 cycles for 30 s at 94°C, 30 s at 58°C and 2 
min at 72°C, followed by a final elongation step at 72°C for 15 min.  Primers used to 
amplify the three overlapping cDNA amplicons were:  
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A1F: 5’-ACCAGCCATTGTCAGGAGAC-3’ 
A1R: 5’-GCAGAAGGTTGAAGAGCAGACTC-3’ (Amplicon 1); 
A2F: 5’-CTTTGCCTGGAAGAAGTATATACAGAG-3’ 
A2R: 5’-CATGCTCTTGGCCTCACC-3’ (Amplicon 2); and 
A3F: 5’-GCACAACCTCCAGATCACAG-3’ 
A3R: 5’-CTAGGGAGCTGATGTGGTTGTTAG-3’ (Amplicon 3). 
The PCR products were analyzed by electrophoresis on 2% agarose gels in 1.0× TBE 
buffer (90 mM Tris/64.6 mM boric acid/2.5 mM EDTA, pH 8.3) and stained with 
ethidium bromide.  The PCR product was purified using QIAquick spin columns. 
Cycle sequencing reactions were performed in a 10 µl reaction volume: 1.5 µl 
Big Dye v3.0, 1.5 µl halfBD (Genetix), 0.5 µl MasterAmp, 0.5 µl of 20 µM primer.  The 
general cycle sequence reaction included an initial denaturation step of 2 min at 96°C 
followed by 35 cycles for 15 s at 96°C, 20 s at 50°C and 4 min at 60°C, followed by a 
final elongation step at 60°C for 15 min.  Unincorporated nucleotides and primers were 
removed from the reactions using a BioMax Spin-50 mini-sephadex column.  
Sequencing reactions were run on a 3100 DNA analyzer (Applied Biosystems).  The 
resulting sequence was entered into ContigExpress and aligned with the genomic 
sequence of bovine CARD15.  
 
Intron sizing.  Primers were developed using sequence data from each exon of 
bovine CARD15.  Two primers were developed from each exon, one extending in the 5’ 
direction and the other extending in the 3’ direction.  The primers were then paired in 
order to amplify introns.  For example, the primer extending in the 3’ direction in exon 1 
was paired with the primer extending in the 5’ direction in exon 2 to amplify intron 1.  
The resulting amplicon contains partial sequence from exon 1, partial sequence from 
exon 2 and the complete sequence from intron 1.  Primer sequences used to amplify 
introns are presented in Table 2.  All intron amplifications were run in a 50 µl reaction 
volume: 15 mM Tris, 50 mM KCl, 1.5 mM MgCl2, 200 µM of each dNTP (dATP, 
dCTP, dGTP, and dTTP), 1µM each primer, 5 µl Master Amp, 100 ng bovine genomic  
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Table 2.  Primers used to amplify introns from bovine CARD15 
Intron Sense 5’ to 3’ Antisense 5’ to 3’ 
1 GGAGCTCTGTGAGATCGCTTCC CAGAATACTCTCAAAGCCCTCCAG 
2 ACCAGCCATTGTCAGGAGAC TGCTGATGTTTTTGCTCTTCA 
3 GGCCTTTTATTGTGGTGGAA GAAGAGCAGACTCTGGACTGACG 
4 GCAGCTGGACCACAACTCTG CAGCTGCTCACAGCGAAGAG 
5 GTCTCTGTGGGGGTTTTGTC GTCCTTGTTTTCAGCGAGGT 
6 ACAAGTTGACCGATGGCTGT AACTGCAAGGAGTTGTTAGTTCTGAG 
7 GCTCAGAACTAACAACTCCTTGC CCCCTCGTCACCCACCTG 
8 AACCAGGTGGGTGACGAG AGTTCTTCCAGGGCCATATTCT 
9 CTGGTGGGGAACAACATTGG CTTGAGTTTCTTGCAAGTCCTTTG 
10 AGAACCACGTCCAGGATGAAG CTAGGGAGCTGATGTGGTTGTTAG 
11 CTAACAACCACATCAGCTCCCTA GAAACATCAGAGCAAGAGTCTGGTATC 
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DNA and 0.75 units of High Fidelity Taq (Applied Biosystems).  The general PCR 
reaction included an initial 2 min hot start at 94°C followed by 10 cycles of 94°C for 15 
s, 61°C for 30 s with a 0.5°C touchdown each cycle, 68°C for 6 min, followed by an 
additional 20 cycles of 94°C for 15 s, 56°C for 30 s, 68°C for 6 min with an additional 5 
s added each cycle, followed by a final elongation step at 68°C for 7 min.  The resulting 
amplicons were then partially sequenced from both directions to confirm identity and to 
obtain sequence flanking each exon. 
 
Real Time PCR/TaqMan.  Oligonucleotide primers and TaqMan probes were 
designed using Primer Express, version 1.0 (Applied Biosystems). Primers used to 
amplify CARD15 were: 
C15TMF: 5’-CAGCCAGTACGAAACTGATGAAA-3’ 
C15TMR: 5’-CACTGTGGCGAGATCAAGGA-3’. 
Primers used to amplify beta-actin (ACTB) were: 
ACTBTMF: 5’- TGTGCTCTCCCTCTATGCTTCTG-3’ 
ACTBTMR: 5’- GGTGACACCATCCCCTGAAT-3’. 
The CARD15 dual labeled probe (C15TMP: 5’-CAGGCGGCCCATCTTCACTTCATC-
3’) was designed to have a 5’ reporter dye (6-FAM) and a 3’ quenching dye (TAMRA).  
The beta-actin dual labeled probe (ACTBTMP: 5’-CGCACAACGGGCATCGTCCTG-
3’) was designed to have a 5’reporter dye (VIC) and a 3’ quenching dye (TAMRA). 
Relative quantitative real-time PCR:  All semi-quantitative PCR was performed 
using an ABI PRISM 7700 Sequence Detection System (Applied Biosystems).  The PCR 
reaction mixture (50 µl) contained 25 µl of 2× TaqMan Universal PCR Master Mix 
(Applied Biosystems), 300 nM primers, 200 nM TaqMan probe, 1 µl of cDNA sample 
and water.  The thermal cycling conditions comprised the initial steps at 50°C for 2 min 
and at 95°C for 10 min, followed by 50 cycles at 95°C for 15 s and at 60°C for 1 min. 
Following RT-PCR, quantitation of gene amplification was made by setting the 
threshold cycle (CT) in the geometric region of the plot after examining the semi-log 
view of the amplification plot.  Relative quantification of gene expression was evaluated 
using the comparative CT method.  The ∆CT value is determined by subtracting the gene 
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CT of each sample from the corresponding sample beta-actin CT value.  Calculation of 
∆∆CT involves using the mean ∆CT from liver as an arbitrary constant to subtract from 
all other ∆CT mean values.  Fold changes in gene expression were then determined by 
exponentiating the mean difference, 2-∆∆Ct. 
 
Results 
 
Genomic localization of bovine CARD15.  To identify the bovine ortholog of 
CARD15, the EST-others database in GenBank was searched for sequences encoding 
peptides with homology to human CARD15 (GenBank accession AF178930).  Four EST 
clones were identified with significant E values for homology to approximately 1100 
bases of the 4485 bp human CARD15 gene (Table 3).  Of these, the first is a clone 
derived from Sus scrofa and the remaining 3 are Bos taurus clones.  Sequence from the 
Bos taurus cDNA clone with the highest E value (GenBank accession BF605150) was 
chosen to develop a set of primers to be used as a probe for integrating bovine CARD15 
into the WGRH5000 RH map.  The 141 bp PCR product produced using these primers 
was sequenced and homology to the bovine EST from which it was derived was 
confirmed.  The sequence was then subjected to BLAST searches which revealed 
significant homology exclusively to human CARD15 and mouse Card15.  This 
confirmed the use of the primer pair as a detector of bovine sequence homologous to 
CARD15.  This confirmed primer pair was then used to screen a cattle-hamster somatic 
hybrid cell panel and localized bovine CARD15 to BTA18 with 97% concordancy.  The 
same primer pair was used to screen a bovine-hamster RH panel and 14 of the 90 hybrid 
cell lines retained fragments harboring CARD15 yielding a retention frequency of 0.156 
(data presented in Table 4).  Integration of CARD15 into the RH map of BTA18 
revealed two alternatives for gene order with high statistical support.  The most likely 
order had a log-likelihood of -97.072355 and placed CARD15 centromeric to ADCY7, 
while the second best estimate of order had a log-likelihood of -97.477136 and placed 
CARD15 telomeric to ADCY7 (Fig. 1). 
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Table 3.  EST sequences in GenBank with homology to human CARD15 
Accession 
Number 
Organism Length 
(bp) 
Identities Human 
homology (bp) 
E value 
 
BI339864 Sus scrofa 511 286/334 2895-3228 2.00E-72 
      
BF605150a Bos taurus 326 219/261 2075-2335 4.00E-43 
      
BM032079 Bos taurus 545 211/254 1708-1961 2.00E-36 
   88/104 1573-1676  
   40/43 2075-2117  
      
BF601658 Bos taurus 489 101/123 3836-3958 4.00E-06 
aBoldface entry indicates EST selected for primer development and used as a probe for 
somatic cell hybrid and radiation hybrid mapping.
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Table 4.  Results from screening the bovine-hamster RH panel 
Cell 
Line 
Scorea Cell 
Line 
Score Cell 
Line 
Score Cell 
Line 
Score Cell 
Line 
Score Cell 
Line 
Score
1 - 16 + 31 - 46 + 61 + 76 - 
2 - 17 - 32 - 47 - 62 - 77 - 
3 + 18 - 33 - 48 - 63 - 78 - 
4 - 19 - 34 + 49 - 64 - 79 - 
5 - 20 - 35 + 50 - 65 - 80 - 
6 - 21 - 36 - 51 - 66 - 81 - 
7 - 22 - 37 - 52 - 67 - 82 - 
8 - 23 - 38 + 53 - 68 - 83 + 
9 - 24 - 39 - 54 - 69 - 84 - 
10 - 25 - 40 - 55 - 70 - 85 - 
11 - 26 - 41 + 56 - 71 - 86 - 
12 + 27 - 42 - 57 - 72 - 87 - 
13 - 28 - 43 - 58 - 73 + 88 - 
14 - 29 - 44 - 59 + 74 - 89 - 
15 - 30 - 45 + 60 + 75 - 90 - 
aPCR products were scored as: ‘+’ for present, ‘–‘ for absent, or ‘?’ for ambiguous. 
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Figure 1.  RH map localization of CARD15 to BTA18.  
Figure to the left represents the most likely marker order, 
the center figure represents the second most likely marker 
order, while the figure to the right shows the approximate 
location of the region of BTA18 harboring CARD15. 
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Sequence of bovine CARD15.  EST clones: To obtain complete sequence data on 
the bovine CARD15 gene, three partial cDNA clones developed at the USDA MARC 
were purchased which contained ESTs with homology to human CARD15.  These 
clones were derived from polyA RNA digested with NotI and ligated into the cloning 
vector pCMVSPORT6 (Smith et al. 2001).  Universal M13 primers were used to 
sequence the clones and sequence data were obtained for regions with homology to 
exons 4-12 of the human CARD15 gene (Fig. 2). 
BAC library screen: The Texas A&M University bovine BAC library was 
screened with the confirmed primer pair developed as previously described and 2 BAC 
clones harboring sequence with homology to CARD15 were identified (BBAC114R1C4; 
BBAC7138-84R4C4).  Sequence analysis of PCR products confirmed the inclusion of 
bovine CARD15 in both clones.  End sequencing of each of the BACs revealed that 
clone BBAC114R1C4 contains sequence with homology to CYLD, while end sequences 
for BBAC7138-84R4C4 produced no homologies to the human genome.  The BAC 
clones were digested with restriction enzymes in order to estimate insert size and to 
confirm that the clones did not contain the same insert.  These digests confirmed that the 
two clones contain different inserts with estimated sizes of 138 kb for BBAC114R1C4 
and 93 kb for BBAC7138-84R4C4. 
To obtain coding sequence data not present in the MARC cDNA clones, human 
and mouse sequence was aligned in Vector NTI (Informax, Frederick, Mar.) and primers 
were developed from areas of high conservation to be used to sequence directly from the 
BAC clones identified as harboring bovine CARD15.  This strategy allowed for the 
capture of missing sequence data from exons 2, 3 and 4 (Fig. 2).  However, due to the 
low levels of sequence homology between mouse and human for exon 1, no suitable 
primers were developed to amplify bovine exon 1 by this process. 
Exon order was confirmed in the coding sequence by generating a population of 
cDNAs using a bovine CARD15 gene specific primer and used this population as a 
template to produce 3 overlapping amplicons.  This approach allowed us to verify both  
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Figure 2.  Strategy for obtaining genomic sequence for bovine CARD15. 
Each boxed region represents an exon and each labeled line represents the 
region for which sequence was obtained by the indicated approach. 
MARC cDNA clones
BACs
5’ RACE
3’ RACE
Confirmed sequence cDNA
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the sequence and exon order from exon 2 through exon 10 of the bovine CARD15 gene 
(Fig. 2). 
5’ and 3’ RACE: To acquire the remaining sequence data from the 5’ and 3’ 
portions of the coding sequence, rapid amplification of cDNA ends (RACE) was used.  
A 14 bp mononucleotide A repeat located in the 3’UTR rendered the 3’RACE 
experiments unsuccessful in gathering the sequence for the entire 3’UTR, as the method 
required attaching an adapter via the polyA tail to the 3’ end of the transcript.  This 
adapter preferentially ligated to the internal mononucleotide A repeat and resulted in the 
production of a single amplicon which lacked the most 3’ sequence of the bovine 
CARD15 gene.  Sequence from an additional EST derived from a cDNA clone 
developed at MARC with homology to human CARD15 was recently deposited to the 
GenBank database (GenBank accession CB427378).  This published EST contained 
sequence that included the internal polyA site in addition to some downstream 3’ 
sequence.  The clone harboring this EST was obtained from MARC (Tim Smith, pers. 
comm.) and was sequenced using the primer 5’-
CAGCGTTGTGTTAATTTCTATACAGC-3’ located downstream of the A14 sequence.  
This primer was also used to sequence directly from the two BACs harboring bovine 
CARD15.  All of the produced sequences were aligned leading to the identification of a 
putative polyA signal and the remnants of a polyA tail, thus elucidating the full 3’UTR 
sequence.  The cDNA and genomic BAC sequences had 100% sequence identity up to 
the polyA tail and subsequent vector sequence of the cDNA clone (Fig. 3).  The resulting 
combination of sequence data demonstrates that the bovine CARD15 messenger RNA is 
5105 bp and the protein it encodes is comprised of 1013 amino acids (Fig. 4).  The 
complete coding sequence has been submitted to GenBank as accession AY518737. 
 
Genomic structure of bovine CARD15.  To obtain intronic flanking sequence 
and to estimate intron size, primers were developed to amplify individual introns.  Of 
these, all but two were successful in amplifying the individual introns.  Problems were 
encountered in developing suitable primers from exon 3, therefore, BACs clones were 
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cDNA TTATGCTTTTTCACAGGATAAACTACTCATAGTTCCTTGTGCTATACATTAGGACTTTTTTATGTATCCA 
BAC TTATGCTTTTTCACAGGANAAACTACTCATAGTTCCTTGTGCTATACATTAGGACTTTTTTATGTATCCA 
 
cDNA TTCAATATATAATACATTTGCTAGCCTCAAAAAAAGAATTCCACTCCCACTGTC 
BAC TTCAATATATAATACATTTGCTAACCTCATAATACATTTGCTAGCCTCAATCTC 
 
Figure 3.  Alignment of cDNA to genomic BAC sequence for determination of the 3’ 
transcript end of bovine CARD15.  Potential alternative polyadenylation signals are 
indicated in bold face.  Arrow indicates cleavage site, shaded region represents remnant 
of polyA tail and vector sequence is italicized. 
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    1 CTCTGGACTC CGTGACCATC ACAGGAGGGA ACCTGCTGAG AGATTTCCTC TGCTGCGTGG 
                                                                    
   61 GGACCCTGCC AGGGCTTGGA GCTCTGTGAG ATCGCTTCCC ACGGACTCCC AGGACCCAGA 
                                M   C  A  Q   D  A  F  Q   T  Q  R  
  121 GTCTGAGGGC TGAGCCCAGG ATTGTGAAAT GTGCGCACAA GATGCTTTTC AGACACAGAG 
 · S  Q  L   V  E  L  L   V  S  G   S  L  E   G  F  E  S   I  L  D  
  181 AAGCCAACTG GTGGAGTTGC TGGTCTCGGG GTCCCTGGAG GGCTTTGAGA GTATTCTGGA 
 · R  L  L   S  R  E  V   L  S  W   E  D  Y   E  G  L  S   L  V  G  
  241 CCGGCTGCTT TCCCGGGAAG TCCTCTCCTG GGAGGACTAT GAGGGGCTTA GCCTCGTGGG 
 · Q  P  I   S  H  L  A   R  R  L   L  D  T   I  W  N  K   G  T  W  
  301 GCAGCCCATC TCCCACTTGG CCAGGCGCCT CCTGGACACC ATCTGGAATA AGGGTACTTG 
 · G  C  E   Q  L  T  A   A  V  R   E  A  Q   A  D  S  Q   P  P  E  
  361 GGGCTGTGAA CAACTGACTG CAGCTGTGCG GGAGGCCCAG GCCGACAGCC AGCCCCCCGA 
 · L  P  S   S  W  D  P   H  S  P   H  P  A   R  D  L  Q   S  H  R  
  421 GCTTCCCAGC TCCTGGGACC CCCACTCACC CCACCCAGCC CGTGACCTGC AGAGTCACCG 
 · P  A  I   V  R  R  L   Y  G  H   V  E  G   V  L  D  L   T  Q  Q  
  481 ACCAGCCATT GTCAGGAGAC TCTACGGCCA CGTGGAGGGT GTGCTGGACC TGACACAGCA 
 · R  G  F   I  S  Q  Y   E  T  D   E  I  R   R  P  I  F   T  S  S  
  541 GCGGGGTTTC ATCAGCCAGT ACGAAACTGA TGAAATCAGG CGGCCCATCT TCACTTCATC 
 · Q  R  A   R  R  L  L   D  L  A   T  V  K   A  N  G  L   A  A  F  
  601 CCAGCGGGCA AGAAGGCTCC TTGATCTCGC CACAGTGAAG GCGAATGGGT TGGCTGCCTT 
 · L  L  Q   C  I  Q  E   L  P  V   P  L  A   L  P  F  E   D  A  A  
  661 TCTTCTACAG TGTATTCAGG AATTACCGGT CCCATTGGCC CTGCCTTTTG AAGATGCTGC 
 · C  K  K   Y  V  S  K   L  R  T   V  I  S   A  Q  S  R   F  L  S  
  721 CTGTAAGAAG TACGTGTCCA AGCTGAGGAC CGTTATATCA GCTCAGTCTC GTTTCCTGAG 
 · T  Y  D   G  A  E  N   L  C  L   E  E  V   Y  T  E  N   V  L  E  
  781 CACCTACGAT GGAGCAGAGA ATCTTTGCCT GGAAGAAGTA TATACAGAGA ATGTTCTGGA 
 · I  Q  M   E  V  G  M   A  G  P   S  Q  Q   S  P  T  T   L  G  L  
  841 AATCCAGATG GAGGTGGGCA TGGCTGGACC TTCGCAGCAG AGCCCTACCA CCCTAGGCCT 
 · E  E  L   F  S  T  R   D  H  F   N  K  E   A  D  T  V   L  V  V  
  901 GGAGGAGCTC TTCAGCACCC GTGACCATTT CAACAAAGAG GCAGACACTG TGCTGGTGGT 
 · G  E  A   G  S  G  K   S  T  L   L  Q  Q   L  H  L  L   W  A  S  
  961 GGGCGAGGCG GGCAGCGGCA AGAGCACGCT CTTGCAGCAG CTGCACCTGC TCTGGGCTTC 
 · G  R  A   F  Q  E  F   L  F  V   F  P  F   S  C  R  Q   L  Q  C  
 1021 CGGGCGGGCC TTCCAGGAAT TTCTCTTCGT CTTCCCATTT AGCTGCCGGC AGCTGCAGTG 
 · L  V  K   P  L  S  M   R  T  L   L  F  E   H  C  C  W   P  D  L  
 1081 CCTGGTGAAA CCGCTGTCCA TGCGGACGCT GCTCTTCGAA CACTGCTGTT GGCCCGACCT 
 · G  P  Q   D  V  F  Q   V  L  L   D  H  P   E  R  I  L   L  T  F  
 1141 TGGCCCCCAG GACGTCTTCC AGGTCCTCCT TGACCACCCT GAGCGCATCC TCTTAACCTT 
 · D  G  F   D  E  F  R   F  R  F   T  D  Q   E  R  H  C   C  P  T  
 1201 TGATGGCTTT GATGAGTTCA GGTTCAGGTT CACGGATCAG GAGCGTCACT GCTGTCCGAC 
 · A  P  T   S  V  Q  S   L  L  F   N  L  L   Q  G  N  L   L  K  N  
 1261 CGCCCCCACG TCAGTCCAGA GTCTGCTCTT CAACCTTCTG CAGGGCAACC TGCTAAAGAA 
 · A  R  K   V  L  T  S   R  P  S   A  V  S   A  S  L  R   K  H  V  
 1321 TGCCCGCAAG GTGTTGACCA GCCGCCCCAG CGCGGTATCG GCGAGCCTCC GAAAGCACGT 
 · R  T  E   L  S  L  K   G  F  S   E  E  G   I  E  L  Y   L  R  K  
 1381 GCGCACGGAA CTCAGCCTCA AGGGCTTCTC GGAAGAGGGC ATCGAACTGT ACCTGAGGAA 
 · R  H  R   E  P  G  V   A  D  R   L  L  C   L  L  R  A   T  S  A  
 1441 GCGGCATCGC GAGCCTGGGG TGGCCGACCG CCTCCTCTGC CTGCTCAGAG CCACCTCGGC 
 · L  H  G   L  C  H  L   P  V  F   S  W  M   V  S  K  C   H  E  E  
 1501 CCTGCACGGT CTGTGCCACC TGCCTGTCTT CTCCTGGATG GTGTCCAAGT GCCACGAGGA 
 · L  L  L   Q  G  R  G   S  P  K   T  T  T   D  M  Y  L   L  I  L  
 1561 GCTGTTGCTG CAGGGCCGGG GGTCCCCAAA GACCACCACG GATATGTACC TGCTGATCCT 
 · R  H  F   L  L  H  A   S  P  L   P  L  A   T  H  G  L   G  P  S  
1621 GCGGCACTTT CTGCTGCACG CCTCCCCGCT ACCCTTAGCC ACCCATGGCC TGGGACCCAG 
Figure 4.  Nucleotide and amino acid sequence of bovine CARD15 
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 · L  I  Q   G  R  L  P   T  L  L   H  L  G   R  L  A  L   W  G  L  
 1681 CCTGATTCAG GGCAGGCTCC CCACACTCCT GCATCTTGGC CGCCTGGCTC TCTGGGGCCT 
 · G  T  C   C  Y  V  F   S  A  K   Q  L  Q   A  A  H  V   D  S  E  
 1741 GGGCACATGC TGCTACGTGT TCTCAGCCAA ACAGCTGCAG GCGGCACATG TCGACAGTGA 
 · D  L  S   L  G  F  L   V  L  A   K  R  V   V  P  G  S   T  A  P  
 1801 GGACCTTTCT CTTGGCTTCC TGGTGCTTGC CAAGAGGGTT GTACCTGGGA GTACAGCCCC 
 · L  E  F   L  H  I  T   F  Q  C   F  F  A   A  F  Y  L   A  L  S  
 1861 CCTGGAATTT TTGCATATCA CTTTTCAGTG CTTCTTTGCT GCATTCTACC TCGCCCTCAG 
 · A  D  T   P  P  S  S   L  R  H   L  F  Q   D  H  R  P   E  S  S  
 1921 TGCCGACACC CCGCCATCCT CGCTCAGACA TCTCTTCCAA GATCACAGGC CTGAAAGCTC 
 · P  L  A   R  V  L  P   K  L  F   L  R  G   S  R  C  R   E  G  S  
 1981 GCCACTGGCC AGGGTGCTGC CCAAATTGTT CCTGCGGGGC TCCCGATGCA GAGAGGGCAG 
 · V  A  A   L  L  Q  G   A  E  P   H  N  L   Q  I  T  G   A  F  L  
 2041 CGTGGCTGCT TTGCTGCAGG GGGCCGAGCC GCACAACCTC CAGATCACAG GGGCCTTCCT 
 · A  G  L   L  S  Q  E   H  R  S   L  L  A   E  C  Q  A   S  E  T  
 2101 GGCGGGGCTG TTGTCACAGG AGCACCGGAG CTTGCTGGCG GAGTGCCAGG CCTCTGAGAC 
 · A  L  L   R  R  W  D   C  V  R   R  C  L   T  R  S  L   R  E  H  
 2161 GGCCCTGCTC CGGCGCTGGG ATTGTGTCCG GCGGTGTCTG ACCCGCAGCC TCCGCGAGCA 
 · F  R  S   I  P  P  A   L  P  G   E  A  K   S  M  H  A   L  P  G  
 2221 TTTCCGCTCC ATCCCACCCG CCTTGCCGGG TGAGGCCAAG AGCATGCACG CCCTGCCTGG 
 · F  L  W   L  I  R  S   L  Y  E   M  Q  E   E  R  L  A   R  E  A  
 2281 CTTCCTCTGG CTCATCCGGA GCCTGTATGA GATGCAGGAG GAGCGACTGG CGCGGGAGGC 
 · V  C  R   L  N  V  G   H  L  K   L  T  F   C  G  V  G   P  A  E  
 2341 CGTTTGCAGG CTGAACGTTG GGCACCTCAA GCTGACCTTC TGCGGTGTGG GCCCGGCCGA 
 · C  A  A   L  A  F  V   L  R  H   L  R  R   P  V  A  L   Q  L  D  
 2401 GTGTGCTGCC CTGGCCTTCG TGCTGCGCCA CCTCCGGCGG CCTGTGGCCC TGCAGCTGGA 
 · H  N  S   V  G  D  I   G  V  E   Q  L  L   P  C  L  G   V  C  K  
 2461 CCACAACTCT GTGGGCGACA TCGGCGTGGA GCAGCTGCTG CCTTGCCTGG GCGTCTGCAA 
 · A  L  Y   L  R  D  N   N  I  S   D  R  G   I  C  K  L   V  E  H  
 2521 AGCTCTTTAC TTGCGAGATA ACAACATCTC AGACCGAGGC ATCTGCAAGT TGGTTGAACA 
 · A  L  R   C  E  Q  L   Q  K  L   A  L  F   N  N  K  L   T  D  G  
 2581 TGCTCTTCGC TGTGAGCAGC TGCAGAAGTT AGCTCTTTTC AACAACAAGT TGACCGATGG 
 · C  A  H   S  M  A  R   L  L  A   C  K  Q   N  F  L  A   L  R  L  
 2641 CTGTGCACAC TCCATGGCCA GGCTCCTTGC GTGCAAGCAG AACTTCTTGG CTTTGAGGCT 
 · G  N  N   H  I  T  A   A  G  A   E  V  L   A  Q  G  L   R  T  N  
 2701 AGGAAACAAC CACATCACGG CTGCGGGAGC CGAGGTGCTT GCCCAGGGGC TCAGAACTAA 
 · N  S  L   Q  F  L  G   F  W  G   N  Q  V   G  D  E  G   A  Q  A  
 2761 CAACTCCTTG CAGTTTTTGG GGTTCTGGGG CAACCAGGTG GGTGACGAGG GGGCCCAGGC 
 · L  A  A   A  L  G  D   H  Q  S   L  R  W   L  S  L  V   G  N  N  
 2821 CTTGGCTGCA GCCTTGGGTG ATCACCAGAG CTTGAGGTGG CTCAGCCTGG TGGGGAACAA 
 · I  G  S   V  G  A  Q   A  L  A   L  M  L   E  K  N  M   A  L  E  
 2881 CATTGGCAGC GTGGGTGCTC AAGCCTTAGC ATTGATGTTG GAAAAGAATA TGGCCCTGGA 
 · E  L  C   L  E  E  N   H  V  Q   D  E  G   V  C  F  L   A  K  G  
 2941 AGAACTCTGC CTGGAGGAGA ACCACGTCCA GGATGAAGGT GTGTGTTTCC TCGCCAAAGG 
 · L  A  R   N  S  S  L   K  V  L   K  L  S   N  N  H  I   S  S  L  
 3001 ACTTGCAAGA AACTCAAGTC TGAAAGTCCT GAAGCTGTCT AACAACCACA TCAGCTCCCT 
 · G  A  E   A  L  L  R   A  L  E   K  N  D   T  I  L  E   V  W  L  
 3061 AGGGGCAGAG GCCCTCCTGC GGGCCCTTGA AAAGAATGAC ACCATTCTGG AAGTCTGGCT 
 · R  G  N   T  F  S  P   E  E  I   E  K  L   S  H  Q  D   T  R  L  
 3121 CCGAGGAAAC ACTTTCTCTC CGGAGGAAAT TGAGAAACTC AGCCACCAGG ATACCAGACT 
 · L  L  * 
 3181 CTTGCTCTGA TGTTTCCAGG CCAGTGTTCA GCTCAGTGTG TTTGGGAGGA GGCCATTGGT 
 3241 TTGGATCCCA GGATGGGACG ACATCTGAGC ACAGCCCACT CAGATGGAAC CTGGATCTGC 
 3301 CCAGGGCCAA CCCAATAGGT CACCTTTGTT CTGGCACAGG AAAGCACATC AGTGCCCTGT 
 3361 GGAGTAGACT TCACTGAATC CCAACTTTGC CATCAACTTC TTGCCAAGAT TCAATCCTGG 
 3421 GATGTTGAAG AGGGGCAGCC TGCCTGTACA GGATGGGGCT GGTCTCAAGT CAAGCTGACA 
 3481 TGCGTCAGGG AGGCCCATGG ATGCCACTGA GTATTTATGG GTGTGGAGAG CTCCCCACGA 
Figure 4.  Continued. 
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 3541 GGAGGGATGC TCGGGAAGTA ACTGTTTGCT TTGTCTTAGC TCATGGTCAT CCATCAGGTT 
 3601 GAGTGGTTCG TCCACTCATC CTGGACCCTA CACATGGCAC TTCCTCTGTG GTTGAGATTC 
 3661 GGAATGTAGG CATTCTCACC TTTGATCTTT CCCTTGTACC CTGGCCCTGC TCCCACCCTC 
 3721 CCATCCGCCT CAACCCTCCC CCCATCCAGG GTGGGAGGGG CTACAACTCA CCCTGCTCTC 
 3781 CTTCTGGTAC TTAGGACAGT ATTGAAAGGG GACAGGTGAC ATACATGTGT TCCTCAAGAC 
 3841 ATTCTAGAGT TTCAAGAAAA ATATGACTGC CCAGCAACTG GACTTTTATT TCCAGTGAAA 
 3901 TCAATTACTC TTCAGTTAAA CCTTTGGGAA CAACTCTGTA TCCAAATGCA ACTTTTAAAA 
 3961 CTAACCTAGG CCAGAATTTT GAACAGCCCC ACCAGGTCTC TGAAGCCTGT GAACTGAACT 
 4021 CTGGCAGCAG ACTTCCAAAA TATATTCATA AGAGATGGTT TGGTTTTGTT TGTGCCAGGC 
 4081 CACTTTAGGA TATAAAGTTA TAGATCAAAA GTTTACAGGG CAAAATCAAA GGCCCTTCCT 
 4141 TACAAAACAA ATGTTTTTCT CTGAATTTTT CAGAAGCTTC TGTAAACTGT CAGGTACTGT 
 4201 GCAAGTGTTA TTATTTCAAC ACTGTTATTT GTGAAAAACT GGTTAATGTT TATAAACCAC 
 4261 TTTGTTTTAT TCTCCCTAGT TCATGATTTT ATAAAAAAAA AAAAAATGAC CATGAATGTT 
 4321 ATGCTGTAAA TAATCACAGA AGATAAAACT ATTGAGTCAC CAGAACTATC TTCATTGTGA 
 4381 CCAAACACAA TGAAGTATTT AAAAATACTC TGAACATTAT CACATATTAA AGCACAATAT 
 4441 TCTCCTTGAA GGGAGGAGAC ATGATGTTTC AACCAGATAA TTGATTGCTT AAGGCACAAG 
 4501 CAGTGTTTAG AAATAGCCTC GCAATCAAAA CACATTTGGC TTCAGTTTAG AGAAGTCTAG 
 4561 CCCAGCGTGG AGTTGTAAGT TATAGAGGAA CCTCAGTGTC CCGGCAGAAA CACAGATGAG 
 4621 AGAGACGCAA GCAGGCCCCT GGGCCTCCCT CCATTCTCTC CAAGTGTCTC CAGGGGAGAA 
 4681 GGATGGAGAA GACTGGGGAA CAGTTCTCCT CTGCAAGCAG CCTCGTGGGT AGGCCTTGGT 
 4741 GAAATAATTC TTAGCTGAAT TTAATTAGCA AGGACTCAGG TGGCTGCTCA TCAAGGTAGA 
 4801 ATCGGCTTCC TTGAATGGTT TCCTGTGTGT CTGGTTGGTT AAATACTGTG GCATCTCCCT 
 4861 GGGCGCCTCC CCAGTAAGGG CATGTGTGTG GGTTCTCTTC ATTTGTTTGA ATTTATTTTA 
 4921 TTGAGGTATG GTTGATTTAC AGCGTTGTGT TAATTTCTAT ACAGCTGAAT GATTCTGTTA 
 4981 TACATATGTG TACATACTCT TTTTCCATTA TGCTTTTTCA CAGGATAAAC TACTCATAGT 
 5041 TCCTTGTGCT ATACATTAGG ACTTTTTTAT GTATCCATTC AATATATAAT ACATTTGCTA 
 5101 ACCTC 
Figure 4.  Continued. 
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used in direct sequencing reactions to obtain flanking sequence for exon 3. Primer pairs 
were then designed to amplify intron 2 and intron 3 by using the flanking sequence.  
PCR was performed and intron size was estimated as the size of the fragment based on 
molecular weight (Fig. 5) reduced by the known size of the coding sequence included in 
each amplicon.  This method was used for all introns except intron 1 and intron 5 for 
which the exact intron size of 1184 bp and 210 bp, respectively, is reported based on 
sequence data.  The estimates for the remaining introns are: intron 2, 2400 bp; intron 3, 
3150 bp; intron 4, 5350 bp; intron 6, 2950 bp; intron 7, 1950 bp; intron 8, 1025 bp; 
intron 9, 1750 bp; intron 10, 3600 bp and intron 11, 1500 bp.  The PCR products 
containing each intron were partially sequenced from both directions to obtain 
intron/exon boundary sequence information (Table 5).  The exon and flanking sequence 
data have been submitted to GenBank as accession numbers AY518738-AY518748.  
The combined sequencing results demonstrate that the bovine CARD15 gene is 
comprised of 12 exons, 11 of which are translated, and that the gene spans 
approximately 30 kB (Fig. 6). 
 
The expression of bovine CARD15 is greatest in peripheral blood leukocytes.  
Bovine CARD15 mRNA was detected in all tissues examined with the exception of 
small intestine.  The expression profile shows a 4.75 fold difference in expression 
between peripheral blood leukocytes and liver, the latter being arbitrarily chosen as a 
calibrator for the analysis (Table 6; Fig. 7).  Thyroid was the only other analyzed tissue 
in which the expression of CARD15 mRNA exceeded that of liver.  These results are 
consistent with the results of Ogura et al. (2001b) in human and in mouse (2003) which 
found that CARD15 is expressed most abundantly in peripheral blood leukocytes. 
 
Discussion 
 
The bovine homolog of the human CARD15 gene was sequenced.  The gene 
transcript is 5105 bp and is translated into a protein of 1013 amino acids.  By somatic 
hybrid cell and radiation hybrid mapping, bovine CARD15 was unequivocally localized  
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Figure 5.  Bovine CARD15 intron amplicons sized by gel 
electrophoresis.  Intron amplicons are ordered according to molecular 
weight in order to aid in the estimation of amplicon size.  Lane 1 contains a 
1 kb DNA step ladder (Promega Corp., Madison, Wisc.).  Lane 12 contains 
a 100 bp step ladder (Promega Corp.). 
 
1   2   3   4    5   6    7   8   9  10 11 12   Lane
8   1  11   9   7   2    6   3  10  4         Intron
1000 bp
1100 bp
1200 bp
1500 bp
2000 bp
3000 bp
4000 bp
1000 bp
2000 bp
3000 bp
4000 bp
5000 bp
6000 bp
7000 bp
8000 bp
9000 bp
10,000 bp
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Table 5.  Intron and exon sizes and boundary sequences for bovine CARD15 
Exons  Introns Splicing sites  
 
No. 
 
cDNA 
location 
(bp) 
 
Size 
(bp) 
 
No. 
 
Approx. 
Size 
(bp) 
 
Donor sites 
 
Exon        Intron 
 
Acceptor sites 
 
Intron        Exon 
 
1 
 
1-140 
 
140 
 
1 
 
1184a 
   
cctcccag 
 
ATTGT 
2 141-607 467 2 2400 AGCGG gtaagcac ccgcacag GCAAG 
3 608-713 106 3 3150 TGAAG gtatatat tcttccag ATGCT 
4 714-2529 1816 4 5350 CTTTA gtgagtga ttgtttag CTTGC 
5 2530-2613 84 5 210a TTAGC gtaagtca ctttccag TCTTT 
6 2614-2697 84 6 2950 TTGAG gtgagcct ccttccag GCTAG 
7 2698-2781 84 7 1950 TTGGG gtaggtgg actttcag GTTCT 
8 2782-2865 84 8 1025 CTCAG gtaagcct acatccag CCTGG 
9 2866-2949 84 9 1750 CTCTG gtgagttt cttgccag CCTGG 
10 2950-3033 84 10 3600 CTGAA gtaaggaa ctctctag GCTGT 
11 3034-3117 84 11 1500 GTCTG gtaagatc   
12 3118-5105 1988       
aIndicates the exact intron size. 
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Figure 6.  Genomic structure of bovine CARD15.  
Boxes represent the relative sizes and positions of 
exons within the genomic sequence. 
~30kB
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Table 6.  Bovine CARD15 expression by tissue using the comparative CT method 
Tissue CARD15 
Avg. CT a 
Beta-actin 
Avg. CT 
∆CT b ∆∆CT c 2−∆∆CT 
PBLd 28.98±0.03 32.59±0.05 -3.61±0.02 -2.25 4.75 
Kidney 31.98±0.14 32.61±0.13 -0.63±0.01 0.73 0.60 
Thyroid 32.30±0.23 33.96±0.41 -1.66±0.31 -0.3 1.23 
Liver 30.45±0.50 31.81±0.34 -1.36±0.18 0 1.00 
Adrenal 31.28±0.26 28.79±0.08 2.49±0.22 3.85 0.07 
Lung 33.30±0.47 27.83±0.31 5.48±0.51 6.83 0.01 
Anterior Pituitary 32.22±0.22 32.28±0.10 -0.06±0.17 1.3 0.41 
Pancreas 31.24±0.26 30.49±0.03 0.75±0.23 2.10 0.23 
Bone Marrow 33.63±0.72 30.22±0.16 3.41±0.64 4.77 0.04 
Muscle 34.53±0.85 30.04±0.32 4.49±0.72 5.85 0.02 
Heart 32.84±0.94 33.04±0.33 -0.20±0.79 1.16 0.45 
Spleen 43.04±0.04 25.71±0.01 17.33±0.02 18.68 0.00 
Hypothalamus 32.84±0.66 33.47±0.38 -0.63±0.40 0.73 0.60 
Small Intestine 53.05±2.76 25.50±0.05 27.55±2.72 28.91 0.00 
aCT = Cycle Threshold:  Cycle number where amplification exceeds the 
threshold determined by the geometric portion of the amplification curve. 
b∆CT = Averaged CARD15 CT – Beta-actin CT :  Normalization of RT-PCR 
cycles for CARD15 target to beta-actin house keeping gene. 
c∆∆CT = Mean ∆CT – Liver mean ∆CT value: Liver was used as a calibrator to 
set the baseline for comparing mean differences in ∆CT values across all 
tissues. 
dPeripheral Blood Leukocytes. 
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Figure 7.  Bovine CARD15 mRNA expression profiles by tissue type. 
PBL = Peripheral Blood Leukocytes.  Ant. Pit. = Anterior Pituitary. 
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to the region of BTA18 that is homologous to HSA16q21.1 and which harbors human 
CARD15.  However, attempts to order bovine CARD15 within the bovine RH map 
revealed two possibilities with high levels of statistical support.  The most likely order 
(Fig. 1) results in a rearrangement when compared to the homologous region in human, 
while the next best order results in conserved synteny with HSA16q21.1. 
The gene order in human is ADCY7, CARD15, CYLD and MMP2.  A 
comparative mapping project of BTA18 to homologous human and mouse chromosomes 
(Goldammer et al. 2002) revealed a small gap between linkage groups 1 and 2 in human 
that spans approximately 8 cR3000 on the human GB4 WGRH cR3000.  The most distal 
marker in group 1 is ADCY7 and the most proximal marker in group 2 is MMP2.  The 
physical distance between these 2 genes in human is approximately 4.7 Mb 
(http://genome.ucsc.edu/cgi-bin/hgGateway?org=human).  In the cattle RH map 
produced by Goldammer et al. (2002) ADCY7 is the most distal marker in linkage group 
2 and MMP2 is the most proximal marker in linkage group 3.  The distance between the 
two linkage groups was estimated to be 42 cR5000.  In this study, CYLD was identified 
within  the same BAC containing bovine CARD15.  Although not present in the human 
or cattle RH maps, CYLD is located approximately 45 kb from CARD15 in human.  To 
test the hypothesis that all loci within this region possess conserved synteny between 
human and cattle and that the second most likely locus order was, in fact, the correct 
gene order, a set of primers was developed to amplify the bovine ADCY7 gene and used 
to screen two bovine BACs known to harbor CARD15 for the presence of ADCY7.  
Neither of these BACs were identified as containing ADCY7.  Since one BAC was 
known to contain both bovine CARD15 and CYLD, the second most likely order 
obtained from the RH mapping is, in fact, the correct gene order and thus gene order is 
completely conserved among these genes between human and cattle.  Since the retention 
frequency of the bovine CARD15 probe in the bovine SHC panel was 0.156 and 
considerably lower than the average panel retention frequency of 0.227, the greater 
likelihood for the incorrect locus order is a statistical artifact due, no doubt, to the small 
physical distance separating the loci. 
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Considerable difficulty was experienced in obtaining the sequence of the target 
gene even when the complete sequence for the human homolog was known.  This was 
due in part to the complexity of structure of the target gene, but also because sequence 
for certain regulatory regions including the 5’UTR was important.  Even though the 
coding regions of most protein coding genes are quite highly conserved across species, 
the development of primers from sequence in one species for use in another species is 
often a tenuous proposition.  Clearly, the closer the two species are evolutionarily the 
greater are the chances for successful primer development.  The likelihood of success of 
this approach may be further enhanced if sequence is available from two, or more, 
divergent species since primers may be designed from regions that are highly conserved 
among all species.  Of course, this approach assumes that there is sufficient conservation 
of sequence identity among the species for the genomic regions that are to be sequenced 
from the target species.  This will not always be the case for coding regions, and is 
unlikely to be the case for noncoding regions such as introns, 5’UTR and 3’UTR. 
In this case, the strategy proved ineffective.  The structure of the human 
CARD15 gene is reasonably complex comprising 12 exons, many of them short, thus 
allowing few opportunities for stretches of sequence with high levels of homology 
between human and mouse from which to design primers.  Furthermore, it is a challenge 
to develop assays to amplify products for which size is unknown in the target species.  
Thus, the lack of success with this approach may have been due either to the unknown 
size of the target amplicon or with the sequence content of the primers themselves. In 
order to generate coding sequence, bovine cDNA clones were completely sequenced, 
from which bovine EST sequences had been produced and that had homology to human 
CARD15.  This strategy allowed the generation of sequence data for the region of the 
bovine CARD15 gene representing a portion of exon 4 through to the 3’UTR.  Suitable 
primer pairs were then developed to amplify across introns of the gene.  To capture 
sequence from the 5’ end of the gene, BACs were isolated harboring the cattle CARD15 
homolog and then used to obtain sequence data by developing primers based on the 
human to mouse alignment.  Contrary to the initial results, this primer development 
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strategy was successful in obtaining sequence data for exons 2, 3 and the missing portion 
of exon 4.  The success in this region of the gene can be attributed to the larger size of 
these exons and the fact that only one suitable primer had to be developed to prime the 
sequencing reactions using BAC DNA as a template.  Although this method did produce 
sequence data, the primers were not successful in amplifying across introns in this region 
of the gene.  However, the sequence data obtained from the flanking regions of exon 3 
was used to develop primer pairs that would amplify across introns 2 and 3. 
Exon 1 which includes the 5’UTR had virtually no homology between human 
and mouse and so no suitable primer pairs could be developed using the comparative 
sequence approach to acquire sequence data for this region of the bovine gene.  Thus, 5’ 
and 3’ RACE was performed to obtain the bovine sequence for the 5’UTR and the 
remainder of the 3’UTR that was not included in the cDNA clones.  While this approach 
was successful for generating sequence in the 5’ region of bovine CARD15, the presence 
of a mononucleotide A14 repeat located approximately 1100 bases into the bovine 
3’UTR and approximately 800 bases upstream of the actual PolyA site defeated the 
attempt to capture the complete 3’UTR sequence by this approach.  The 3’ RACE 
approach utilizes an adapter that ligates to the PolyA tail of the transcript which is then 
used to prime the subsequent amplification steps.  In this application, the adapter 
preferentially ligated to the internal PolyA repeat site effectively isolating the remainder 
of the 3’UTR from the sequencing attempt.  Fortunately, a recent deposit by the USDA 
MARC to the GenBank bovine EST sequence database was found to be homologous to 
the 3’UTR of the bovine CARD15 gene.  The new sequence included the PolyA repeat 
as well as additional downstream sequence.  The cDNA clone was sequenced from 
which the EST sequence was derived and thus the complete sequence for the entire 
3’UTR of the bovine CARD15 gene was acquired. 
While the difficulties encountered in obtaining sequence data for a target gene in 
a sequence-poor species are not unique, these experiences demonstrate the considerable 
resource cost that can be faced by researchers investigating genomic diversity in 
sequence-poor species.  Fortunately, bovine has been identified as a high priority species 
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by the NHGRI for sequencing and an 8× deep sequence coverage should be produced, 
assembled and annotated within the next two years.  The rapid increase in availability of 
whole genome sequence assemblies should alleviate some of these problems for 
researchers in the future. 
Overall, these data provide comprehensive sequence information for the bovine 
CARD15 gene which may provide a basis for future comparative studies of the gene.  
The map location of bovine CARD15 is presented which may prove beneficial for QTL 
or candidate gene studies targeted at identifying regions of the bovine genome harboring 
genes associated with disease resistance or susceptibility. 
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COMPARATIVE SEQUENCE ANALYSIS OF CARD15 
 
Introduction 
 
Comparative genomics is increasingly becoming an important tool for 
deciphering the information contained in the completed genome sequences of both 
closely and distantly related species and taxa.  Previously, comparative genomics has 
played a large role in gene discovery using information from sequence-rich species to 
obtain sequence for application in sequence-poor species.  It has also been extensively 
used to analyze the effects of genome organization in a multitude of species.  The basic 
premise of comparative genomics assumes that features that are common between two 
organisms will likely reflect features encoded in the DNA that are conserved between 
the species.  This includes both sequences that encode proteins and various RNAs as 
well as the DNA sequences that regulate the expression of coding genes.  Similarly, 
features that differ between species should reflect a divergence in the DNA sequences 
that encode or control the expression of the proteins that are responsible for variation in 
these features. 
With the current availability of whole genome sequences for a number of species, 
it is now possible to align complete genome sequences and begin to address the 
important questions concerning the roles of elements of the DNA sequence.  It has long 
been recognized that regions of noncoding DNA with high levels of homology between 
divergent species are excellent candidates for being functional regions (Hardison et al. 
1997).  It has further been shown that the comparison of genomic sequences from more 
than two species provides even greater resolution for distinguishing regulatory regions 
(Thomas et al. 2003) since the likelihood of conservation of non-functional sequence is 
reduced exponentially assuming that the region is free to evolve independently among 
the compared species. 
Two groups have now examined the structure and function of the Card15 gene in 
mouse and both studies have concluded a conserved role for the gene in human and 
mouse NF-kB activation (Iwanaga et al. 2003; Ogura et al. 2003).  In both human and 
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mouse, CARD15 has been shown to respond to bacterial components (LPS, PGN) 
(Ogura et al. 2001b; Ogura et al. 2003) and mutations in the gene that hinder 
responsiveness to bacterial components have been associated with susceptibility to 
Crohn’s disease.  However, there is currently no information available concerning the 
cis- or trans-acting elements that regulate the CARD15 gene.  Plant R genes that are 
similar to CARD15 contain leucine rich repeats (LRR) which vary in copy number and 
provide protection/recognition of diverse types of bacteria.  These genes have been 
extensively studied in terms of their structural organization, sequence evolution and 
genome distribution; however, information on the regulation of these genes is also 
limited. 
An improved understanding of the elements responsible for the regulation of 
CARD15 should prove to be useful for elucidating the function of CARD15 in disease 
susceptibility.  In this study, the bovine CARD15 sequence was exploited and a three 
species comparative analysis was performed in the hope of gaining further insight into 
the regulation of the gene.  Results are provided from the alignment of the complete 
transcript of the gene in human, mouse and bovine.  A comparison of the intronic 
sequences which closely flank exons conserved across the three species is also included.  
Finally, CARD15 sequence for Bos indicus and Bison bison is reported and a 
comparative analysis between the subspecies Bos taurus and Bos indicus and the closely 
related Bison bison is included. 
 
Materials and Methods 
 
Sequence alignment and analysis.  All alignments were constructed using 
AlignX in the Vector NTI suite (Informax, Frederick, Mar.).  Alignments for the 
comparative analysis used published sequence data available for human, mouse and 
bovine CARD15 (Accession numbers AF178930, AF520774, AY518737).  Nucleotide 
and amino acid identities were computed using pairwise alignments.  Intron sizes from 
human and mouse were calculated by aligning full length transcript sequences to the 
genome sequence. 
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Protein domain identification.  To identify protein domains within the bovine 
gene, bovine sequence was analyzed using two domain analysis programs AnDom 
(http://www.bork.embl-heidelberg.de/AnDom; Schmidt et al. 2002) and ProDom 
(http://www.toulouse.inra.fr/prodom.html, Sonnhammer and Kahn 1994; Corpet et al. 
2000).  Additionally, the bovine CARD15 gene was aligned with the domains identified 
in human and mouse (Ogura et al. 2001a; Iwanaga et al. 2003; Ogura et al. 2003). 
 
Identification of putative regulatory regions.   The bovine sequence was 
searched for regulatory motifs in the 5’UTR and 3’UTR using the program UTRscan 
(http://www.ba.itb.cnr.it/BIG/UTRScan/; Pesole and Liuni 1999).  The 5’ and 3’ 
flanking intronic regions for ~200 bp each side of each CARD15 exon were also aligned.  
Short motifs identified as being conserved between the three species in these intronic 
regions as well as in the 5’UTR and 3’UTR were then analyzed using the TFSCAN 
(http://zeon.well.ox.ac.uk/git-bin/tfscan) and NSITE (available through SoftBerry 
http://www.softberry.com/berry.phtml?topic=promoter) programs to identify putative 
regulatory motifs.  Motifs selected for analysis required homology consisting of 6 or 
more bases with no more than 2 substitutions among the 3 species. 
 
Bos indicus and Bison bison CARD15 sequence.  Using the flanking intronic 
sequence that was previously obtained from the amplified intronic sequence generated 
for intron sizing, primers were designed to amplify each exon in its entirety (Table 7).  
These primer sets were used to amplify all exonic and some flanking intronic portions of 
CARD15 in one indicus and one bison animal.  The PCR reactions were performed in a 
50 µl reaction volume: 15 mM Tris, 50 mM KCl, 1.5 mM MgCl2, 200 µM of each dNTP 
(dATP, dCTP, dGTP and dTTP), 1 µM each primer, 50 ng DNA, 0.5 units of AmpliTaq 
Gold DNA Polymerase (Applied Biosystems, Foster City, Calif.).  The general PCR 
reaction included an initial hot start of 10 min at 95°C followed by 35 cycles for 30 s at 
94°C, 30 s at the optimized annealing temperature and 45 s (or 1 min see Table 7) at 
72°C, followed by a final elongation step at 72°C for 7 min.  The PCR products were 
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Table 7.  Primers used to amplify the exons of bovine CARD15 
 
Exon Sense 5' to 3’ 
 
Antisense 5' to 3' 
 
Anneal. 
Temp.a 
Approx.
product 
size 
1 ATGTCCCTGTTTTGTAGACAGACG CAGAACACTGCTGTGAAGATGC 58/1min ext 900 
2 CTCAGTTTGAACACCTGTACAATGG AGGAGGACTATGACCCACATCTC 52 690 
3 GGCCTTTTATTGTGGTGGAA TGCTGATGTTTTTGCTCTTCA 55 300 
4.1 TGGGTTCCTACCTGCAAAAC CACTGAGGGCGAGGTAGAAT 52/1min ext 2250 
4.2 CAGTCCAGAGTCTGCTCTTCAAC GCCATTCCATGAATTTCAACTATC 55/1min ext 1360 
5-6 GTCTCTGTGGGGGTTTTGTC GTCCTTGTTTTCAGCGAGGT 55 500 
7 GGGAGCAGTAAGGGTCCTC CAGAGATCTTGGGGCTGAAG 55 300 
8 CACTTGCTGGGACCTGAGT CCCTCCTCACACTGGCTTC 53 200 
9 GCATTTTGCCCTTCTTGAGT ACGCAGTCATCCATCTTGGT 53 200 
10 GGGCACATGGGTTCATCTT CCCTCTCAAGGCCAATCAT 55 200 
11 CCAGCTCCCAAAGTCTCCTT GAGGCTCAGAGAGGTTAAAGAGG 53 200 
12.1 AGGTTTACAAAGCAGCATCTTCC ATGTCACCTGTCCCCTTTCA 58/1min ext 750 
12.2 CACCTTTGATCTTTCCCTTGTACC CCCTGGAGACACTTGGAGAG 56/1min ext 1000 
12.3 CCAGCGTGGAGTTGTAAGTTATAG AGACAAAGGACACAGAGACCAGAC 58/1min ext 700 
aExtension (ext) time was 45 s unless otherwise indicated. 
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analyzed by electrophoresis on 2% agarose gels in 1.0× TBE buffer (90 mM Tris/64.6 
mM boric acid/2.5 mM EDTA, pH 8.3) and stained with ethidium bromide. The PCR 
product was purified using QIAquick® (Qiagen, Valencia, Calif.) spin columns. 
Cycle sequence reactions were performed in a 10 µl reaction volume: 1 µl Big 
Dye v3.0 (Applied Biosystems), 10 ng amplified DNA, 0.5 µl of 5% dimethylsulfoxide 
(DMSO), 0.5 µl of 20 µM primer.  The cycle sequence reaction included an initial 
denaturation step of 2 min at 96°C, 35 cycles for 15 s at 96°C, 20 s at 50°C and 4 min at 
60°C, followed by a final elongation step at 60°C for 15 min.  Unincorporated 
nucleotides and primers were removed from the reactions using a BioMax® Spin-50 
mini-column (Millipore Corp., Bedford, Mass.).  Sequencing reactions were run on an 
ABI 3100 DNA analyzer (Applied Biosystems).  The resulting sequence was aligned 
with Bos taurus CARD15 sequence (Accession number AY518737) and nucleotide and 
amino acid homology was inferred by pairwise comparison. 
 
Results 
 
Bovine CARD15 is highly homologous to human and mouse counterparts.  The 
bovine CARD15 mRNA is 5105 base pairs and the protein it encodes is comprised of 
1013 amino acids (Fig. 4).  This compares to the human CARD15 gene with an mRNA 
length of 4485 bp and the mouse Card15 gene with an mRNA length of 4585 bp.  The 
number and size of exons are completely conserved between human, mouse and bovine 
with the exception of exon 1 (Table 8).  There is some variation in intron size which is 
primarily responsible for the variability in the genomic size of CARD15 among the 3 
species (Table 8).  Domain analysis of the bovine CARD15 gene and alignment with its 
mouse and human homologs, revealed that the bovine gene is comprised of two N-
terminal caspase recruitment domains (CARD) (residues 4-93; 96-191), one centrally 
located nucleotide binding oligomerization domain (NOD) (residues 243-548) and 10 
tandem LRR at the C-terminus (residues 715-992).  A representation of the domain 
structure of bovine CARD15 in relation to the human and mouse homologs is presented 
in Fig. 8.  The pairwise amino acid homology between the species for each of the 
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Table 8.  Genomic structure of CARD15 in human, mouse and bovine 
Chromosome HSA16 MMU8 BTA18 
Genomic size kb ~36 ~39 ~30 
Transcript length bp: 4485 4585 5105 
Protein length aa: 1040/1013 1020/1013 1013 
No. Exon Intron Exon Intron Exon Intron 
1 178 2169 110 1415 140 1184 
2 467 7899 467 7342 467 ~2400 
3 106 2596 106 3053 106 ~3150 
4 1816 4192 1816 5239 1816 ~5350 
5 84 221 84 169 84 210 
6 84 2948 84 1926 84 ~2950 
7 84 2613 84 2145 84 ~1950 
8 84 592 84 456 84 ~1025 
9 84 2104 84 5160 84 ~1750 
10 84 4242 84 5531 84 ~3600 
11 84 1844 84 2500 84 ~1500 
12 1330  1498  1988  
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Figure 8.  Comparative protein alignment for CARD15.  Bold lines represent CARD 
domains; small dashed lines represent the NOD including the P-loop and Mg2+ binding 
site within boxes; larger dashed lines represent the 10 LRR.  Shaded amino acids are 
identical.  Arrow heads indicate amino acids associated with Crohn’s disease.  Four 
point stars indicate amino acids associated with Blau Syndrome. 
 
    mouse --------------------MRSSCCDMCSQEEFQAQRSQLVALLISGSLEGFESILDWLLSWDVLSRED   
   bovine ---------------------------MCAQDAFQTQRSQLVELLVSGSLEGFESILDRLLSREVLSWED 
    human MGEEGGSASHDEEERASVLLGHSPGCEMCSQEAFQAQRSQLVELLVSGSLEGFESVLDWLLSWEVLSWED 
 
    mouse YEGLSLPGQPLSHSARRLLDTVWNKGVWGCQKLLEAVQEAQANSHTFELYGSWDTHSLHPTRDLQSHRPA 
   bovine YEGLSLVGQPISHLARRLLDTIWNKGTWGCEQLTAAVREAQADSQPPELPSSWDPHSPHPARDLQSHRPA 
    human YEGFHLLGQPLSHLARRLLDTVWNKGTWACQKLIAAAQEAQADSQSPKLHGCWDPHSLHPARDLQSHRPA 
 
    mouse IVRRLYNHVEAMLELAREGGFLSQYECEEIRLPIFTSSQRARRLLDLAAVKANGLAAFLLQHVRELPAPL 
   bovine IVRRLYGHVEGVLDLTQQRGFISQYETDEIRRPIFTSSQRARRLLDLATVKANGLAAFLLQCIQELPVPL 
    human IVRRLHSHVENMLDLAWERGFVSQYECDEIRLPIFTPSQRARRLLDLATVKANGLAAFLLQHVQELPVPL 
 
    mouse PLPYEAAECQKFISKLRTMVLTQSRFLSTYDGSENLCLEDIYTENILELQTEVGTAGALQKSPAILGLED 
   bovine ALPFEDAACKKYVSKLRTVISAQSRFLSTYDGAENLCLEEVYTENVLEIQMEVGMAGPSQQSPTTLGLEE 
    human ALPLEAATCKKYMAKLRTTVSAQSRFLSTYDGAETLCLEDIYTENVLEVWADVGMAGPPQKSPATLGLEE 
 
    mouse LFDTHGHLNRDADTILVVGEAGSGKSTLLQRLHLLWATGRSFQEFLFIFPFSCRQLQCVAKPLSLRTLLF 
   bovine LFSTRDHFNKEADTVLVVGEAGSGKSTLLQQLHLLWASGRAFQEFLFVFPFSCRQLQCLVKPLSMRTLLF 
    human LFSTPGHLNDDADTVLVVGEAGSGKSTLLQRLHLLWAAGQDFQEFLFVFPFSCRQLQCMAKPLSVRTLLF 
 
    mouse EHCCWPDVAQDDVFQFLLDHPDRVLLTFDGLDEFKFRFTDRERHCSPIDPTSVQTLLFNLLQGNLLKNAC 
   bovine EHCCWPDLGPQDVFQVLLDHPERILLTFDGFDEFRFRFTDQERHCCPTAPTSVQSLLFNLLQGNLLKNAR 
    human EHCCWPDVGQEDIFQLLLDHPDRVLLTFDGFDEFKFRFTDRERHCSPTDPTSVQTLLFNLLQGNLLKNAR 
 
    mouse KVLTSRPDAVSALLRKFVRTELQLKGFSEEGIQLYLRKHHREPGVADRLIQLIQATSALHGLCHLPVFSW 
   bovine KVLTSRPSAVSASLRKHVRTELSLKGFSEEGIELYLRKRHREPGVADRLLCLLRATSALHGLCHLPVFSW 
    human KVVTSRPAAVSAFLRKYIRTEFNLKGFSEQGIELYLRKRHHEPGVADRLIRLLQETSALHGLCHLPVFSW 
 
    mouse MVSRCHRELLLQNRGFPTTSTDMYLLILQHFLLHASPPDSSPLGLGPGLLQSRLSTLLHLGHLALRGLAM 
   bovine MVSKCHEELLLQGRGSPKTTTDMYLLILRHFLLHASPLPLATHGLGPSLIQGRLPTLLHLGRLALWGLGT 
    human MVSKCHQELLLQEGGSPKTTTDMYLLILQHFLLHATPPDSASQGLGPSLLRGRLPTLLHLGRLALWGLGM 
 
    mouse SCYVFSAQQLQAAQVDSDDISLGFLVRAQSSVPGSKAPLEFLHITFQCFFAAFYLAVSADTSVASLKHLF 
   bovine CCYVFSAKQLQAAHVDSEDLSLGFLVLAKRVVPGSTAPLEFLHITFQCFFAAFYLALSADTPPSSLRHLF 
    human CCYVFSAQQLQAAQVSPDDISLGFLVRAKGVVPGSTAPLEFLHITFQCFFAAFYLALSADVPPALLRHLF 
 
    mouse SCGRLGSSLLGRLLPNLCIQGSRVKKGSEAALLQKAEPHNLQITAAFLAGLLSQQHRDLLAACQVSERVL 
   bovine QDHRPESSPLARVLPKLFLRGSRCREGSVAALLQGAEPHNLQITGAFLAGLLSQEHRSLLAECQASETAL 
    human NCGRPGNSPMARLLPTMCIQASEGKDSSVAALLQKAEPHNLQITAAFLAGLLSREHWGLLAECQTSEKAL 
 
    mouse LQRQARARSCLAHSLREHFHSIPPAVPGETKSMHAMPGFIWLIRSLYEMQEEQLAQEAVRRLDIGHLKLT 
   bovine LRRWDCVRRCLTRSLREHFRSIPPALPGEAKSMHALPGFLWLIRSLYEMQEERLAREAVCRLNVGHLKLT 
    human LRRQACARWCLARSLRKHFHSIPPAAPGEAKSVHAMPGFIWLIRSLYEMQEERLARKAARGLNVGHLKLT 
 
    mouse FCRVGPAECAALAFVLQHLQRPVALQLDYNSVGDVGVEQLRPCLGVCTALYLRDNNISDRGARTLVECAL 
   bovine FCGVGPAECAALAFVLRHLRRPVALQLDHNSVGDIGVEQLLPCLGVCKALYLRDNNISDRGICKLVEHAL 
    human FCSVGPTECAALAFVLQHLRRPVALQLDYNSVGDIGVEQLLPCLGVCKALYLRDNNISDRGICKLIECAL 
 
    mouse RCEQLQKLALFNNKLTDACACSMAKLLAHKQNFLSLRVGNNHITAAGAEVLAQGLKSNTSLKFLGFWGNS 
   bovine RCEQLQKLALFNNKLTDGCAHSMARLLACKQNFLALRLGNNHITAAGAEVLAQGLRTNNSLQFLGFWGNQ 
    human HCEQLQKLALFNNKLTDGCAHSMAKLLACRQNFLALRLGNNYITAAGAQVLAEGLRGNTSLQFLGFWGNR 
 
    mouse VGDKGTQALAEVVADHQNLKWLSLVGNNIGSMGAEALALMLEKNKSLEELCLEENHICDEGVYSLAEGLK 
   bovine VGDEGAQALAAALGDHQSLRWLSLVGNNIGSVGAQALALMLEKNMALEELCLEENHVQDEGVCFLAKGLA 
    human VGDEGAQALAEALGDHQSLRWLSLVGNNIGSVGAQALALMLAKNVMLEELCLEENHLQDEGVCSLAEGLK 
 
    mouse RNSTLKFLKLSNNGITYRGAEALLQALSRNSAILEVWLRGNTFSLEEIQTLSSRDARLLL 
   bovine RNSSLKVLKLSNNHISSLGAEALLRALEKNDTILEVWLRGNTFSPEEIEKLSHQDTRLLL 
    human KNSSLKILKLSNNCITYLGAEALLQALERNDTILEVWLRGNTFSLEEVDKLGCRDTRLLL 
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1020 
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1040
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domains is presented in Table 9. 
In addition to the CARD15 domain structure, Fig. 8 also represents the protein 
alignment of the three species’ sequences.  One notable difference between the species is 
that both mouse and human have two in-frame translation initiation sites, while the 
bovine sequence contains only one translation start site.  In human, these sites are 
separated by 81 nucleotides, whereas, in mouse the sites are separated by 21 nucleotides 
resulting in 2 different protein products consisting of 1040/1013 amino acids in human 
and 1020/1013 amino acids in mouse.  In both species, the second translation initiation 
site corresponds to the unique bovine translation initiation site. 
A comparison of the 1013 amino acid bovine protein product to the 
corresponding 1013 amino acid human and mouse products revealed an 83.7% and 
76.8% homology at the nucleotide level and an 81.2% and 76% homology at the amino 
acid level, respectively.  Additionally, the extent of conservation of the amino acids that 
have been shown to be associated with susceptibility to Crohn’s disease and Blau 
Syndrome was examined.  The consensus sequence of two of the amino acids associated 
with susceptibility to Crohn’s disease has recently been reported as being conserved 
(G908R, 1007fs) between human and mouse, while that for a third is variable (R702W).  
The results of this study indicate that the consensus sequences for all three of these 
amino acids are conserved between cattle and human (Fig. 8).  Furthermore, the 
consensus sequences of both amino acids associated with susceptibility to Blau 
Syndrome are conserved across all three species (Fig. 8). 
 
The CARD15 5’UTR and 3’UTR are not conserved across species.  Pairwise 
alignment of the 5’UTR revealed only a 35.4% homology between human and bovine, 
42.1% homology between mouse and bovine and 33.3% homology between human and 
mouse (Fig. 9).  The 3’UTR alignments also revealed low overall levels of homology, 
with only small contiguous regions of homology among the 3 species (Fig. 10).  
Pairwise alignments of just over 1000 bases of sequence from the region of highest 
homology within the 3’UTR revealed a 44.2% homology between bovine and mouse, 
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Table 9.  Pairwise percent amino acid homology by CARD15 domain 
Domain No. Amino Acids human/mouse human/bovine bovine/mouse 
CARD1 94 76.6 76.6 72.3 
CARD2 96 81.2 83.3 72.9 
NOD 305 82.3 82.3 78.4 
LRRs 277 81.2 88.1 80.1 
LRR1 28 75 85.7 82.1 
LRR2 28 89.3 85.7 89.3 
LRR3 25 88 100 88 
LRR4 28 82.1 89.3 85.7 
LRR5 28 78.6 92.9 78.6 
LRR6 28 78.6 82.1 85.7 
LRR7 28 75 92.9 67.9 
LRR8 28 82.1 89.3 85.7 
LRR9 28 82.1 78.6 71.4 
LRR10 28 82.1 85.7 67.9 
No Domain 241 75.1 74.3 70.5 
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    Human    (1) GTAGACAGATCCAGGCTCACCAGTCCTGTGCCACTGGGCTTTTGGCGTTC 
    Mouse    (1) ------------------------CCTTTTCTCCGGGTGTACTGGCTGGT 
   Bovine    (1) --------------------------------------CTCTGGACTCCG 
                                                             
    Human   (51) TGCACAAGGCCTACCCGCAGATGCCATGCCTGCTCCCCCAGCCTAATGGG 
    Mouse   (27) TTTGTGTGTCAATTTGACACAGGCTG-GAG--TTATCACAGAGAAAGGAG 
   Bovine   (13) TGACCATCACAGGAGGGAACCTGCTGAGAGA-TTTCCTCTGCTGCGTGGG 
                                                            
    Human  (101) --CTTTGATGGGGGAAGAGGGTGGTTCAGCCTC-TCACGATGAGGAGGAA 
    Mouse   (74) --CTTCAGTTGGGGAAGTGCCTCCATGAGATC----CAGCT--------- 
   Bovine   (62) GACCCTGCCAGGGCTTGGAGCTCTGTGAGATCGCTTCCCACGGACTCCCA 
                                                   Exon 2   
    Human  (148) AGAGCAAGTGTCCTCCTCGGACATTCTCCGGGTTGTGAAATG 
    Mouse  (109) -------------------------------GTTGTGACATG 
   Bovine  (112) GGACCCAGAGTCTGAG--GGCTGAGCCCAGGATTGTGAAATG 
 
Figure 9.  CARD15 5’UTR alignment for human, mouse and bovine.  Bases 
conserved among all three species are shaded.  Translation initiation sites are indicated 
in bold face. 
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 bovine3'   ------------------------------------------------------------ 
  human3'   ------------------------------------------------------------ 
  mouse3'   TGTCTCCGTTTGTGAGTGGACTGTAGGGGCCTGGACTCTGGAGGCTGAGTAACATCAGGC 
                   
 bovine3'   ------------------------------------------------------------ 
  human3'   ------------------------------------------------------------ 
  mouse3'   AGAATCCCTCTGCTACGCAGGGCTGGTTTGCTTTTCTGGATGCAGTATAGTCACCTTCTG 
                   
 bovine3'   ------------------------------------------------------------ 
  human3'   ------------------------------------------------------------ 
  mouse3'   TTAGCAGAGAAAGTCACCCCATTGCCGTCTGGAATTGACTTTTCCCGAGGAGTCGTGATG 
                   
 bovine3'   ------------------------------------------TGTTTCCAGGCCAGTGTT 
  human3'   ------------------------------------------AGTCTCCGGGAGGATGTT 
  mouse3'   GTTGGTCTTGGTTGTTAACTGCACTGACTTAAGAGAGTCATGAGCCGAGAGGACCGCGTT 
                   
 bovine3'   ----CAGCTCAGTGTGTTTGGGA-GGAGGCCATTGGTTTGGATCCC--AG-GATGGGACG 
  human3'   ----CGTCTCAGTTTGTTTGTGA-GCAGGCTGTGAGTTTGGGCCCC--AGAGGCTGGGTG 
  mouse3'   TCTGCCTCTAAAGAGGATCACCATGCAGAATTAGTGACTGGAAGGGGAAAGGCCCTCACT 
                   
 bovine3'   ACATCTGAG---CACAGCCCACTCAGATGGAACCTGGATCTGCCCAGGGCC--------- 
  human3'   ACATGTGTT---GGCAGCCTCTTCAAAATGAGCCCTGTCCTGCCTAAGGCTGAACTTGTT 
  mouse3'   GCATGTGGGTGACACAATCCTCTCTGGTTGCCCCGTGGGAGGATGATGGAGGAGGAGGAA 
                   
 bovine3'   -------AACCC---AATAGGTCACC-TTTGTTCTGGCACAGGAAAGCACA--TCAGTGC 
  human3'   TTCTGGGAACAC---CATAGGTCACC-TTTATTCTGGCAGAGGAGGGAGCA--TCAGTGC 
  mouse3'   GACAGGGTATGCTTGCATATGTGAGCATTTCTTCTGAGTGAGGACAGCTGTGGTTGCTGC 
                  
 bovine3'   CCTGTGGAGTAGACTTCA--CTGAATCCCAACTTTGCCATC-AACTTCTTGCCAAGATTC 
  human3'   CCTCCAGGATAGACTTTT--CCCAAGCCTACTTTTGCCATT-GACTTCTTCCCAAGATTC 
  mouse3'   CCTCATGTTTGAACAGCAGACTCCAGCGT-CTTTGGCCATTCAACATGGACCCA----TC 
                   
 bovine3'   AATCCTGGGATGTTGAAGAGGGGCAGCCTGCCTGTACAGGATGGGGCTGGTCTCAAGTCA 
  human3'   AATCCCAGGATGTACAAGGACAGC--CCCTCCTCCATAGTATGGGACTGGCCTCTGCTGA 
  mouse3'   A--CCAGTGATGTTTTAGGGAGTTTTCAGGCCTGGAGCTTGATGGAACGTGAGGAGTCGA 
                   
 bovine3'   AGCTGACATGC----------GTCAGGGAGGCCCATGGATGCC-------ACTGAGTATT 
  human3'   TCCTCCCAGGCTTCCGTGTGGGTCAGTGGGGCCCATGGATGTGCTTGTTAACTGAGTGCC 
  mouse3'   GCTTCTCCAGCTGAGAAGGTTCTCTGCCTCTCCACTGTTGGACTACTCTATCTGGATGGT 
                   
 bovine3'   TATGGGTGTGGAG------------------AGCTCCC----CAC---------GAGGAG 
  human3'   TTTTGGTGGAGAGGCCCGGC-CTCTCACAAAAGACCCCTTACCACTGCTCTGATGAAGAG 
  mouse3'   ACTCCAAGCACTGGATGAGCTCAAGCAGGCCACCCCCACCCCCACCCCCATTACTATGTT 
                   
 bovine3'   GGATGC--------------TCGGGAAGTAACTGTT--TGCTTTGT--CTTAGCTC---A 
  human3'   GAGTACACAGAACACATAATTCAGGAAGCAGCT-TT--CCCCATGT--CTCGACTC---A 
  mouse3'   GCTGGCCT----CTGGCTGGTCAAGCAGATTCCCCTGATACTATGTTGCTGGCCTCTGAA 
                   
 bovine3'   TGGTCA----TCCA------TCAGGT-------TGAGTGGTTCGTCCACTCATCCTG--- 
  human3'   TC--CA----TCCAGGCCATTCCCCG-------TCTCTGGTTCCTCCCCTCCTCCTG--- 
  mouse3'   TGGCCAGGATTCCGAAGGGTTCAGTGGAAAGCATGGATGTTAACTGAACGCCTGTTGCTG 
                   
 bovine3'   --GAC-CCTACACATGGC-ACTTCCTCTGTGGTTGAGATTCGGAATGTAGGCATTCTCAC 
  human3'   --GACTCCTGCACACGCT-CCTTCCTCTGAGGCTGAAATTCAGAATATTAGTGACCTCAG 
  mouse3'   TGGATCCACATACAAGACGCCTTCCTCCTCCTTTTTGAAGAGGAGTATTCAGGAAG-CAG 
                   
Figure 10.  CARD15 3’UTR alignment for human, mouse and bovine.  Bases 
conserved among all three species are shaded. 
57 
 bovine3'   CTTTGATCTTTCCCTTGTACCCTGGCCCTGCTCCCACCCTCCCATCCGCCTC--AACCCT 
  human3'   CTTTGATATTTCACTTA-------------------------CAGCACCCCC--AACCCT 
  mouse3'   CTCTGGCCGTGTCTGGACTCACTCTCTAAGGT----------CATCCCACTCTGATACCT 
                   
 bovine3'   CCCCCCATCCAGGGTGGGAGGGGCTACAACTCACC-CTGCTCTCCTT-CTGGTACTTAGG 
  human3'   GGCAC---CCAGGGTGGGAAGGGCTACACCTTAGC-CTGCCCTCCTTTCCGGTGTTTAAG 
  mouse3'   CCACTTGTCCTGCCTGAGGCCCAACAGGACTCAACTCCGACAACCAACATAATACCCCGC 
                   
 bovine3'   ACAGTATTGAAAGGGGACAGGTGACATACATGTGTTCCTCAAGACATTCTAGAGTTTCAA 
  human3'   ACATTTTTGGAAGGGGACACGTGACAGCCGTTTGTTCCCCAAGACATTCTAGGTTTGCAA 
  mouse3'   TCTCCTTTCTTAAC--ACAAACAACAGTCCTTTGC-CCCCAGGATGTTCTAGATTTATAA 
                   
 bovine3'   GAAAAA-TATGACTGC---CCAGC---------AACTGGACTTTTATTTCCAGTGAAATC 
  human3'   GAAAAA-TATGACCACACTCCAGCTGGGATCACATGTGGACTTTTATTTCCAGTGAAATC 
  mouse3'   GAAAAAATGTGACCACACTCCAGCTGGGATCACACATGGCCTTTGGTTTCCAGTAACATC 
                   
 bovine3'   AATTACTCTTCAGTTA-AACCTTTGGGAACAACTC---TGTA------TCCAAATGCAAC 
  human3'   AGTTACTCTTCAGTTA-AGCCTTTGGAAACAGCTCGACTTTAAAAAGCTCCAAATGCAGC 
  mouse3'   AATTACTCTATAGTTTGAGCCTTTGGAATCAGTTC--CTC-------CCTCAACTGCAGC 
                   
 bovine3'   TTTTAAAACT-AACCTAGGCCAGAATTTTGAACAGCCCCACCAGGTCTCTG----AAGCC 
  human3'   TTTAAAAAATTAATCTGGGCCAGAATTTCAAACGGCCTCACTAGGCTTCTGGTTGATGCC 
  mouse3'   TCTTTAGAATTAATCTGGGCCAGAATTTCAAACGACCCCACCAGGCCCGGAGTCGGTGCC 
                   
 bovine3'   TGTGAACTGAACTCTGGCAGCAGACTTCCAAAATATATTCATAAGAGATGGTTTGGTTTT 
  human3'   TGTGAACTGAACTCTGACAACAGACTTCTGAAATAGACCCACAAGAGGCAGTTCCATTTC 
  mouse3'   TGTGAACTGAACTCTGACAACAGACTTCTGAAACATATTCCTGAAAGACAGCTCCATTTT 
                   
 bovine3'   GTTTGTGCCAGGCCACTTTAGGATATA-AGTTATAGATCAAAAGTTTACAGGGCAAAATC 
  human3'   ATTTGTGCCAGAATGCTTTAGGATGTACAGTTATGGATTGAAAGTTTACAGGAAAAAAAA 
  mouse3'   ATTTATGACA--ATGCTTTAGGACATGGAGTTGGGGCTTGGAGGCTTGCAGGGGACAAAA 
                   
 bovine3'   AAAGGCCCTTCCTTACAAAACAAATGTTTTTCTCTGAATTTTTCA--------------G 
  human3'   TTAGGCCGTTCCTT-CAAAGCAAATGTCTTCCT--GGATTATTCAAAATGATGTATGTTG 
  mouse3'   CCAAGCCTTTCTTT-CTGAGCAAG-GTCTTTCTGTGG-TTTTTCAAAAT----------G 
                   
 bovine3'   AAGCTTCTGTAAACTGTCAGGTACTGTGCAAGTGTTATTATTTCAA-CACTGTTATTTGT 
  human3'   AAGCCTTTGTAAATTGTCAGATGCTGTGCAAATGTTATTATTTTAAACATTATGATGTGT 
  mouse3'   TCACCTTTGTAATTTTTAA---ATTGTACAAGTTTTACTACCTCCA-TTTTATTTAGCGT 
                   
 bovine3'   GAAAAACTGGTTAATGTTTATAAACCACTTTGTTTTATTCTCCCTAGTTCATGATTTTAT 
  human3'   GAAAA-CTGGTTAATATTTATAGGTCACTTTGTTTTACTGTCTTAAGTTTATACTCTTAT 
  mouse3'   GAAAG-CGGGTTAATATTTATAAATGGCACTGTTTTATTTT------------------- 
                   
 bovine3'   AAAAAAAAAAAAAATGACCATGAATGTTATGCTGTAAATAATCACAGAAGATAAAACTAT 
  human3'   AGACAA------CATGGCCGTGAACTTTATGCTGTAAATAATCAGAGGGGAATAAACTGT 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   TGAGTCACCAGAACTATCTTCATTGTGACCAAACACAATGAAGTATTTAAAAATACTCTG 
  human3'   TGAGTCAAAAC------------------------------------------------- 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   AACATTATCACATATTAAAGCACAATATTCTCCTTGAAGGGAGGAGACATGATGTTTCAA 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
Figure 10.  Continued. 
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 bovine3'   CCAGATAATTGATTGCTTAAGGCACAAGCAGTGTTTAGAAATAGCCTCGCAATCAAAACA 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   CATTTGGCTTCAGTTTAGAGAAGTCTAGCCCAGCGTGGAGTTGTAAGTTATAGAGGAACC 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   TCAGTGTCCCGGCAGAAACACAGATGAGAGAGACGCAAGCAGGCCCCTGGGCCTCCCTCC 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   ATTCTCTCCAAGTGTCTCCAGGGGAGAAGGATGGAGAAGACTGGGGAACAGTTCTCCTCT 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   GCAAGCAGCCTCGTGGGTAGGCCTTGGTGAAATAATTCTTAGCTGAATTTAATTAGCAAG 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   GACTCAGGTGGCTGCTCATCAAGGTAGAATCGGCTTCCTTGAATGGTTTCCTGTGTGTCT 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   GGTTGGTTAAATACTGTGGCATCTCCCTGGGCGCCTCCCCAGTAAGGGCATGTGTGTGGG 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   TTCTCTTCATTTGTTTGAATTTATTTTATTGAGGTATGGTTGATTTACAGCGTTGTGTTA 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   ATTTCTATACAGCTGAATGATTCTGTTATACATATGTGTACATACTCTTTTTCCATTATG 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   CTTTTTCACAGGATAAACTACTCATAGTTCCTTGTGCTATACATTAGGACTTTTTTATGT 
  human3'   ------------------------------------------------------------ 
  mouse3'   ------------------------------------------------------------ 
                   
 bovine3'   ATCCATTCAATATATAATACATTTGCTAACCTCA 
  human3'   ---------------------------------- 
  mouse3'   ---------------------------------- 
Figure 10.  Continued. 
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47.5% homology between human and mouse and 65.7% homology between bovine and 
human.  The length of the 3’UTR is also quite variable among the species; 1257 bp in 
human, 1425 bp in mouse and 1915 bp in bovine. 
A search for putative 5’UTR regulatory motifs revealed two known motifs in the 
bovine gene.  The first of these is a terminal oligopyrimidine tract (TOP) which includes 
the first five bases of the transcript and the second is an internal ribosome entry site or 
internal regulatory sequence (IRES) which includes bases 61-151 of the 5’UTR and the 
ATG translation initiation codon.  The TOP motif is also present in mouse and includes 
the first 11 bases of the transcript, but the motif is not present in human.  The IRES 
motif is not present in either human or mouse. 
The search for putative regulatory motifs present in the 3’UTR resulted in the 
identification of three motifs in human: an alcohol dehydrogenase 3’UTR down 
regulation control element (ADH_DRE) (bases 187-194); a Brd-Box (bases 907-913) 
and a Gy-Box (bases 1114-1120).  These motifs were not identified in mouse or bovine.  
However, the bovine and the mouse 3’UTR each contain a single 15-lipoxygenase 
differentiation control element (15 LOX-DICE) repeat.  The 3’UTR sequence in all three 
species was searched for the presence of polyadenylation signals and 15, 7 and 3 
putative sites were identified in bovine, human and mouse, respectively (Table 10). 
 
CARD15 flanking intronic sequence is not conserved across species.  The 
percent identity between species comparisons for ~200 bases of intronic sequence 
flanking each exon is presented in Table 11.  Pairwise alignments between human and 
mouse revealed a range in percent identity from 39% (5’ region of intron 1) to 75% (5’ 
region of intron 7), between bovine and mouse from 34.7% (3’ region of intron 7) to 
65% (5’ region of intron 7) and between human and bovine from 39% (5’ region of 
intron 1) to 74% (5’ region of intron 5).  Percent identities calculated from the multiple 
alignment of bovine, human and mouse ranged from 21.8% (3’ region of intron 7) to 
52.5% (5’ region of intron 5).  In addition to examining the extent of overall homology 
in each intronic region flanking an exon, this intronic sequence was searched for 
conserved motifs.  The hexamer TGCATG was found to be present in four of the 22 
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Table 10.  Putative CARD15 polyadenylation signals by species 
Bovine  Human Mouse 
Putative 
Signal 
3’UTR 
position 
 Putative 
Signal 
3’UTR 
position 
 Putative 
Signal 
3’UTR 
position 
AAGAAA 664-669  AAGAAA 717-722  AAGAAA 994-999 
AATCAA 709-714  AAAAAA 840-845  AATTAA 1114-1119 
AATCAA 933-938  AATTAA 844-849  TATAAA 1405-1410 
AACAAA 955-960  AATAGA 928-933    
TATAAA 1060-1065  AAAAAA 1009-1014    
TATAAA 1099-1104  AATAAT 1223-1228    
AATAAT 1138-1143  AATAAAa 1237-1242    
GATAAA 1151-1156       
AATGAA 1198-1203       
ATTAAA 1235-1240       
AATCAA 1332-1337       
AATAAT 1551-1556       
GATAAA 1832-1837       
AATATA 1890-1895       
AATACA 1897-1902       
aMost frequent and efficient form. 
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Table 11.  Percent conservation of CARD15 intronic sequences flanking exons 
Intron Bovine:Mouse:Human Bovine:Human Mouse:Human Bovine:Mouse
1-5' 24 39 39 43 
1-3' 41.5 68.3 51.5 42.6 
2-5' 41 61 60 57 
2-3' 45.5 70.3 58.4 55.4 
3-5' 37 62 55 45 
3-3' 47.5 68.3 63.4 62.4 
4-5' 46 63 63 63 
4-3' 41.6 73.3 57.4 51.5 
5-5' 39 74 40 44 
5-3' 52.5 68.3 65.3 59.4 
6-5' 43 67 55 58 
6-3' 34.7 57.4 49.5 51.5 
7-5' 56 73 75 65 
7-3' 21.8 70.3 47.5 34.7 
8-5' 49 80 59 55 
8-3' 41.6 63.4 57.4 47.5 
9-5' 35 69 45 49 
9-3' 36.6 62.4 54.5 51.5 
10-5' 40.6 70 48 54 
11-3' 50 70.3 58.4 57 
10-3' no mouse data 68.3 no mouse data no mouse data
11-5' no mouse data 76 no mouse data no mouse data
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introns, including bovine intron 2 flanking exon 1, bovine and human intron 5 flanking 
exon 4, human and mouse intron 7 flanking exon 6 (1 bp mismatch in bovine) and in 
human and bovine intron 11 flanking exon 10 (no mouse data available).  In addition to 
the multiple occurrences of the TGCATG hexamer, other short stretches of conservation 
within the human, mouse and bovine introns were identified.  Considering only motifs 
with at least 6 bp of conservation and no more than two internal mismatches between 
species, conserved blocks ranging from 6 to 19 bp in length (Table 12) were identified. 
 
CARD15 is highly conserved in Bos taurus, Bos indicus and Bison bison.  
CARD15 sequence from one Bos indicus and one Bison bison animal by exon are 
presented in Figs. 11 and 12, respectively and have been deposited in GenBank as 
accession numbers AY518749-AY518770.  Alignment of the nucleotide sequence 
revealed 26/5105 substitutions between bison and indicus, 21/5105 substitutions 
between bison and taurus and 17/5105 substitutions between indicus and taurus.  All of 
these substitution sites were unique, occurring in only one of the species or subspecies.  
Alignment of the protein sequence revealed 1/1013 substitution between indicus and 
taurus, 1/1013 substitution between indicus and bison and 2/1013 substitutions between 
taurus and bison (Fig. 13).  The amino acid substitution present in bison is located at 
residue 641 interstitial to the NOD and the LRR domains.  This residue is conserved 
across human, mouse, taurus and indicus.  The amino acid substitution present in taurus 
is located at residue 733 which is located within the first LRR.  This residue is conserved 
between human, mouse, indicus and bison.  In addition to surveying the coding portion 
of the gene for homology, ~200 bases of intronic sequence flanking each exon was 
examined and these regions were found to possess high levels of homology among the 
bovids, ranging from 95.2% to 100% in each pairwise comparison. 
 
Discussion 
 
An extensive comparison of the bovine, mouse and human CARD15 genes was 
performed.  As expected, high levels of sequence conservation were found throughout 
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Table 12.  CARD15 intronic sequence motifs identified as conserved between 
human, mouse and bovine 
Intron Conserved motifa Intronb Conserved motif 
1-5' none 8-3' CTgAaATGGAG 
1-3' TCAgTTT  TCTtTGAaGTC 
 AGAAGcC  TTTTgTT 
 CTGACCT 9-5' CTgGCCTCaTC 
 CCTCCC  TGTGTG 
2-5' none  TGGATGA 
2-3' TTCAcTT  TTGtCTTT 
 CCTTCtCACA  AGAgCCTGG 
3-5' none  TtGGtTTGtTGGTT 
3-3' AGcCAGGA  TtCCTcCA 
 AGGTCCC 9-3' AtTGAG 
 ACCaTGG  TtTTCTC 
 TCTTCTG 10-5' ACAgTAAT 
4-5' none  AGGTGgC 
4-3' CCAGtGTTCTTTAGT 10-3' CCTAAGgGAG 
 GGGTgTCcA  CTACTTAAT 
 TGgGGTgCTC  GTGAATGGA 
 TGGGGG  GAGAGA 
5 TCACTG  TACATTTCACT 
 TGCTTT  TCATTGGGAATCTCAGACA 
6-5' CTGAGT  CAGGTGGGCTTCAG 
 GTCTCA  AGTCTC 
 ATGCTGTG  AAAACCAAG 
 CTcTGGA  TCACCATT 
 GCTgAgG  TATCTTC 
 TCCTGcCcTTTG 11-5' TGGGCAGGCCT 
 TTTCcAGG  CCTCAGTTTT 
6-3' TCTTCC  GGGAGAGAGGAA 
7-5' AGAGGG  AGAATTT 
 GCATGcAGG  GATCCCTT 
 GGGgCTT  TTCTGCATG 
 GATTTAGGaGCgGgTGAc  TTTAAG 
 GGtTgGGG  TTTTTAAA 
7-3' ACTaAAAAgTCT  TCTCTG 
 AGtTTGGcCAT 11-3' CAGTGT 
 CACtTTGCTGGGACC  AGTCATGGAGgCTTGtT 
 TGAGgCC  CCCTGG 
 AACACA  GGTAAAA 
8-5' GTTaTGAAGgTC  CAGGCA 
 TGAACTTTaTtT  CACTCA 
 TGgGCT   
aBase mismatches among species indicated in lower case. 
bBold face indicates that no mouse data were available. 
cThis sequence contains 3 mismatches but was included because it also contained 
at least 6 contiguous bases containing only 2 mismatches. 
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Exon 1 
agacgctggagttcctcttcagttcccatgcctacgtccttttactttcgctttctgtgggcactgaacca
gcccacgtCTCTGGACTCCGTGACCATCACAGGAGGGAACCTGCTGAGAGATTTCCTCTGCTGCGTGGGGA
CCCTGCCAGGGCTTGGAGCTCTGTGAGATCGCTTCCCACGGACTCCCAGGACCCAGAGTCTGAGGGCTGAG
CCCAGGgtaagccattggcagatgtgacagcacacggtgtgtggtggtggggggagggcctgggcatttgg
ggaggggagcagtagatgggagtcagtgcatccataggcttgaaatgcaccacgagt 
 
Exon 2 
cctctccactaccctccgcctgctttctgagaagccctgccctgacctcattctcctcccagATTGTGAAA
TGTGCGCACAAGATGCTTTTCAGACACAGAGAAGCCAACTGGTGGAGTTGCTGGTCTCGGGGTCCCTGGAG
GGCTTTGAGAGTATTCTGGACCGGCTGCTTTCCCGGGAAGTCCTCTCCTGGGAGGACTATGAGGGGCTTAG
CCTCGTGGGGCAGCCCATCTCCCACTTGGCCAGGCGCCTCCTGGACACCATCTGGAATAAGGGTACTTGGG
GCTGTGAACAACTGACTGCAGCTGTGCGGGAGGCCCAGGCCGACAGCCAGCCCCCCGAGCTTCCCAGCTCC
TGGGACCCCCACTCACCCCACCCAGCCCGTGACCTGCAGAGTCACCGACCAGCCATTGTCAGGAGACTCTA
CGGCCACGTGGAGGGTGTGCTGGACCTGACACAGCAGCGGGGTTTCATCAGCCAGTACGAAACTGATGAAA
TCAGGCGGCCCATCTTCACTTCATCCCAGCGGgtaagcacttccctct 
 
Exon 3 
ataaataatgacttttgctttccgcacagGCAAGAAGGCTCCTTGATCTCGCCACAGTGAAGGCGAATGGG
TTGGCTGCCTTTCTTCTACAGTGTATTCAGGAATTACCGGTCCCATTGGCCCTGCCTTTTGAAGgtatata
tgtgttcttttcagttatcagaaaaggaaaggaagactttcagattc 
 
Exon 4 
accccttatcaggtcccattttcaccatggtcccagctcctcggtttcgtcttctgtcttccagATGCCGC
CTGTAAGAAGTACATGTCCAAGCTGAGGACCGTTATATCAGCTCAGTCTCGTTTCCTGAGCACCTACGATG
GAGCAGAGAATCTTTGCCTGGAAGAAGTATATACAGAGAATGTTCTGGAAATCCAGATGGAGGTGGGCATG
GCTGGACCTTCGCAGCAGAGCCCTACCACCCTAGGCCTGGAGGAGCTCTTCAGCACCCGTGACCATTTCAA
CAAAGAGGCAGACACTGTGCTGGTGGTGGGCGAGGCGGGCAGCGGCAAGAGCACGCTCTTGCAGCAGCTGC
ACCTGCTCTGGGCTTCCGGGCGGGCCTTCCAGGAATTTCTCTTCGTCTTCCCATTTAGCTGCCGGCAGCTG
CAGTGCCTGGTGAAACCGCTGTCCATGCGGACGCTGCTCTTCGAACACTGCTGTTGGCCCGACCTTGGCCC
CCAGGACGTCTTCCAGGTCCTCCTTGACCACCCTGAGCGCATCCTCTTAACCTTTGATGGCTTTGATGAGT
TCAGGTTCAGGTTCACGGATCAGGAGCGTCACTGCTGTCCGACCGCCCCCACGTCAGTCCAGAGTCTGCTC
TTCAACCTTCTGCAGGGCAACCTGCTAAAGAATGCCCGCAAGGTGTTGACCAGCCGCCCCAGCGCGGTATC
GGCGAGCCTCCGAAAGCACGTGCGCACGGAACTCAGCCTCAAGGGCTTCTCGGAAGAGGGCATCGAACTGT
ACCTGAGGAAGCGGCATCGCGAGCCTGGGGTGGCCGACCGCCTCCTCTGCCTGCTCAGAGCCACCTCGGCC
CTGCACGGTCTGTGCCACCTGCCTGTCTTCTCCTGGATGGTGTCCAAGTGCCACGAGGAGCTGTTGCTGCA
GGGCCGGGGGTCCCCAAAGACCACCACGGATATGTACCTGCTGATCCTGCGGCACTTTCTGCTGCACGCCT
CCCCGCTACCCTTAGCCAACCATGGCCTGGGACCCAGCCTGATTCAGGGCAGGCTCCCCACACTCCTGCAT
CTCGGCCGCCTGGCTCTCTGGGGCCTGGGCACATGCTGCTACGTGTTCTCAGCCAAACAGCTGCAGGCGGC
ACATGTCGACAGTGAGGACCTTTCTCTTGGCTTCCTGGTGCTTGCCAAGAGGGTTGTACCTGGGAGTACAG
CCCCCCTGGAATTTCTGCATATCACTTTTCAGTGCTTCTTTGCTGCATTCTACCTCGCCCTCAGTGCCGAC
ACCCCGCCATCCTCGCTCAGACATCTCTTCCAAGATCACAGGCCTGAAAGCTCGCCACTGGCCAGGGTGCT
GCCCAAATTGTTCCTGCGGGGCTCCCGATGCAGAGAGGGCAGCGTGGCTGCTTTGCTGCAGGGGGCCGAGC
CGCACAACCTCCAGATCACAGGGGCCTTCCTGGCGGGGCTGTTGTCACAGGAGCACCGGAGCTTGCTGGCG
GAGTGCCAGGCCTCTGAGACGGCCCTGCTCCGGCGCTGGGATTGTGTCCAGCGGTGTCTGACCCGCAGCCT
CCACGAGCATTTCCGCTCCATCCCACCCGCCTTGCCGGGTGAGGCCAARAGCATGCACGCCCTGCCTGGCT
TCCTCTGGCTTATCCGGAGCCTGTATGAGATGCAGGAGGAGCGACTGGCGCGGGAGGCCGTTCGCAGGCTG
AACGTTGGGCACCTCAAGCTGACCTTCTGCGGTGTGGGCCCGGCCGAGTGTGCTGCCCTGGCCTTCGTGCT
GCGCCACCTCCGGCGGCCTGTGGCCCTGCAGCTGGACCACAACTCTGTGGGCGACATCGGCGTGGAGCAGC 
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TGCTGCCTTGCCTGGGTGTCTGCAAAGCTCTTTAgtgagtgatgctgggtgatgctggctgggcactgtgg
gaatgctgccatcctggtgcaggtaggggagccccctttatgctgggagccaggagtccaggcccagcccc 
 
Exons 5 and 6 
gtctttgtttagCTTGCGAGATAACAACATCTCAGACCGAGGCATCTGCAAGTTGGTTGAACATGCTCTTC
GCTGTGAGCAGCTGCAGAAGTTAGCgtaagtcaggctgtggacattgggccccatgtccccagactcagcc
caagccatgccgcctgggcagcaattgtgagcgagtgatgggctgggatgtttgcatggccagagggcaca
ggggactcctgagggagccagtgacccagggttggggtggtcactgtccactatgctttatctccatgtct
cttctctctcggaactttccagTCTTTTCAACAACAAGTTGACCGATGGCTGTGCACACTCCATGGCCAGG
CTCCTTGCGTGCAAGCAGAACTTCTTGGCTTTGAGgtgagcctggggcttccctactcctggagactttcg
tccccacaactgagtcagtttggtctggtctcgccccataatgcgcatatgac 
 
Exon 7 
ttcccttccagGCTAGGAAACAACCACATCACGGCTGCGGGAGCCGAGGTGCTTGCCCAGGGGCTCAGAAC
TAACAACTCCTTGCAGTTTTTGGGgtaggtgggattctggggcagaggggcagcatgcaggggttgggggc
ttgcgaggatttaggagcgggtgaaaccgg 
 
Exon 8 
tgtttactctgttgaaactttcagGTTCTGGGGCAACCAGGTGGGTGACGAGGGGGCCCAGGCCTTGGCTG
CAGCCTTGGGTGATCACCAGAGCTTGAGGTGGCTCAGgtaagcctcagagttcgtcccgc 
 
Exon 9 
ttttgttttttgacgacatccagCCTGGTGGGGAACAACATTGGCAGCGTGGGTGCTCAAGCCTTAGCATT
GATGTTGGAAAAGAATATGGCCCTGGAAGAACTCTGgtgagtttaggggattcatctctctagggaggcag
acactagccttttttcattctctggcctcatctgtggaagctgatgtgtgtgtaagaccaagatggacgac
tgcg 
 
Exon 10 
tgggttttctcctttattcttgccagCCTGGAGGAGAACCACGTCCAGGATGAAGGTGTGTGTTTCCTCGC
CAAAGGACTTGCAAGAAACTCAAGTCTGAAAGTCCTGAAgtaaggaatctgtaagcaagagctagac 
 
Exon 11 
tcaccattctatcttcctctctagGCTGTCTAACAACCACATCAGCTCCCTAGGGGCAGAGGCCCTCCTGC
GGGCCCTTGAAAAGAATGACACCATTCTGGAAGTCTGgtaagatcctgggcaggcctctttaacctctctg
agcctca 
 
Exon 12 
tgatctaaagcacagctctggtccagtcctcactcaaatctctctttgctttatccctttcagGCTCCGAG
GAAACACTTTCTCTCCGGAGGAAATTGAGAAACTCAGCCACCAGGATACCAGACTCTTGCTCTGATGTTTC
CAGGCCAGTGTTCAGCTCAGTGTGTTTGGGAGGAGGCCATTGGTTTGGATCCCAGGATGGGACGACATCTG
AGCACAGCCCACTCAGATGGAACCTGGATCTGCCCAGGGCCAACCCAATAGGTCACCTTTGTTCTGGCACA
GGAAAGCACATCAGTGCCTTGTGGAGTAGACTTCACTGAATCCCAACTTTGCCATCAACTTCTTGCCAAGA
TTCAATCCTGGGATGTTGAAGAGGGGCAGCCTGCCTGTACAGGATGGGGCTGGTCTCAAGTCAAGCTGACA
TGCGTCAGGGAGGCCCATGGATGCCACTGAGTATTTATGGGTGTGGAGAGCTCCCCACGAGGAGGGATGCT
CGGGAAGTAACTGTTTGCTTTGTCTTAGCTCATGGTCATCCATCAGGTTGAGTGGTTCGTCCACTCATCCT
GGACCCTACACATGGCACTTCCTCTGTGGTTGAGATTCGGAATGTAGGCATTCTCACCTTTGATCTTTCCC
TTGTACCCTGGCCCTGCTCCCACCCTCCCATCCGCCTCAACCCTCCCCCCATCCAGGGTGGGAGGGGCTAC
AACTCACCCTGCTCTCCTTCTGGTACTTAGGACAGTATTGAAAGGGGACAGGTGACATACATGTGTTCCTC
AAGACATTCTAGAGTTTCAAGAAAAATATGACTGCCCAGCAACTGGACTTTTATTTCCAGTGAAATCAATT
ACTCTTCAGTTAAACCTTTGGGAACAACTCCGTATCCAAATGCAACTTTTAAAACTAACCTAGGCCAGAAT
TTTGAACAGCCCCACCAGGTCTCTGAAGCCTGTGAACTGAACTCTGGCAGCAGACTTCCAAAATATATTCA 
Figure 11.  Continued. 
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TAAGAGATGGTTTGGTTTTGTTTGTGCCAGGCCACTTTAGGATATAAAGTTATAGATCAAAAGTTTACAGG
GCAAAATCAAAGGCCCTTCCTTACAAAACAAATGTTTTTCTCTGAATTTTTCAGAAGCTTCTGTAAACTGT
CAGGTACTGTGCAAGTGTTATTATTTCAACACTGTTATTTGTGAAAAACTGGTTAATGTTTATAAACCACT
TTGTTTTATTCTCCCTAGTTCATGATTTTATAAAAAAAAAAAAAATGACCATGAATGTTATGCTGTAAATA
ATCACAGAAGATAAAACTATTGAGTCACCAGAACTATCTTCATTGTGACCAAACACAATGAAGTATTTAAA
AATACTCTGAACATTATCACATATTAAAGCACAATATTCTCCTTGAAGGGAGGGGACATGATGTTTCAACC
AGATAATTGATTGCTTAAGGCACAAGCAGTGTTTAGAAATAGCCTCGCAATCAAAACACATTTGGCTTCAG
TTTAGAGAAGTCTAGCCCAGCGTGGAGTTGTAAGTTATAGAGGAACCTCAGTGTCCCAGCAGAAACACAGA
TGAGAGAGACGCAAGCAGGCCCCTGGGCCTCCCTCCATTCTCTCCAAGTGTCTCCAGGGGAGAAGGATGGA
GAAGACTGGGGAACAGTTCTCCTCTGCAAGCAGCCTCGTGGGTAGGCCTTGGTGAAATAATTCTTAGCTAA
ATTTAATTAGCAAGGACTCAGGTGGCTGCTCATCAAGGTGGATTCGGCTTCCTTGAATGGTTTCCTGTGTG
TCTGGTTGGTTAAATACTGTGGCATCTCCCTGGGCGCCTCCCCAGTAAGGGCATGTGTGTGGGTTCTCTTC
ATTTGTTTGAATTTATTTTATTGAGGTATGGTTGATTTACAGCGTTGTGTTAATTTCTATACAGCTGAATG
ATTCTGTTATACATATGTGTACATACTCTTTTTCCATTATGCTTTTTCACAGGATAAACTACTCATAGTTC
CTTGTGCTATACATTAGGACTTTTTTATGTATCCATTCAATATATAATACATTTGCTAACCTCataataca
tttgctagcctcaatctcttactccat 
Figure 11.  Continued. 
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Exon 1 
tcagttcccatgcctacgtccttttactttcgctttctgtgggcactgcaccagcccacgtCTCTGGACTC
CGTGACCATCACAGGAGGGAACCTGCTGAGAGATTTCCTCTGCTGCGTGGGGACCCTGCCAGGGCTTGGAG
CTCTGTGAGATCGCTTCCCACGGACTCCCAGGACCCAGAGTCTGAGGGCTGAGCCCAGGgtaagccattgg
cagaggtgacagcacacggtgtgtggtggtggggggagggcctgggcatttggggaggggagcagtagatg
ggagtcagtgcatccataggcttgaaatgcaccacgagt 
 
Exon 2 
cctctccactaccctccgcctgctttctgagaagccctgccctgacctcattctcctcccagATTGTGAAA
TGTGCGCACAAGATGCTTTTCAGACACAGAGAAGCCAACTGCTGGAGTTGCTGGTCTCGGGGTCCCTGGAG
GGCTTTGAGAGTATTCTGGACCGGCTGCTTTCCCGGGAAGTCCTCTCCTGGGAGGACTATGAGGGGCTTAG
CCTCGTGGGGCAGCCCATCTCCCACTTGGCCAGGCGCCTCCTGGACACCATCTGGAATAAGGGTGCTTGGG
GCTGTGAACAACTGACTGCAGCTGTGCGGGAGGCCCAGGCCGACAGCCAGCCCCCCGAGCTTCCCAGCTCC
TGGGACCCCCACTCACCCCACCCAGCCCGTGACCTGCAGAGTCACCGACCAGCCATTGTCAGGAGACTCTA
CGGCCACGTGGAGGGTGTGCTGGACCTGACACAGCAGCGGGGTTTCATCAGCCAGTACGAAACTGATGAAA
TCAGGCGGCCCATCTTCACTTCATCCCAGCGGgtaagcacttccctctaagcacttttcagaggaaaagtg
tgcttagttactg 
 
Exon 3 
ataaataatgacttttgctttccccacagGCAAGAAGGCTCCTTGATCTCGCCACAGTGAAGGCGAATGGG
TTGGCTGCCTTTCTTCTACAGTGTATTCAGGAATTACCGGTCCCATTGGCCCTGCCTTTTGAAGgtatata
tgtgttcttttcagttatcagaaaaggaaaggaagactttcagattc 
 
Exon 4 
acccctcatcaggtcccattttcaccatggtcccagctcctcagtttcttcttctgtcttccagATGCCGC
CTGTAAGAAGTACGTGTCCAAGCTGAGGACCGTTATATCAGCTCAGTCTCGTTTCCTGAGCACCTACGATG
GAGCAGAGAATCTTTGCCTGGAAGAAGTATATACAGAGAATGTTCTGGAAATCCAGATGGAGGTGGGCATG
GCTGGACCTTCGCAGCAGAGCCCTACCACCCTAGGCCTGGAGGAGCTCTTCAGCACCCGTGACCATTTCAA
CAAAGAGGCAGACACTGTGCTGGTGGTGGGCGAGGCGGGCAGCGGCAAGAGCACGCTCTTGCAGCAGCTGC
ACCTGCTCTGGGCTTCCGGGCGGGCCTTCCAGGAATTTCTCTTCGTCTTCCCATTTAGCTGCCGGCAGCTG
CAGTGCCTGGTGAAACCGCTGTCCATGCGGACGCTGCTCTTCGAACACTGCTGTTGGCCCGACCTTGGCCC
CCAGGATGTCTTCCAGGTCCTCCTTGACCACCCTGAGCGCATCCTCTTAACCTTCGATGGCTTTGATGAGT
TCAGGTTCAGGTTCACGGATCAGGAGCGTCACTGCTGTCCGACCGCCCCCACGTCAGTCCAGAGTCTGCTC
TTCAACCTTCTGCAGGGCAACCTGCTAAAGAATGCCCGCAAGGTGTTGACCAGCCGCCCCAGCGCGGTATC
GGCGAGCCTCCGAAAGCACGTGCGCACGGAACTCAGCCTCAAGGGCTTCTCGGAAGAGGGCATCGAACTGT
ACCTGAGGAAGCGGCATCGCGAGCCTGGGGTGGCCGACCGCCTCCTCTGCCTGCTCAGAGCCACCTCGGCC
CTGCACGGTCTGTGCCACCTGCCTGTCTTCTCCTGGATGGTGTCCAAGTGCCACGAGGAGCTGTTGCTGCA
GGGCCGGGGGTCCCCAGAGACCACCACGGATATGTACCTGCTGATCCTGCGGCACTTTCTGCTGCACGCCT
CCCCGCTACCCTTAGCTACCCATGGCCTGGGACCCAGCCTGATTCAGGGCAGGCTCCCCACACTCCTGCAT
CTCGGCCGCCTGGCTCTCTGGGGCCTGGGCACATGCTGCTACGTGTTCTCAGCCAAACAGCTGCAGGCGGC
ACATGTCGACAGTGAGGACCTTTCTCTTGGCTTCCTGGTGCTTGCCAAGAGGGTTGTACCTGGGAGTACAG
CCCCCTTGGAATTTCTGCATATCACTTTTCAGTGCTTCTTTGCTGCATTCTACCTCGCCCTCAGTGCCGAC
ACCCCGCCATCCTCGCTCAGACATCTCTTCCAAGATCACAGGCCTGAAAGCTCGCCACTGGCCAGGGTGCT
GCCCAAATTGTTCCTGCGGGGCTCCCGATGCAGAGAGGGCAGCGTGGCTGCTTTGCTGCAGGGGGCCGAGC
AGCACAACCTCCAGATCACAGGGGCCTTCCTGGCGGGGCTGTTGTCACAGGAGCACCGGAGCTTGCTGGCG
GAGTGCCAGGCCTCTGAGACGGCCCTGCTCCGGCGCTGGGATTGTGTCCGGCGATGTCTGACCCGCAGCCT
CCGCGAGCATTTCCGCTCCATCCCACCCGCCTTGCCGGGTGAGGCCAAGAGCATGCACGCCCTGCCTGGCT
TCCTCTGGCTCATCCGGAGCCTGTATGAGATGCAGGAGGAGCGACTGGCGCGGGAGGCCGTTCGCAGGCTG
AACGTTGGGCACCTCAAGCTGACCTTCTGCGGTGTGGGCCCGGCCGAGTGTGCTGCCCTGGCCTTCGTGCT 
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GCGCCACCTCCGGCGGCCTGTGGCCCTGCAGCTGGACCACAACTCTGTGGGCGACATCGGCGTGGAGCAGC 
TGCTGCCTTGCCTGGGCGTCTGCAAAGCTCTTTAgtgagtgatgctgggtgatgctggctgggcactgtgg
gaatgctgccatcctggtgcaggtaggggagccccctttatgctgggagccaggagtccaggcccagcccc 
 
Exons 5 and 6 
gtctttgtttagCTTGCGAGATAACAACATCTCAGACCGAGGCATCTGCAAGTTGGTTGAACATGCTCTTC
GCTGTGAGCAGCTGCAGAAGTTAGCgtaagtcaggctgtggacattgggccccatgtccccagactcagcc
caagccatgccgcctgggcagcaattgtgagcgagtgatgggctgggatgtttgcatggctagagggcaca
ggggactcctgagggagccagtgacccagggttggggtggtcactgtccactatgctttatctccatgtct
cttctctctcggaactttccagTCTTTTCAACAACAAGTTGACCGATGGCTGTGCACACTCCATGGCCAGG
CTCCTTGCGTGCAAGCAGAACTTCTTGGCTTTGAGgtgagcctggggcttccctactcctggagactttcg
tccccacaactgagtcagtttggtctggtctcgccccataatgcgcatatgac 
 
Exon 7 
ttcccttccagGCTAGGAAACAACCACATCACGGCTGCGGGAGCCGAGGTGCTTGCCCAGGGGCTCAGAAC
TAACAACTCCTTGCAGTTTTTGGGgtaggtgggattctggggcagaggggcagcatgcaggggttgggggc
ttgcaaggatttaggagcaggtgaaaccgg 
 
Exon 8 
tgaaactttcagGTTCTGGGGCAACCAGGTGGGTGACGAGGGGGCCCAGGCCTTGGCTGCAGCCTTGGGTG
ATCACCAGAGCTTGAGGTGGCTCAGgtaagcctcagagttcgtcccgc 
 
Exon 9 
ttttgttttttgacgacatccagCCTGGTGGGGAACAACATTGGCAGCGTGGGTGCTCAAGCCTTAGCATT
GATGTTGGAAAAGAATATGGCCCTGGAAGAACTCTGgtgagtttaggggattcatctctctagggaggcag
acactagccttttttcattctctggcctcatctgtggaagctgatgtgtgtgtaagaccaagatggatgac
tgcg 
 
Exon 10 
tgggttttctcctttattcttgccagCCTGGAGGAGAACCACGTCCAGGATGAAGGTGTGTGTTTCCTCGC
CAAAGGACTTGCAAGAAACTCAAGTCTGAAAGTCCTGAAgtaaggaatctgtaagcaagagctagac 
 
Exon 11 
tcaccattctatcttcctctctagGCTGTCTAACAACCACATCAGCTCCCTAGGGGCAGAGGCCCTCCTGC
GGGCCCTTGAAAAGAATGACACCATTCTGGAAGTCTGgtaagatcctgggcaggcctctttaacctctctg
agcctca 
 
Exon 12 
tgatctaaagcacagctctggtccagtcctcactcaaatctgtctttgctttatccccttcagGCTCCGAG
GAAACACTTTCTCTCCGGAGGAAATTGAGAAACTCAGCCACCAGGATACCAGACTCTTGCTCTGATGTTTC
CAGGCCAGTGTTCAGCTCAGTGTGTTTGGGAGGAGGCCATTGGTTTGGATCCCAGGATGGGACGACATCTG
AGCACAGCCCACTCAGATGGAACCTGGATCTGCCCAGGGCCAACCCAATAGGTCACCTTTGTTCTGGCACA
GGAAAGCACATCAGTGCCCTGTGGAGTAGACTTCACTGAATCCCAACTTTGCCATCAACTTCTTGCCAAGA
TTCAATCCTGGGATGTTGAAGAGGGGCAGCCTGCCTGTACAGGATGGGGCTGGTCTCAAGTCAAGCTGACA
TGCGTCAGGGAGGCCCATGGATGCCACTGAGTATTTATGGGTGTGGAGAGCTCCCCACGAGGAGGGATGCT
CGGGAAGTAACTGTGTGCTTTGTCTTAGCTCATGGTCATCCATCAGGTTGAGTGGTTCGTCCACTCATCCT
GGACCCTACACATGGCACTTCCTCTGTGGTTGAGATTCGGAATGTAGGCATTCTCACCTTTGATCTTTCCC
TTGTACCCTGGCCCTGCTCCCACCCTCCCATCCGCCTCAACCCTCCCCCCATCCAGGGTGGGAGGGGCTAC
AACTCACCCTGCTCTCCTTCTGGTACTTAGGACAGTATTGAAAGGGGACAGGTGACATACATGTGTTCCTC
AAGACATTCTAGAGTTTCAAGAAAAATATGACTGCCCAGCAACTGGACTTTTATTTCCAGTGAAATCAATT
ACTCTTCAGTTAAACCTTTGGGAACAACTCCGTATCCAAATGCAACTTTTAAAACTAACCTAGGCCAGAAT 
Figure 12.  Continued. 
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TTTGAACAGCCCCACCAGGTCTCTGAAGCCTGTGAACTGAACTCTGGCAGCAGACTTCCAAAATATATTCA
TAAGAGATGGTTTGGTTTTGTTTGTGCCAGGCCACTTTAGGATATAAAGTTATAGATCAAAAGTTTACAGG
GCAAAATCAAAGGCCCTTCCTTACAAAACAAATGTTTTTCTCTGAATTTTTCAGAAGCTTCTGTAAACTGT
CAGGTACTGTGCAAGTGTTATTATTTCAACACTGTTATTTGTGAAAAACTGGTTAATGTTTATAAACCACT
TTGTTTTATTCTCCCTAGTTCATGATTTTATAAAAAAAAAAAATGACCATGAATGTTATGCTGTATATAAT
CACAGAAGATAAAACTATTGAGTCACCAGAACTATCTTCATTGTGACCAAACACAATGAAGTATTTAAAAA
TACTCTGAACATTATCACATATTAAAGCACAATATTCTCCTTGAAGGGAGGAGACATGATGTTTCAACCAG
ATAATTGATTGCTTAAGGCACAAGCAGTGTTTAGAAATAGCCTCGCAATCAAAACACATTTGGCTTCAGTT
TAGAGAAGTCTAGCCCAGCGTGGAGTTGTAAGTTATAGAGGAACCTCAGTGTCCCGGCAGGAACACAGATG
AGAGAGACGCAAGCAGGCCCCTGGGCCTCCCTCCATTCTCTCCAAGTGTCTCCAGGGGAGAAGGATGGAGA
AGACTGGGGAACAGTTCTCCTCTGCAAGCAGCCTCGTGGGTAGGCCTTGGTGAAATAATTCTTAGCTGAAT
TTAATTAGCAAGGACTCAGGTGGCTGCTCATCAAGGTGGAATCGGCTTCCTTGAATGGTTTCCTGTGTGTC
TGGTTGGTTAAATACTGTGGCATCTCCCTGGGCGCCTCCCCAGTAAGGGCATGTGTGTGGGTTCTCTTCAT
TTGTTTGAATTTATTTTATTGAGGTATGGTTGATTTACAGCGTTGTGTTAATTTCTATATAGCTGAATGAT
TCTGTTATACATATGTGTACATACTCTTTTTCCATTATGCTTTTTCACAGGATAAACTACTCATAGTTCCT
TGTGCTATACATTAGGACTTTTTTATGTATCCATTCAATATATAATACATTTGCTAACCTCataatacatt
tgctagcctcaatctcttactccatcc 
Figure 12.  Continued. 
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  Indicus     (1) MCAQDAFQTQRSQLVELLVSGSLEGFESILDRLLSREVLSWEDYEGLSLVGQPISHLARR 
   Taurus     (1) MCAQDAFQTQRSQLVELLVSGSLEGFESILDRLLSREVLSWEDYEGLSLVGQPISHLARR 
    Bison     (1) MCAQDAFQTQRSQLLELLVSGSLEGFESILDRLLSREVLSWEDYEGLSLVGQPISHLARR 
                   
  Indicus    (61) LLDTIWNKGTWGCEQLTAAVREAQADSQPPELPSSWDPHSPHPARDLQSHRPAIVRRLYG 
   Taurus    (61) LLDTIWNKGTWGCEQLTAAVREAQADSQPPELPSSWDPHSPHPARDLQSHRPAIVRRLYG 
    Bison    (61) LLDTIWNKGAWGCEQLTAAVREAQADSQPPELPSSWDPHSPHPARDLQSHRPAIVRRLYG 
                   
  Indicus   (121) HVEGVLDLTQQRGFISQYETDEIRRPIFTSSQRARRLLDLATVKANGLAAFLLQCIQELP 
   Taurus   (121) HVEGVLDLTQQRGFISQYETDEIRRPIFTSSQRARRLLDLATVKANGLAAFLLQCIQELP 
    Bison   (121) HVEGVLDLTQQRGFISQYETDEIRRPIFTSSQRARRLLDLATVKANGLAAFLLQCIQELP 
                   
  Indicus   (181) VPLALPFEDAACKKYMSKLRTVISAQSRFLSTYDGAENLCLEEVYTENVLEIQMEVGMAG 
   Taurus   (181) VPLALPFEDAACKKYVSKLRTVISAQSRFLSTYDGAENLCLEEVYTENVLEIQMEVGMAG 
    Bison   (181) VPLALPFEDAACKKYVSKLRTVISAQSRFLSTYDGAENLCLEEVYTENVLEIQMEVGMAG 
                   
  Indicus   (241) PSQQSPTTLGLEELFSTRDHFNKEADTVLVVGEAGSGKSTLLQQLHLLWASGRAFQEFLF 
   Taurus   (241) PSQQSPTTLGLEELFSTRDHFNKEADTVLVVGEAGSGKSTLLQQLHLLWASGRAFQEFLF 
    Bison   (241) PSQQSPTTLGLEELFSTRDHFNKEADTVLVVGEAGSGKSTLLQQLHLLWASGRAFQEFLF 
                   
  Indicus   (301) VFPFSCRQLQCLVKPLSMRTLLFEHCCWPDLGPQDVFQVLLDHPERILLTFDGFDEFRFR 
   Taurus   (301) VFPFSCRQLQCLVKPLSMRTLLFEHCCWPDLGPQDVFQVLLDHPERILLTFDGFDEFRFR 
    Bison   (301) VFPFSCRQLQCLVKPLSMRTLLFEHCCWPDLGPQDVFQVLLDHPERILLTFDGFDEFRFR 
                   
  Indicus   (361) FTDQERHCCPTAPTSVQSLLFNLLQGNLLKNARKVLTSRPSAVSASLRKHVRTELSLKGF 
   Taurus   (361) FTDQERHCCPTAPTSVQSLLFNLLQGNLLKNARKVLTSRPSAVSASLRKHVRTELSLKGF 
    Bison   (361) FTDQERHCCPTAPTSVQSLLFNLLQGNLLKNARKVLTSRPSAVSASLRKHVRTELSLKGF 
                   
  Indicus   (421) SEEGIELYLRKRHREPGVADRLLCLLRATSALHGLCHLPVFSWMVSKCHEELLLQGRGSP 
   Taurus   (421) SEEGIELYLRKRHREPGVADRLLCLLRATSALHGLCHLPVFSWMVSKCHEELLLQGRGSP 
    Bison   (421) SEEGIELYLRKRHREPGVADRLLCLLRATSALHGLCHLPVFSWMVSKCHEELLLQGRGSP 
                   
  Indicus   (481) KTTTDMYLLILRHFLLHASPLPLANHGLGPSLIQGRLPTLLHLGRLALWGLGTCCYVFSA 
   Taurus   (481) KTTTDMYLLILRHFLLHASPLPLATHGLGPSLIQGRLPTLLHLGRLALWGLGTCCYVFSA 
    Bison   (481) ETTTDMYLLILRHFLLHASPLPLATHGLGPSLIQGRLPTLLHLGRLALWGLGTCCYVFSA 
                   
  Indicus   (541) KQLQAAHVDSEDLSLGFLVLAKRVVPGSTAPLEFLHITFQCFFAAFYLALSADTPPSSLR 
   Taurus   (541) KQLQAAHVDSEDLSLGFLVLAKRVVPGSTAPLEFLHITFQCFFAAFYLALSADTPPSSLR 
    Bison   (541) KQLQAAHVDSEDLSLGFLVLAKRVVPGSTAPLEFLHITFQCFFAAFYLALSADTPPSSLR 
                   
  Indicus   (601) HLFQDHRPESSPLARVLPKLFLRGSRCREGSVAALLQGAEPHNLQITGAFLAGLLSQEHR 
   Taurus   (601) HLFQDHRPESSPLARVLPKLFLRGSRCREGSVAALLQGAEPHNLQITGAFLAGLLSQEHR 
    Bison   (601) HLFQDHRPESSPLARVLPKLFLRGSRCREGSVAALLQGAEQHNLQITGAFLAGLLSQEHR 
                   
  Indicus   (661) SLLAECQASETALLRRWDCVQRCLTRSLHEHFRSIPPALPGEAKSMHALPGFLWLIRSLY 
   Taurus   (661) SLLAECQASETALLRRWDCVRRCLTRSLREHFRSIPPALPGEAKSMHALPGFLWLIRSLY 
    Bison   (661) SLLAECQASETALLRRWDCVRRCLTRSLREHFRSIPPALPGEAKSMHALPGFLWLIRSLY 
                   
  Indicus   (721) EMQEERLAREAVRRLNVGHLKLTFCGVGPAECAALAFVLRHLRRPVALQLDHNSVGDIGV 
   Taurus   (721) EMQEERLAREAVCRLNVGHLKLTFCGVGPAECAALAFVLRHLRRPVALQLDHNSVGDIGV 
    Bison   (721) EMQEERLAREAVRRLNVGHLKLTFCGVGPAECAALAFVLRHLRRPVALQLDHNSVGDIGV 
                   
  Indicus   (781) EQLLPCLGVCKALYLRDNNISDRGICKLVEHALRCEQLQKLALFNNKLTDGCAHSMARLL 
   Taurus   (781) EQLLPCLGVCKALYLRDNNISDRGICKLVEHALRCEQLQKLALFNNKLTDGCAHSMARLL 
    Bison   (781) EQLLPCLGVCKALYLRDNNISDRGICKLVEHALRCEQLQKLALFNNKLTDGCAHSMARLL 
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  Indicus   (841) ACKQNFLALRLGNNHITAAGAEVLAQGLRTNNSLQFLGFWGNQVGDEGAQALAAALGDHQ 
   Taurus   (841) ACKQNFLALRLGNNHITAAGAEVLAQGLRTNNSLQFLGFWGNQVGDEGAQALAAALGDHQ 
    Bison   (841) ACKQNFLALRLGNNHITAAGAEVLAQGLRTNNSLQFLGFWGNQVGDEGAQALAAALGDHQ 
                   
  Indicus   (901) SLRWLSLVGNNIGSVGAQALALMLEKNMALEELCLEENHVQDEGVCFLAKGLARNSSLKV 
   Taurus   (901) SLRWLSLVGNNIGSVGAQALALMLEKNMALEELCLEENHVQDEGVCFLAKGLARNSSLKV 
    Bison   (901) SLRWLSLVGNNIGSVGAQALALMLEKNMALEELCLEENHVQDEGVCFLAKGLARNSSLKV 
                   
  Indicus   (961) LKLSNNHISSLGAEALLRALEKNDTILEVWLRGNTFSPEEIEKLSHQDTRLLL 
   Taurus   (961) LKLSNNHISSLGAEALLRALEKNDTILEVWLRGNTFSPEEIEKLSHQDTRLLL 
    Bison   (961) LKLSNNHISSLGAEALLRALEKNDTILEVWLRGNTFSPEEIEKLSHQDTRLLL 
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the protein coding regions of the gene.  The overall amino acid homology was 81.2 % 
between bovine and human, 76% between bovine and mouse and 79.4% between human 
and mouse.  However, the pairwise comparisons revealed that there was a slightly higher 
homology within the protein domains than in the inter-domain regions of CARD15.  The 
5’UTR of CARD15 is poorly conserved across the species with both the mouse and 
human transcripts containing two in-frame translation initiation sites within the first and 
second exons respectively, whereas, the bovine transcript contains only the translation 
initiation site located in the second exon.  Studies in both human and mouse reveal that 
the 1013 amino acid protein produced from the second translation initiation site is most 
commonly detected.  Similarly, there is little sequence conservation in the CARD15 
3’UTR between the species, with the bovine 3’UTR being considerably longer than 
those for the human and mouse genes.  The total genomic size of the gene is also 
variable among the three species: ~36 kb in human, ~39 kb in mouse and ~30 kb in 
bovine. 
The 5’UTR and 3’UTR of genes often contain key regulatory elements involved 
in the post-transcriptional regulation of gene expression.  While function has been 
ascribed to relatively few of the elements residing within 3’UTRs, these motifs generally 
enable interactions with RNA-binding proteins, and/or facilitate the formation of 
secondary structures in the 3’UTR of the mRNA.  Effects mediated by these elements 
include the regulation of transcript stability, specification of subcellular transcript 
localization and the regulation of translation.  Polyadenylation may also be a useful 
mechanism in the regulation of gene expression, since the efficiency of 3’ mRNA end-
processing may be impacted by the location and motif of the polyadenylation signal site 
within the 3’UTR.  Because most pre-mRNAs in a cell are not efficiently processed, 
even small changes in the overall processing efficiency of a particular pre-mRNA may 
have a substantial effect on the overall level of gene expression.  Greener et al. (2002) 
have shown that loss of the dystrophin gene 3’UTR results in a pronounced reduction in 
the level of dystrophin protein and is sufficient to cause Becker muscular dystrophy, 
indicating the importance and regulatory role of the 3’UTR.  Polyadenylation signal 
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motifs also determine the efficiency of addition of the polyA tail.  In bovine, three 
putative alternative polyadenylation signal motifs within the last 82 bp of the transcript 
(Table 10) were identified.  Of these, two were found within the last 25 bp of the 
sequenced transcript and from experimental results in fruit fly (Graber et al. 1999), each 
should have approximately the same efficiency of polyadenylation (20 and 22%).  The 
third motif, which is located further from the end of the transcript has only a 5% 
efficiency of polyadenylation.  Thus, it is likely that one (or both) of the two signal 
motifs located within the last 25 bases is most commonly used for the regulation of 
polyadenylation of the bovine CARD15 transcript. 
A total of 15 putative polyadenylation signal motifs were identified in the bovine 
3’UTR.  Further upstream is located a motif with a 68% polyadenylation efficiency in 
fruit fly and another two motifs each with a 28% efficiency.  In all three cases, a possible 
cleavage site (CA) and a downstream motif of 5 bases which included at least 4 uracils 
were found.  Clearly, the most likely signal used to produce the transcript sequenced was 
one of the two motifs within the last 25 bases of the transcript, however, it seems likely 
that these additional three sites may also be utilized as alternative bovine 
polyadenylation signals.  Several recent reports provide evidence that alternative 
polyadenylation signal sites with different polyadenylation efficiencies are used in the 
tissue specific regulation of gene expression.  In particular, the D. melanogaster Su(f) 
gene possesses at least three distinct polyadenylation signal sites that are involved in 
mRNA processing, one of which produces a severely truncated transcript that is not 
translated (Audibert and Simonelig 1998).  However, production of the nonfunctional 
transcript is correlated with levels of the functional protein, implying a self-regulation 
mechanism for the gene. 
Two putative regulatory motifs were identified in the bovine 5’UTR.  The 
identified terminal oligopyrimidine tract is a motif consisting of from 5 to15 pyrimidines 
and has been identified in vertebrate ribosomal protein and translation elongation 
factors.  This tract is required for the coordination of translational repression and its 
deletion has been shown to result in unregulated translation (Levy et al. 1991).  This 
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suggests that this region is likely to be involved in the regulation of translation of the 
bovine and mouse genes.  The fact that this motif is not found in human suggests that 
translation of the human gene is controlled by some other mechanism.  In addition to the 
terminal oligopyrimidine tract, the bovine gene also contains an internal ribosome entry 
site or internal regulatory sequence, the function of which is currently under debate.  
This motif is believed to be involved in internal mRNA ribosome binding, which is a 
mechanism of translation initiation that is an alternative to the conventional 5’-cap 
dependent ribosome scanning mechanism.  This mechanism is thought to be 
advantageous for the translation of specific mRNAs during the cell cycle, when under-
phosphorylated eIF-4F prevents the conventional mechanism of initiation of translation.  
Thus, the bovine gene may allow translation to proceed by both mechanisms allowing 
production of the CARD15 protein even during the cell cycle when it is presumably not 
produced in human or mouse. 
Three putative regulatory motifs were detected in the 3’UTR of human, but only 
one was found in bovine and mouse.  The ADH_DRE found in human has been shown 
to produce a 2× down-regulation of ADH gene expression.  The Brd-box motif mediates 
negative post-transcriptional regulation by affecting transcript stability and translational 
efficiency and the GY-box motif is believed to function in concert with the Brd-box 
motif in the mediation of post-transcriptional regulation.  This suggests that one or more 
of these elements are associated with down-regulation of CARD15 expression in human 
and may thus be important elements in susceptibility to Crohn’s disease.  The bovine and 
mouse 3’UTR both contain one 15 LOX-DICE repeat which is known to specifically 
bind regulatory proteins which inhibit mRNA translation.  However, functional 15 LOX-
DICE elements require at least two of these elements and because only a single element 
was found in bovine and mouse, this motif probably has no functional relevance. 
Recent work comparing intronic sequence between human and mouse suggests 
that motifs within conserved sequence within 100 bp of exon boundaries may regulate 
the alternative splicing of exons (Sorek and Ast 2003).  These authors found that intronic 
sequences flanking exons that were constitutively expressed in transcripts from both 
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species were not conserved between the species.  Approximately 200 bases of intronic 
sequence flanking both the 5’ and 3’ ends of each exon of the CARD15 gene in bovine, 
human and mouse were examined.  All of the examined sequences contained low levels 
of conservation between human and mouse with homology ranging from 39-75%.  The 
level of nucleotide conservation within the flanking intronic regions between human, 
mouse and bovine ranged from 21.8-56%.  The hexamer TGCATG has been shown to 
be involved in the regulation of alternative splicing of exons when found in the 
downstream intron (Lim and Sharp 1998; Deguillien et al. 2001).  Sorek and Ast (2003) 
found that this motif occurred 9× more often than expected in the intronic sequences 
downstream of alternatively spliced exons.  The TGCATG motif was found in 4 of the 
22 intronic flanking sequences and in each case the hexamer was detected within 200 
bases downstream of an exon (130 bp from bovine exon 1, 104 bp from human and 98 
bp from bovine exon 4, 27 bp from human, 27 bp from bovine and 27 bp from mouse 
exon 6 (AGCATG in bovine) and 134 bp from human and 130 bp from bovine exon 10).  
Transcript isoforms of the human CARD15 gene have recently been deposited in 
GenBank (Accession nos. AY187233 to AY187246).  These represent partial sequences 
derived from cDNAs, however, they indicate that human CARD15 exons 3, 5, 6 and 7 
are alternatively spliced.  Thus, there must be additional elements, potentially located 
within the exons (such as Exonic Splice Enhancers) responsible for the alternate splicing 
of human exons 3, 5 and 7.  Whether the detected motif is responsible for the regulation 
of alternate splicing of any of the designated exons in these species is a matter that will 
require further investigation. 
In addition to harboring sequence motifs that are involved in the alternative 
splicing of exons, introns have also been shown to harbor other forms of regulatory 
elements.  Giacopelli et al. (2003) found that sequence located in the first untranslated 
exon and first intron of the human osteopontin gene enhanced promoter activity.  Brend 
et al. (2003) identified an enhancer located within the intron of the mouse Hoxb4 gene to 
be sufficient for appropriate temporal activation of expression and the establishment of 
the correct anterior boundary in the paraxial mesoderm.  Borchert et al. (2003) identified 
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negative regulatory elements located within the first intron of the human ph/snGPx gene 
which are involved in the joint regulation of the snGPx and phGPx GPx isoforms.  A 
regulatory mutation within intron 3 of IGF2 results in a threefold increase in expression 
of mRNA when paternally inherited and has quantitative effects on muscle growth, fat 
deposition and size of the heart in pig (Van Laere et al. 2003).  Several short stretches of 
conserved sequence within human, mouse and bovine introns were identified.  These 
conserved regions could be functional regulatory RNA or protein binding regions, or 
could simply be ancient remnants of conserved sequence from the last common ancestor 
of these species.  The unequivocal identification of regulatory elements is challenging 
because these elements are typically short (6–15 bp), they tolerate some degree of 
sequence variation and rules useful for their recognition are generally unknown.  Since 
the divergence of human, mouse and bovine occurred at least 100 mya (Burt et al. 1999), 
it appears likely that unconstrained, nonfunctional genomic sequences would have 
diverged in at least one of the species within this time period.  Consequently, the intronic 
regions found in this study to be conserved between all three species probably have 
functional relevance. 
The mechanism by which CARD15 mutations confer susceptibility to Crohn’s 
disease remains poorly understood.  Since Crohn’s disease is thought to involve an 
abnormal immune response to enteric bacteria in a genetically susceptible individual, it 
is possible that a defect in this signaling pathway is involved in the etiology of the 
disease.  A deficit in CARD15 activity may lead to an impaired ability of the host to 
recognize and respond normally to enteric bacteria.  The mutations associated with 
susceptibility to Crohn’s disease have been shown to result in a deficit in CARD15 
activity in response to the bacterial component muramyl dipeptide.  Consequently, 
further investigation into the existence of genetic variability within the identified 
putative regulatory regions seems warranted since variation in these regions may be 
associated with variation in susceptibility to Crohn’s disease. 
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MUTATION AND ASSOCIATION ANALYSES FOR BOVINE CARD15 
 
Introduction 
 
In vertebrates, the first line of defense against microbial pathogens is mediated 
by the innate immune system.  Toll-like receptors (TLR) are responsible for the initial 
recognition of pathogens and these receptors have been shown to mediate the response to 
pathogen-associated molecular patterns such as lipopolysaccharide (LPS) and 
peptidoglycan (PGN).  Toll-like receptors are composed of multiple extracellular leucine 
rich repeats (LRR) and an intracellular Toll-IL1 receptor domain which mediates a 
signaling cascade to the nucleus.  The plant counterparts to the TLR are the disease 
resistance (R) genes.  These genes also contain LRR and appear to recognize pathogen 
components both at the cell surface and within the cytoplasm.  CARD15 has a structure 
similar to these two classes of genes consisting of an effector domain region (2 caspase 
recruitment domains), a centrally located nucleotide binding/oligomerization domain and 
carboxy-terminal LRR. 
It has been shown that mutant forms of CARD15 lacking the LRR have an 
enhanced ability to activate NF-kB (Miceli-Richard et al. 2001).  Additionally, the LRR 
of CARD15 have been shown to generally recognize bacterial products (Ogura et al. 
2001b) and to confer responsiveness to LPS and PGN (Inohara et al. 2001).  More 
specifically, muramyl dipetide (MDP) from peptidoglycan has been shown to be the key 
component selected by the CARD15 LRR (Girardin et al. 2003, Inohara et al. 2003).  
Specific mutations in the CARD15 gene in human have been shown to be associated 
with Crohn’s disease (Hugot et al. 2001; Ogura et al. 2001) and Blau Syndrome (Miceli-
Richard et al. 2001) two very distinct granulomatous disorders.  The R702W, G908R 
and L1007fsinsC variants associated with Crohn’s disease are associated with a reduced 
level of NF-kB activation in response to MDP in comparison to the normal CARD15 
gene (Girardin et al. 2003; Inohara et al. 2003). 
Whether there is a connection between Crohn’s disease in human and Johne’s 
disease in cattle has been a subject of contention since the diseases were first discovered 
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in the late 1800s.  There are many commonalities between the diseases which support 
the hypothesis that they are related.  For example, both diseases result in diarrhea and 
weight loss and both result in granuloma formation in the ileum.  Additionally, M. ptb. is 
known to be the causative agent for Johne’s disease and in many cases mycobacteria (M. 
ptb. and other spp.) have been cultured from human Crohn’s patient tissues (Chiodini et 
al. 1984; Coloe et al. 1986; Graham et al. 1987; Gitnick et al. 1989; Thorel et al. 1990; 
Collins et al. 2000; Schwartz et al. 2000).  The belief, by some, that the two diseases are 
related and the recently discovered associations between mutations in the CARD15 gene 
and Crohn’s disease make CARD15 an interesting candidate gene for susceptibility to 
Johne’s disease.  In order to evaluate CARD15 as a candidate gene for susceptibility to 
Johne’s disease, it is necessary to elucidate the naturally occurring variation in the gene 
within the cattle population.  DNA sequence including flanking intronic sequence for the 
bovine CARD15 gene was previously reported.  Here, the results of a mutation analysis 
of the CARD15 gene in several breeds and subspecies of cattle and also an association 
study between these mutations and their haplotypes with Johne’s disease is reported. 
 
Materials and Methods 
 
Breed panel.  A breed panel of thirty unrelated cattle was assembled from nine 
domestic cattle populations (White 2003).  The panel comprised: eight Bos indicus 
individuals including 6 Brahman and 2 Gir; and twenty Bos taurus individuals including 
3 Angus, 7 Holstein, 3 Texas Longhorn, 2 Limousin, 3 Jersey and 2 N’Dama.  Two 
Ankole-Watusi animals which represent an ancient taurus × indicus cross were also 
included in the panel. 
 
Panel diagnosed with Johne’s disease.  In addition to the above mentioned 
breed panel, a panel of 11 DNA samples from animals that had been visually examined 
and diagnosed by a veterinarian with Johne’s disease was assembled.  Eight tissue 
samples were purchased from Dr. Michael Collins (University of Wisconsin) and 
included: three unrelated Holstein calves that had been experimentally infected with M. 
ptb. at 1 mo of age, one Holstein female that had been an embryo transfer recipient and 
79 
was determined to have the disease after her calf was found to be infected; one Holstein 
that was a clinical Johne’s case and that was found to be ELISA positive on repeated 
assay; one Holstein that was culture positive; and two Jerseys, one of which had a low 
grade infection based on tissue M. ptb. counts.  Three samples were kindly provided by 
Dr. Allen Roussel (Texas A&M University) and included one Holstein, Jersey and 
Brahman. All of the latter animals were both ELISA and culture positive. 
 
DNA extractions.  DNA was extracted from tissue samples received from Dr. 
Michael Collins (ileum, spleen, lymph node, lung) using the following protocol.  
Approximately 500 mg of tissue that had been flash frozen was ground using a mortar 
and pestle and resuspended in 5 ml of saline EDTA.  To this was added 360 µl of saline 
EDTA, 180 µl Proteinase K and the sample was incubated at 55°C while being rotated 
overnight.  The samples were then extracted twice with phenol-chloroform and 
precipitated with 450 µl 3M sodium acetate and 14 mL of 95% ethanol.  Samples were 
incubated at room temperature for 2 hr and then washed with 10 mL of ice-cold 70% 
ethanol.  The samples were centrifuged for 5 min at 2000 rpm and the alcohol removed.  
The samples were then placed in a SpeedVac and allowed to dry for approximately 1 hr.  
The dried pellets were resuspended in 500 µl of TE and placed in a 37°C water bath 
overnight.  The samples were then allowed to rotate for 1 hr and were quantified using a 
spectrophotometer. 
 
PCR and sequencing.  To screen the breed panel for the presence of 
polymorphisms, each exon of CARD15 along with a small amount of flanking intronic 
sequence was amplified in every individual and sequenced in the forward and reverse 
directions.  The primers developed for the amplification of the individual exons in Bos 
taurus, Bos indicus and Bison bison (Table 7) were amplified in a 50 µl volume: 15 mM 
Tris, 50 mM KCl, 1.5 mM MgCl2+, 200 µM of each dNTP (dATP, dCTP, dGTP and 
dTTP), 1 µM each primer, 50 ng DNA, 0.5 units of AmpliTaq Gold DNA Polymerase 
(Applied Biosystems, Foster City, Calif.).  The general PCR reaction included an initial 
hot start of 10 min at 95°C followed by 35 cycles for 30 s at 94°C, 30 s at the optimized 
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annealing temperature and 45 s at 72°C, followed by a final elongation step at 72°C for 7 
min.  The PCR products were analyzed by electrophoresis on 2% agarose gels in 1.0× 
TBE buffer (90 mM Tris/64.6 mM boric acid/2.5 mM EDTA, pH 8.3) and stained with 
ethidium bromide.  The PCR product was purified using QIAquick® (Qiagen, Valencia, 
Calif.) spin columns. 
Cycle sequence reactions were performed in a 10 µl reaction volume: 1 µl Big 
Dye v3.0 (Applied Biosystems), 10 ng amplified DNA, 0.5 µl of 5% dimethylsulfoxide 
(DMSO), 0.5 µl of 20 µM primer.  The general cycle sequence reaction included an 
initial denaturation step of 2 min at 96°C followed by 35 cycles for 15 s at 96°C, 20 s at 
50°C and 4 min at 60°C, followed by a final elongation step at 60°C for 15 min.  
Unincorporated nucleotides and primers were removed from the reactions using a 
BioMax® Spin-50 mini- sephadex column (Millipore Corp., Bedford, Mass.).  
Sequencing reactions were run on an ABI 3100 DNA analyzer (Applied Biosystems). 
All identified single nucleotide polymorphisms (SNPs) were validated by 
performing a second PCR and resequencing the produced amplicon in both the forward 
and reverse directions.  This approach was used in order to reduce the risk of reporting 
PCR artifacts as polymorphisms. 
 
SNP detection.  The sequences acquired for each animal were aligned using 
Contig Express in Vector NTI (Informax, Frederick, Mar.) and were examined for 
sequence variation against each other and the consensus Bos taurus CARD15 sequence 
(Fig. 4).  This approach allowed us to identify polymorphisms within both the coding 
and flanking intronic sequences for each individual exon. 
 
Haplotype determination.  Haplotyper (Niu et al. 2002) was used to predict 
haplotypes for each individual from the genotype data.  This analysis was performed 
using all 41 animals from the breed and Johne’s panels simultaneously.  SNPtagger was 
then employed to determine the minimum number and position of SNP markers 
necessary to distinguish among the observed haplotypes (Ke and Cardon 2003). 
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Results 
 
SNPs in the breed panel.  Thirty-six SNPs were identified in a thirty animal 
breed panel from a total of 6176 bases examined (Fig. 14).  Nineteen SNPs were located 
in the translated portion of the gene (cSNPs) and, of these, eight were nonsynonymous 
and caused amino acid substitutions (nsSNPs).  Of the remaining SNPs, ten were located 
in intronic sequence and seven within the last 500 bases of the 3’UTR.  All identified 
SNPs are presented in Table 13.  Each SNP is described relative to the reference allele 
present in the originally generated taurus sequence.  SNPs located within intons are 
identified by reference to the nearest coding region.  For example, E2(-32) refers to a 
SNP 32 bp upstream of exon 2, while E8(+12) refers to a SNP 12 bp downstream of 
exon 8. 
Included in the polymorphism survey was a total of 1071 bp of intronic sequence 
flanking the CARD15 exons.  Table 14 indicates the number of flanking bases surveyed 
for each exon.  Of the SNPs identified in the intronic regions of the bovine CARD15 
gene, two appear to be within potential regulatory regions and therefore may have a 
functional role.  The E2(-32) SNP is located within a 7 bp motif (AGAAGcC) detected by 
homology between human, mouse and bovine (Table 12).  The bolded ‘G’ indicates the 
SNP site, while the lower case ‘c’ represents a mismatch in the sequence motif between 
human, mouse and bovine.  Further, the E3(-6) SNP is located within the first 6 bases 
upstream of exon 3 and the high level of conservation of these closely flanking 
sequences is thought to be involved in the regulation of intron splicing (Sorek and Ast 
2003).  Complete sequence data for intron 5 and revealed that this intron was completely 
conserved among all individuals.  This was a surprising finding and again, this high level 
of sequence conservation may be related to the regulation of splicing. 
Of the thirty-six identified SNPs, twenty-four segregate in only one of the 
subspecies, eight segregate in both (in 3 cases only one taurus individual, a longhorn, 
was segregating) and four had subspecies specific alleles.  For five of the loci, all indicus 
animals were alternate homozygotes at the SNP locus.  Segregation of SNP loci by 
subspecies is reported in Table 13.  Examining the polymorphisms by protein domain, 
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Figure 14.  Location of SNP loci within bovine CARD15.  Arrows 
indicate the location of nonsynonymous coding SNPs. 
5 6 7 8 9 10 11 12 & 3’UTR43 1 2 
CARD CARD NOD LRR
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Table 13.  Characteristics of bovine CARD15 SNP loci 
SNP position 
and allelesa 
Domain 
affectedb 
Amino 
acid 
Segregatingc Allele 
frequencyd 
     T      I 
E2(-32)  G/A PRR  T&I 0.5    0.75 
208      A/G CARD1 T70A T&I (LH) 0.98   0.5 
363†      C/T CARD2 121 I 1      0.75 
E3(-6)  G/A/C Splice site  T&I 0.8    0.38 
E4(-58)  C/T Intron  T 0.92   0 
E4(-22)  A/G Intron  T 0.92   0 
E4(-16)  T/G Intron  T 0.92   0 
570†      T/C CARD2 191 I vs T 1      0 
586†      G/A LIBD V196M I 1      0.13 
873†      C/A NOD 291 I 1      0.94 
969†      C/T NOD 324 I 1      0.88 
1194†     C/T NOD 398 AK (0.75) 1      1 
1514†     C/A NOD T505N I 1      0.13 
1569†     T/C NOD 523 I 1      0.31 
1723†     T/C LIBD C575L I 1      0.44 
1992†     G/A LIBD 664 I 1      0.81 
2042†     G/A LIBD R681Q I 1      0.25 
2066†     G/A LIBD R689H I 1      0.13 
2145†     C/T LRR 715 I vs T 1      0 
2197†     T/C LRR C733R I vs T 1      0 
2364†     C/T LRR 788 T&I 0.98   0.19 
E5(-11) †  T/A Intron  T 0.95   1 
2481†     G/A LRR 827 AK (0.5) 1      1 
E8(+12) †  T/A Intron  T 0.88   0 
2787†     C/T LRR 929 I 1      0.88 
E11(-14) † A/G Intron  T 0.85   1 
E11(-8) †  C/T Intron  T&AK(0.75) 0.97   1 
E12(-6) †  C/T Intron  T&I 0.9    0.14 
3020†     A/T LOD Q1007L T&AK(0.25) 0.88   1 
4648     C/A 3’UTR (PRR)  T 0.83   1 
4757     G/A 3’UTR (PRR)  T&I (LH) 0.97   0.25 
4798     A/G 3’UTR (PRR)*  T&I 0.8    0.17 
4801     A/T 3’UTR (PRR)*  T&I (LH) 0.95   0.17 
4911     A/G 3’UTR (PRR)  I 1      0.83 
5010     A/T 3’UTR  T 0.93   1 
5098     C/T 3’UTR (PRR)  T 0.93   1 
aLoci in bold face represent nonsynonymous mutations. † = Loci used to 
estimate haplotypes. 
bPRR = Putative Regulatory Region. LIBD = Located in-between domains. 
LOD = Located outside of last domain. * = Located within the same 
regulatory motif. 
cLH = Segregating in one Texas Longhorn (taurus) animal. AK = Ankole-
Watusi. 
dFrequency of the Bos taurus wild type allele in Bos taurus (T) and 
in Bos indicus (I). 
84 
 
 
 
 
 
 
 
 
 
 
 
Table 14.  Size of sequenced bovine CARD15 intronic flanking regions 
5’ flank 
(bp) 
Exon 3’ flank 
(bp) 
61 2 19 
29 3 53 
64 4 107 
12 5 210a 
210a 6 86 
11 7 76 
24 8 21 
23 9 109 
26 10 27 
24 11 40 
49 12  
aThe entire 210 bp of intron 5 was 
sequenced. 
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reveals one site in CARD1, two sites in CARD2, 5 sites in the NOD and 5 sites in the 
LRR which harbor a total of 13 SNPs.  Six SNP sites are located outside of domains and 
7 sites were found within the 3’UTR (Table 13).  Allele frequencies by subspecies 
reported in Table 13 are relative to the wild type allele detected within Bos taurus for 
each SNP.  Sequence that included the SNPs located within intronic regions and in the 3’ 
and 5’UTRs were analyzed using NSITE (available through SoftBerry at 
http://www.softberry.com/berry.phtml?topic=promoter) to identify putative regulatory 
motifs.  Regions identified by the software to have homology to known regulatory 
regions are presented in Table 15. 
A chi-squared test revealed that the frequency of synonymous and 
nonsynonymous (cSNPs) substitutions was greater in the indicus than the taurus 
population (χ2 = 84.53; 2 df).  Chi-square tests were also used to reveal that the 
frequency of synonymous substitutions was the same as the frequency of 
nonsynonymous substitutions within indicus but the frequency of nonsynonymous 
substitutions greatly exceeded the frequency of synonymous substitutions in taurus.  The 
numbers of synonymous and nonsynonymous cSNP substitutions within each subspecies 
are reported in Table 16. 
Association tests.  Within each subspecies, association tests were first performed 
by testing for SNP allele frequency differences between the group of animals in the 
breed panel (control group) and the group of sick animals (case group).  Of the examined 
SNPs, 4 loci indicated a significant difference in allele frequency between the sick and 
control groups.  Within taurus, the frequency of the wild type allele for E2(-32) was 1 in 
the case group and 0.5 within the control group (χ2 = 10.8; 1 df).  Also within taurus, the 
frequency of the wild type allele for 3020 was 0.6 in the case group and 0.875 in the 
control group (χ2 = 4.43; 1 df).  Both E4(-58) and E4(-16) revealed allele frequency 
differences between the indicus control and case groups(χ2 = 4.73; 1 df); however, there 
was only a single animal within the case group and the genotype of this animal was 
atypical of the indicus genotypes within the control group for many of the loci. 
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Table 15.  Putative regulatory motifs harboring SNPs within  
the bovine CARD15 3’UTR 
SNP Motif a TRANSFAC 
Accession # 
4648 CTCcCTCcaTTC R02081 
 TCCcTCCAtTCT R02372 
 CctCCATTCTCT R04351 
4757 GAATTTAATTAg R00964 
 TCTtAGcTG R02003 
 TAAtTCtTAgCTGA R02819 
4798 CAAGgTAgAAtCGG R03055 
4801 CAAGgTAgAAtCGG R03055 
4911 GAATTTAtTTtA R00964 
5098 ATTtGCT R01443 
 TAcaTTTGCTaA R02046 
aBold face nucleotide represents position of SNP in 
motif.  Lower case represents sequence mismatches 
between bovine sequence and regulatory motifs. 
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Table 16.  Synonymous and nonsynonymous substitutions at cSNPs within  
bovine CARD15 
Subspeciesa 
Synonymous 
substitutionsb 
Nonsynonymous 
substitutionsc 
Bos taurus (N=30) 1/360 (0.28%) 9/240 (3.75%) 
Bos indicus (N=9) 18/108 (16.67%) 16/69 (23.19%) 
aNumber of animals in parentheses. 
bNumber of synonymous substitutions/Number of 
genotypes at 12 sSNPs. 
cNumber of nonsynonymous substitutions/Number of 
genotypes at 8 nsSNPs. 
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Associations between CARD15 and disease status were next tested by examining 
differences in the frequencies of heterozygotes, homozygous mutants and heterozygotes 
+ homozygous mutants across SNP loci.  Tests were also performed for differences in 
the frequency of mutant alleles across SNP loci between the case and control groups. 
These analyses were performed at four levels of locus stratification:  by considering all 
loci, ncSNPs, synonymous cSNPs and nonsynonymous cSNP loci.  Within Bos taurus, 
there was no effect of multi-locus heterozygosity at CARD15 SNP loci on the likelihood 
of being classified within the case or control groups.  However, there was a higher 
frequency of mutant alleles among the control group animals computed across all SNP 
loci (0.05 in control and 0.02 in case; χ2 = 12.1; 1 df) due in large part to a large 
difference in the ncSNPs (0.11 in control and 0.03 in case; χ2 = 17.0; 1 df).  There was 
also a difference in allele frequency for sSNPs, but for this class the frequency of mutant 
alleles was greater in the case group (0.002 in control and 0.03 in case; χ2 = 4.8; 1 df).  
These allele frequency differences produced an increase in the frequencies of 
homozygous mutants and heterozygous + homozygous mutants in the case group for the 
ncSNPS and in homozygous mutants + heterozygotes for all SNPs.  No associations 
were found between any mutant allele or genotype characteristic for nsSNPs.  Within the 
Bos indicus population, there was a higher frequency of mutant alleles within the case 
group for all loci (0.11 in control and 0.36 in case; χ2 = 32.5; 1 df), ncSNPs (0.08 in 
control and 0.34 in case; χ2 = 18.2; 1 df), sSNPs (0.21 in control and 0.42 in case; χ2 = 
4.1; 1 df) and nsSNPs (0.09 in control and 0.31 in case; χ2 = 4.2; 1 df).  These 
differences also resulted in differences in genotypic frequencies, however, as previously 
discussed, there was only a single animal within this case group and the genotype of this 
animal was not typical of the control Bos indicus genotypes at most of the SNP loci. 
Finally, the control and case groups were examined for differences in haplotype 
frequencies.  For haplotype estimation, loci with missing genotypes were removed, 
leaving 23 of the original 36 loci which included all but one of the cSNPs (Table 13). 
 
 
89 
 
 
 
 
Table 17.  Bovine CARD15 haplotypes estimated for 23 SNP loci 
Population Control Case Total frequency Haplotype 
Taurus  24 10 .415 00000000000000000000000 
Taurus 2  .024 00000000000000000000010 
Taurus 6 2 .098 00000000000000000001000 
Taurus  4 8 .146 00000000000000000000001 
N’Dama 2  .024 00000000000000000100000 
Longhorn 1  .012 00000000000000100000101 
N’Dama 2  .024 00000000000000010100010 
Ankole 2  .024 00000000000000001000001 
Ankole 1  .012 00000100000000000000101 
Indicus 2  .024 01100011001111100100010 
Indicus 3  .037 01100011111111100100010 
Indicus 2  .024 01100010101111100100010 
Indicus 1  .012 01100011101111100100010 
Indicus 1  .012 01100011100111100100010 
Indicus 1  .012 01100011100111000100010 
Indicus 2  .024 11100011001111100100010 
Indicus 1  .012 11100011001111100110000 
Indicus 1  .012 11100010101111100100000 
Indicus 1  .012 01001000000011000110000 
Indicus 1  .012 01011000000011000100000 
Indicus  0 1 .012 11001000111111000100010 
Indicus  0 1 .012 11101010010011100110000 
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Twenty-two haplotypes were predicted by Haplotyper (Niu et al. 2002) from a total of 
41 animals and these are reported in Table 17.  All haplotypes were subspecies specific 
with four unique haplotypes explaining the diversity within 28 Bos taurus animals and 
13 unique haplotypes explaining the diversity within 9 Bos indicus animals.  One unique 
and three of the Bos taurus haplotypes were predicted in Texas Longhorn, while two 
unique haplotypes were each predicted in N’Dama and Ankole.  Loci that were not 
included in the haplotype analysis include cSNP 208, all of the 3’UTR SNPs and the 
SNPs from introns 1 and 3.  It was impossible to complete genotypes for all animals for 
these loci due to depletion of the available DNA samples.  To test for haplotypic 
associations with Johne’s disease the animals were again separated by subspecies but 
excluded the Texas Longhorn, N’Dama and Ankole-Watusi animals from the Bos taurus 
control group due to the presence of haplotypes that were not represented within the Bos 
taurus case group, which comprised Holsteins and Jerseys.  Despite the presence of 
unique indicus haplotypes within the case Bos indicus animal, no significant association 
between haplotypes and the risk of Johne’s disease was found in either the Bos taurus or 
the Bos indicus animals. 
Tagged SNPs.  SNPtagger (Ke and Cardon 2003) was used to identify the 
minimum number of SNPs required to completely represent the diversity represented 
within the predicted haplotypes in Table 17.  Only 14 of the 23 SNPs must be scored in 
order to completely predict these 22 haplotypes (Table 18).  However only three loci are 
required to generate the haplotypes for Bos taurus if Texas Longhorn, N’Dama and 
Ankole-Watusi are excluded.  Including these breeds requires the use of 7 SNP loci.  A 
total of 7 SNPs are required to regenerate the 13 haplotypes found in Bos indicus. 
Eight PCR reactions are required to amplify the fragments harboring the 14 SNPs 
required to distinguish all 22 predicted haplotypes.  Three PCR reactions are required to 
amplify the 7 SNP sites represented in the Bos indicus assay and 5 PCR reactions are 
required to amplify the 7 SNP sites to distinguish all Bos taurus haplotypes.  If N’Dama 
and Ankole are excluded, only 2 PCR reactions are required to assay the SNPs required 
to distinguish among the Bos taurus (including Texas Longhorn) haplotypes.  A list of 
91 
 
 
 
 
 
 
 
 
Table 18.  SNPs within bovine CARD15 predicted to discriminate among Bos 
indicus and Bos taurus haplotypes 
         
SNPa Sense 5' to 3' 
 
Antisense 5' to 3' 
 
Anneal 
Temp 
Approx. 
product 
size 
363**  CTCAGTTTGAACACCTGTACAATGG AGGAGGACTATGACCCACATCTC 52 690 
570 TGGGTTCCTACCTGCAAAAC CACTGAGGGCGAGGTAGAAT 52/1min ext 2250 
1194* CAGTCCAGAGTCTGCTCTTCAAC GCCATTCCATGAATTTCAACTATC 55/1min ext 1360 
1569** ‘’ ‘’ ‘’ ‘’ 
1723** ‘’ ‘’ ‘’ ‘’ 
1992** ‘’ ‘’ ‘’ ‘’ 
2042** ‘’ ‘’ ‘’ ‘’ 
2364** ‘’ ‘’ ‘’ ‘’ 
2481* GTCTCTGTGGGGGTTTTGTC GTCCTTGTTTTCAGCGAGGT 55 500 
E8(+12)* CACTTGCTGGGACCTGAGT CCCTCCTCACACTGGCTTC 53 200 
2787** GCATTTTGCCCTTCTTGAGT ACGCAGTCATCCATCTTGGT 53 200 
E11(-14)* CCAGCTCCCAAAGTCTCCTT GAGGCTCAGAGAGGTTAAAGAGG 53 200 
E11(-8)* ‘’ ‘’ ‘’ ‘’ 
E12(-6)* AGGTTTACAAAGCAGCATCTTCC ATGTCACCTGTCCCCTTTCA 58/1min ext 750 
3020* ‘’ ‘’ ‘’ ‘’ 
aAll loci except 1194 are used to distinguish the 22 haplotypes present in Bos indicus and Bos taurus. * = SNPs used in 
the Bos taurus assay including Texas Longhorn, N’Dama and Ankole. Bolded SNPs used in the Bos taurus assay 
excluding Texas Longhorn, N’Dama and Ankole. ** = SNPs used in the Bos indicus assay. 
92 
the SNPs required for each assay and of the primers required to amplify the regions of 
bovine CARD15 harboring these SNPS are presented Table 18. 
 
Discussion 
 
A panel of cattle was surveyed representing 9 different breeds and 2 subspecies 
in order to gain insight as to the extent of natural variation within the bovine CARD15 
gene.  All 12 exons were examined including the coding region of the gene (3042 bp), 
the 5’UTR which includes the first exon and 8 bp of the second exon (148 bp), the 
3’UTR comprising the last 1988 bp of exon 12 and 1071 bp of flanking intronic 
sequence.  Obtaining this sequence required 14 separate PCR reactions and 28 
sequencing reactions.  From this sequence, 36 SNP sites were identified in 6176 bp 
indicating a SNP, on average, every 172 bases (including flanking intronic sequence).  
Twenty-six SNPs were found in the 5105 bp transcript, indicating a SNP, on average, 
every 196 bp.  These results are consistent with previous reports for the rate of 
occurrence of SNPs within bovine coding sequence (Heaton et al. 2001). 
Genetic heterozygosity is thought to enhance the resistance of hosts to infectious 
diseases.  For example, it is believed that heterozygosity at the MHC loci may enhance 
resistance to infectious diseases by increasing the diversity of antigens presented to T 
cells (Doherty and Zinkernagel 1975).  Furthermore, it has been shown that diversity in 
the leucine rich repeat region (LRR) of the plant disease resistance genes allows for 
recognition of different pathogen components (Parniske et al. 1997).  Although it is 
difficult to make definitive conclusions because of the small sample size employed in 
this study, a significantly higher rate of synonymous and nonsynonymous substitutions 
within Bos indicus than in Bos taurus was found which is consistent with previous 
findings (MacHugh et al. 1997) and the fact that Bos indicus cattle are known to possess 
greater disease and parasite resistance than Bos taurus cattle.  There was also a 
significantly higher rate of nonsynonymous to synonymous substitutions in Bos taurus 
indicating that positive Darwinian selection is acting on the gene within this subspecies.  
Within Bos indicus, the rate of nonsynonymous substitutions the same as the rate of 
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synonymous substitutions indicating selective neutrality.  Due to the small sample size 
and admixture of breeds within both the Bos taurus and Bos indicus samples, the 
individual loci were not tested for Hardy-Weinberg equilibrium.  However, visual 
inspection of the data suggested a deficit of heterozygotes within each of the loci.  This 
was further reinforced when the program Haplotyper was used to infer haplotypes based 
upon all 36 SNP loci.  The data contained missing data for animals whose DNA samples 
had been exhausted and Haplotyper invariably estimated the missing genotypes to be 
heterozygotes, presumably because the underlying model assumes panmixia, although 
Niu et al. (2002) indicate the program can be used for inference within stratified 
populations.  For this reason, loci with missing data (predominantly ncSNPs) were 
dropped from the haplotype analysis reducing the number of SNPs to 23 used to infer 
haplotypes. 
In human, mutations within the NBD are associated with Blau Syndrome and 
mutations in the LRR are associated with Crohn’s disease.  Five mutation sites were 
identified, including one nonsynonymous site, in each of the NOD and LRR domains.  In 
human, the mutations associated with Crohn’s disease are believed to result in a defect in 
recognition of pathogen components resulting in aberrant NF-kB activation.  If this is the 
case, variation in gene expression mediated by the efficiency of transcription, mRNA 
stability or translation may also result in the aberrant activation of NF-kB.  Variation in 
regulatory regions of the gene that result in a reduction of CARD15 protein may mimic 
the effects of the human CARD15 mutations in the LRR that are associated with Crohn’s 
disease.  This prompted the examination of the 5’ and 3’UTRs which are known to be 
important regulatory regions of genes.  Intronic sequences that flank CARD15 were also 
examined since these regions have recently been shown to harbor regions responsible for 
the regulation of alternative splicing of exons. 
Two interesting SNPs were found within the CARD15 flanking intronic regions.  
E2(-32) is located in a short motif of 7 bp that is conserved in human, mouse and bovine.  
Known regulatory binding motifs consist of 5-15 nucleotides and have tolerance for 
mismatches located within the sequence.  Thus, it is possible that the E2(-32) SNP 
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creates variability within an important regulatory region in the cattle CARD15 gene.  
SNP E3(-6) was identified which falls within 6 bases of the start of the third exon.  
Sorek and Ast (2003) found evidence that the first seven bases flanking the 5’ end of an 
exon are involved in the regulation of splicing of the intron which makes this an 
interesting SNP from the perspective of regulating the production of protein isoforms.  
No SNPs were found within the 5’UTR among the cattle tested which suggests that 
conservation of this region is necessary to preserve function in cattle.  However, the 
5’UTR was not conserved between human, mouse and bovine and since this region is 
important for the effective translation of the gene, the mechanisms for accomplishing 
this have evolved differently among the species.  An additional 7 SNP sites were 
identified within the last 500 bases of the 3’UTR.  The bovine 3’UTR does not align 
with human or mouse and contains additional sequence not found in these species.  
Thus, this region of the bovine gene may be free to evolve, or it may have evolved new 
functional elements for the regulation of transcript expression, localization or stability.  
While there are no recognized 3’UTR regulatory elements in this region, the sequence 
was scanned for known regulatory motifs and 6 of the 7 SNPs were within sequence 
motifs known to regulate transcription. 
In the association studies, the frequency of the E2(-32) ‘G’ allele was 
significantly greater in the Bos taurus case group than in the control group.  In fact, this 
allele was fixed within the case group but only at a frequency of 50% among the controls 
where all genotyped individuals were homozygotes.  If this locus plays a role in 
susceptibility to Johne’s disease, the lack of complete penetrance suggests that 
susceptibility is either polygenic, environmentally influenced or that the remaining GG 
and control animals were not exposed to the mycobacterium.  However, it seems most 
likely that this locus is free to evolve and that it was the small sample size alone that led 
to the spurious association. 
The lone Brahman animal within the Bos indicus case group had a multilocus 
genotype that was not typical of the Bos indicus animals with the control group.  This 
animal tended to be either heterozygous (8 out of 23 loci included in the haplotype 
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analysis) or homozygous for Bos taurus alleles suggesting that the animal may have 
been a hybrid at the CARD15 locus.  This sample size effect made impossible any 
meaningful association analysis within Bos indicus.  However, it is nevertheless 
interesting to note that the single Bos indicus animal with Johne’s disease was 
genetically extremely dissimilar to its Bos indicus control counterparts at the CARD15 
locus. 
Haplotype analysis has recently gained favor for application in genome-wide 
association studies due to the increase in power that can be achieved through the 
integration of information at closely linked SNP loci.  In this study, the Bos taurus 
haplotypes were fewer in number and completely distinct from the Bos indicus 
haplotypes.  Only four haplotypes were found among the Angus, Limousin, Jersey and 
Holstein breeds and this number increased to 5 with the addition of Texas Longhorn, 7 
with the addition of N’Dama and 9 with the addition of Ankole-Watusi.  Conversely, 13 
distinct haplotypes were found among the 9 Bos indicus animals.  It is well known that 
there is more genomic diversity among Bos indicus than among Bos taurus, however, 
why this is the case is unclear.  It may reflect the relatively recent history of 
development of the Brahman breed which involved crossing among Nellore, Gir and 
Guzerat along with grading-up from crosses to various Bos taurus breeds.  On the other 
hand, the Bos taurus breeds represented in this study have been within the U.S. for many 
more generations than Bos indicus cattle, have been maintained as pure breeds and have 
been under effective selection for various production traits for at least 20 generations.  
Nevertheless, no associations between CARD15 haplotypes and the prevalence of 
Johne’s disease were found in this study. 
Finally it is important to consider the inherent difficulty of designing experiments 
to unequivocally determine the identities of genes involved (or not involved) in 
resistance to diseases which require some type of environmental exposure and where 
resistance may be polygenic.  First consider the issues underlying phenotype definition 
in both the control and case animals.  For many diseases, it is difficult to define the 
phenotype associated with disease.  In the case of Johne’s disease, some animals respond 
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positively to ELISA and culture tests, but never display any clinical signs of the disease.  
These animals have clearly been infected with the causal agent and are able to propagate 
the spread of the pathogen but whether or not they will ever develop clinical indications 
of disease is uncertain.  Should these animals be classified as having Johne’s disease 
when the definitive diagnosis of Johne’s disease requires necropsy?  Similarly, animals 
will be identified that respond negatively to ELISA and culture tests and thus clearly 
have not been infected by M. ptb. and will not develop Johne’s disease based upon their 
current status.  However, it is not clear if these animals have ever been exposed to the 
pathogen or whether they were exposed at some stage and were resistant to infection.  
Thus, these control animals may either be susceptible animals that would have 
developed an infection had they been exposed or they are genetically resistant.  
Consequently, the control group of animals will usually represent an admixture of 
genotypes that are representative of susceptible and resistant animals. 
It may be acceptable to characterize animals as being subclinically infected if 
they shed <10 cfu/g feces and clinically infected if they shed >100 cfu/g feces (Stabel 
pers. comm.).  While this phenotype may be useful from the perspective of identifying 
genes responsible for the elimination of the mycobacterium if control of spread of 
disease is considered the goal, it may not be wholly appropriate for management of 
productivity loss if the infected animals progress to express clinical signs of the disease.  
Ideally, the phenotyping of animals should be based upon their development of 
granulomas in the ileum rendering the animal inefficient and resulting in weight loss and 
low productivity.  However, the impracticality of this approach is not only economic, but 
also because of the slow onset of disease in infected animals.  It is for these reasons that 
animals were only included in this study that had either been necropsied and confirmed 
to have Johne’s disease, or that tested ELISA and culture positive and were exhibiting 
clinical signs of Johne’s disease. 
Even in the presence of the perfect experimental design including true controls 
(exposed but not infected) and true Johne’s disease cases, there remains a significant 
problem in the event that disease resistance or susceptibility is polygenic, epistatic or 
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requires some unknown environmental stimulus.  In the case of polygenic or epistatic 
inheritance, several genetic architectures may lead to the expression of the phenotype of 
interest and very large populations are required to elucidate the genetic mechanisms 
underlying the disease phenotype.  Of course, this may also require a whole genome 
association study to be performed to detect the effects of trans-acting mutations. 
Considering all of these issues, the naturally occurring variation present in the 
bovine CARD15 gene in Bos taurus and Bos indicus animals is reported.  A complete 
survey of SNPs in 11 diseased animals was performed and then characteristics of these 
loci between the diseased animals and those animals present in the breed panel were 
compared.  There was no overwhelming evidence for a simple causal relationship 
between variation in the bovine CARD15 gene and Johne’s disease.  However, the small 
sample size, the admixture of breeds present in the control group and the fact that no 
animal within the control group was challenged with M. ptb. could easily have conspired 
to obscure a causal genetic relationship between CARD15 and disease.  Consequently, it 
is important to utilize the SNP loci developed in this study to screen larger populations 
of animals in which a more robust experimental design has been possible in terms of 
breed composition and phenotype definition of the control group membership. 
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CONCLUSIONS AND DISCUSSION 
 
In these studies, the bovine CARD15 gene has been characterized and tools have 
been made available for future researchers working in livestock disease resistance.  The 
first study provided the nucleotide sequence and genomic localization for the previously 
unidentified bovine CARD15 gene.  Both should prove useful in future QTL or 
candidate gene studies targeting genes associated with disease resistance or 
susceptibility.  An assay has been developed mRNA expression profiles have been 
provided for the bovine CARD15 gene in a large variety of tissues, which should prove 
useful in future mRNA expression studies involving the bovine CARD15 gene. 
In the second study, a comparative sequence analysis of the bovine CARD15 
gene to its human and mouse homologs is provided.  In this analysis sequence for 
flanking intronic regions that have not previously been examined is included.  High 
levels of sequence conservation within the coding portion of the gene is reported, but 
very low levels of interspecies conservation in both of the UTRs and in the flanking 
intronic sequence with the exception of several short, conserved motifs (6-19 
nucleotides).  These conserved motifs could function as putative regulatory regions and 
homology in the regions harboring these motifs to previously identified regulatory 
motifs is reported.  Information is provided concerning diversity of the UTRs among the 
species, including an additional 100 bases in the mouse 3’UTR and more than 700 
additional bases in the bovine 3’UTR when compared to human.  Multiple unique 
polyadenylation signal motifs in all three species were identified.  Furthermore, it is 
reported that the bovine CARD15 gene possesses only one in-frame translation initiation 
site, whereas both the mouse and human forms of the gene have 2 such sites.  Finally, it 
is demonstrated that the 3’ and 5’UTRs in all three species contain different regulatory 
motifs.  Considering that the UTRs of genes often contain key regulatory elements 
involved in the transcriptional and post-transcriptional regulation of gene expression, 
these interspecies differences are perhaps indicators that these genes have evolved to 
meet particular, but different regulatory needs in each organism. 
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In the third study, a survey of the extent of natural variation present in the bovine 
CARD15 gene is provided and association analyses between these mutations and 
Johne’s disease is performed.  This will prove a useful tool in future comparisons 
involving this gene and disease resistance or susceptibility.  There is no overwhelming 
evidence for a simple causal relationship between variation in the bovine CARD15 gene 
and Johne’s disease.  However, a large number of polymorphisms located within the last 
500 bases of the 3’UTR are reported.  While homology in this region to typical 3’UTR 
regulatory elements was not detected, homology to short protein binding motifs typically 
found in enhancers was identified.  It is possible these regions possess regulatory 
functions not commonly ascribed to the 3’UTR.  Future studies testing hypotheses 
concerning the role of the 3’UTR in the enhancement or repression of the CARD15 
transcript appear to be interesting and warranted.  Sets of SNPs are provided which are 
completely predictive of multi-locus haplotypes in Bos taurus and Bos indicus which 
may be used to screen populations in future disease resistance association studies. 
Overall, these studies provide a foundation for future studies addressing the role 
of CARD15 as an intrinsic disease resistance gene.  Although no overwhelming 
evidence for a simple causal relationship between variation in the bovine CARD15 gene 
and Johne’s disease was found, the relationship could have been masked due to the small 
sample size and lack of control animals known to have been exposed to M. ptb.  
Consequently, it is important to utilize the SNP loci developed in this study to screen 
larger populations of animals in which a more robust experimental design has been 
possible in terms of breed composition and phenotype definition of the control group 
membership.  If the mutations identified in this study are not associated with 
susceptibility to Johne’s disease then other regions of the gene such as the introns and 
the promoter should be interrogated for polymorphisms before discounting CARD15 as 
a candidate gene.  Therefore, the gene remains an excellent candidate gene for disease 
resistance in cattle and its associations with other disease phenotypes should now be 
considered. 
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